background	NN	ROOT
:	:	punct

patentee	NN	nsubj
bring	VBD	ROOT
action	NN	dobj
allege	VBG	acl
infringement	NN	dobj
of	IN	prep
-PRON-	PRP$	poss
patent	NNS	pobj
relate	VBG	acl
to	IN	prep
extended	JJ	amod
release	NN	compound
formulation	NNS	pobj
of	IN	prep
clarithromycin	NN	pobj
.	.	punct

the	DT	det
United	NNP	compound
States	NNP	compound
District	NNP	compound
Court	NNP	nsubj
for	IN	prep
the	DT	det
Northern	NNP	compound
District	NNP	pobj
of	IN	prep
Illinois	NNP	pobj
,	,	punct
David	NNP	compound
H.	NNP	compound
Coar	NNP	conj
,	,	punct
J.	NNP	appos
,	,	punct
2005	CD	nummod
WL	NNP	nmod
1323435,granted	CD	nummod
patentee	NN	poss
's	POS	case
motion	NN	appos
for	IN	prep
a	DT	det
preliminary	JJ	amod
injunction	NN	pobj
,	,	punct
and	CC	cc
defendant	NN	nsubj
appeal	VBD	ROOT
.	.	punct

 	_SP	

the	DT	det
Court	NNP	nsubj
of	IN	prep
Appeals	NNPS	pobj
,	,	punct
Prost	NNP	npadvmod
,	,	punct
Circuit	NNP	compound
Judge	NNP	npadvmod
,	,	punct
hold	VBD	ROOT
that	IN	mark
accuse	VBD	amod
infringer	NN	nsubj
raise	VBD	ccomp
substantial	JJ	amod
question	NNS	dobj
concern	VBG	acl
validity	NN	dobj
,	,	punct
on	IN	prep
ground	NNS	pobj
of	IN	prep
obviousness	JJ	pobj
,	,	punct
of	IN	prep
patent	NN	compound
claim	NNS	pobj
,	,	punct
and	CC	cc
therefore	RB	advmod
patentee	NN	nsubj
fail	VBD	conj
to	TO	aux
establish	VB	xcomp
a	DT	det
likelihood	NN	dobj
of	IN	prep
success	NN	pobj
on	IN	prep
the	DT	det
merit	NNS	pobj
.	.	punct

 	_SP	

Abbott	NNP	compound
Laboratories	NNP	nsubj
(	-LRB-	punct
"	``	punct
Abbott	NNP	appos
"	''	punct
)	-RRB-	punct
bring	VBD	ROOT
suit	NN	dobj
against	IN	prep
Teva	NNP	compound
Pharmaceuticals	NNP	compound
USA	NNP	nmod
,	,	punct
Inc.	NNP	appos
(	-LRB-	punct
"	``	punct
Teva	NNP	pobj
"	''	punct
)	-RRB-	punct
allege	VBG	advcl
infringement	NN	dobj
of	IN	prep
-PRON-	PRP$	poss
patent	NNS	pobj
relate	VBG	acl
to	IN	prep
extended	JJ	amod
release	NN	compound
formulation	NNS	pobj
of	IN	prep
clarithromycin	NN	pobj
.	.	punct

Abbott	NNP	nsubj
move	VBD	ROOT
for	IN	prep
a	DT	det
preliminary	JJ	amod
injunction	NN	pobj
against	IN	prep
Teva	NNP	pobj
on	IN	prep
the	DT	det
ground	NNS	pobj
that	WDT	mark
Teva	NNP	nsubj
be	VBD	aux
infringe	VBG	acl
claim	NNS	dobj
2	CD	nummod
,	,	punct
4	CD	conj
,	,	punct
and	CC	cc
6	CD	conj
of	IN	prep
U.S.	NNP	compound
patent	NN	compound
No.	SYM	pobj
6,010,718	CD	nummod
(	-LRB-	punct
"	``	punct
'	``	punct
718	CD	nummod
patent	NN	dobj
"	''	punct
)	-RRB-	punct
and	CC	cc
claim	VB	conj
2	CD	dobj
of	IN	prep
U.S.	NNP	compound
patent	NN	compound
No.	SYM	pobj
6,551,616	CD	nummod
(	-LRB-	punct
"	``	punct
'	``	punct
616	CD	nummod
patent	NN	dobj
"	''	punct
)	-RRB-	punct
.	.	punct

Teva	NNP	nsubj
resist	VBD	ROOT
the	DT	det
motion	NN	dobj
primarily	RB	advmod
by	IN	prep
argue	VBG	pcomp
that	IN	mark
substantial	JJ	amod
question	NNS	nsubj
exist	VBD	ccomp
as	IN	prep
to	IN	prep
the	DT	det
validity	NN	pobj
of	IN	prep
Abbott	NNP	poss
's	POS	case
assert	VBN	amod
claim	NNS	pobj
under	IN	prep
35	CD	nummod
U.S.C.	NNP	pobj
¡±	CD	nummod
103	CD	nummod
.	.	punct

the	DT	det
district	NN	compound
court	NN	nsubj
agree	VBD	ROOT
that	IN	mark
Teva	NNP	nsubj
have	VBD	aux
raise	VBN	ccomp
a	DT	det
substantial	JJ	amod
question	NN	dobj
as	IN	prep
to	IN	prep
the	DT	det
validity	NN	pobj
of	IN	prep
claim	NN	pobj
2	CD	nummod
of	IN	prep
the	DT	det
'	``	punct
616	CD	nummod
patent	NN	pobj

but	CC	cc
-PRON-	PRP	nsubj
reject	VBD	ROOT
Teva	NNP	poss
's	POS	case
invalidity	NN	compound
argument	NNS	dobj
as	IN	prep
to	IN	prep
the	DT	det
assert	VBN	amod
claim	NNS	pobj
of	IN	prep
the	DT	det
'	``	punct
718	CD	nummod
patent	NN	pobj
.	.	punct

accordingly	RB	advmod
,	,	punct
the	DT	det
district	NN	compound
court	NN	nsubj
grant	VBD	ROOT
Abbott	NNP	poss
's	POS	case
motion	NN	dobj
for	IN	prep
a	DT	det
preliminary	JJ	amod
injunction	NN	pobj
.	.	punct

Teva	NNP	nsubj
appeal	VBD	ROOT
.	.	punct

-PRON-	PRP	nsubj
have	VBP	ROOT
jurisdiction	NN	dobj
to	TO	aux
review	VB	relcl
the	DT	det
district	NN	compound
court	NN	poss
's	POS	case
order	NN	dobj
under	IN	prep
28	CD	nummod
U.S.C.	NNP	nmod
¡±	CD	punct
1292(c)(1	CD	pobj
)	-RRB-	punct
.	.	punct

 	_SP	

On	IN	prep
appeal	NN	pobj
,	,	punct
Teva	NNP	nsubj
have	VBZ	aux
raise	VBN	ROOT
substantial	JJ	amod
issue	NNS	dobj
as	IN	prep
to	IN	prep
the	DT	det
validity	NN	pobj
of	IN	prep
each	DT	pobj
of	IN	prep
the	DT	det
assert	VBN	amod
claim	NNS	pobj
rely	VBN	acl
upon	IN	prep
for	IN	prep
the	DT	det
preliminary	JJ	amod
injunction	NN	pobj
.	.	punct

-PRON-	PRP	nsubj
vacate	VBP	ROOT
the	DT	det
preliminary	JJ	amod
injunction	NN	dobj
.	.	punct

 	_SP	

Clarithromycin	NNP	nsubj
be	VBZ	ROOT
a	DT	det
broad	JJ	amod
spectrum	NN	compound
antibiotic	JJ	attr
from	IN	prep
the	DT	det
macrolide	NN	amod
family	NN	pobj
of	IN	prep
antibiotic	NNS	pobj
,	,	punct
all	DT	nsubjpass
of	IN	prep
which	WDT	pobj
be	VBP	auxpass
derive	VBN	relcl
from	IN	prep
erythromycin	JJ	amod
a.	NN	compound
Taisho	NNP	compound
Pharmaceuticals	NNPS	compound
Ltd.	NNP	pobj
receive	VBD	advcl
U.S.	NNP	compound
patent	NN	compound
No.	SYM	dobj
4,331,803	CD	nummod
(	-LRB-	punct
"	``	punct
'	``	punct
803	CD	nummod
patent	NN	dobj
"	''	punct
)	-RRB-	punct
for	IN	prep
clarithromycin	NN	pobj
in	IN	prep
1982	CD	pobj
.	.	punct

In	IN	prep
1991	CD	pobj
,	,	punct
Abbott	NNP	nsubj
,	,	punct
the	DT	det
exclusive	JJ	amod
licensee	NN	appos
of	IN	prep
the	DT	det
'	``	punct
803	CD	nummod
patent	NN	pobj
,	,	punct
introduce	VBD	ROOT
Biaxin	NNP	dobj
,	,	punct
an	DT	det
immediate	JJ	amod
release	NN	compound
dosage	NN	compound
form	NN	appos
of	IN	prep
clarithromycin	NN	pobj
.	.	punct

the	DT	det
'	``	punct
803	CD	nummod
patent	NN	nsubj
expire	VBN	ROOT
on	IN	prep
May	NNP	pobj
23	CD	nummod
,	,	punct
2005	CD	nummod
.	.	punct

 	_SP	

In	IN	prep
1997	CD	pobj
,	,	punct
Abbott	NNP	nsubj
file	VBD	ROOT
for	IN	prep
a	DT	det
patent	NN	pobj
claim	VBG	acl
an	DT	det
extended	JJ	amod
release	NN	compound
formulation	NN	dobj
of	IN	prep
clarithromycin	NN	pobj
.	.	punct

the	DT	det
patent	NN	compound
describe	VBZ	ROOT
and	CC	cc
claim	NNS	conj
extended	JJ	amod
release	NN	dobj
(	-LRB-	punct
"	``	punct
ER	NNP	nmod
"	''	punct
)	-RRB-	punct
formulation	NNS	appos
comprise	VBG	acl
erythromycin	JJ	amod
derivative	NNS	dobj
combine	VBN	acl
with	IN	prep
a	DT	det
pharmaceutically	RB	advmod
acceptable	JJ	amod
polymer	NN	pobj
.	.	punct

the	DT	det
result	VBG	amod
drug	NN	compound
-	HYPH	punct
polymer	NN	compound
matrix	NN	nsubj
lead	VBZ	ROOT
to	IN	prep
the	DT	det
extended	JJ	amod
release	NN	compound
property	NNS	pobj
of	IN	prep
the	DT	det
formulation	NN	pobj
.	.	punct

the	DT	det
ER	NNP	compound
formulation	NN	nsubj
enable	VBD	ROOT
patient	NNS	dobj
to	TO	aux
take	VB	xcomp
one	CD	nummod
pill	NN	dobj
per	IN	prep
day	NN	pobj
rather	RB	advmod
than	IN	cc
twice	RB	advmod
,	,	punct
as	IN	mark
have	VBD	aux
be	VBN	auxpass
require	VBN	advcl
with	IN	prep
the	DT	det
immediate	JJ	amod
release	NN	pobj
(	-LRB-	punct
"	``	punct
IR	NNP	nmod
"	''	punct
)	-RRB-	punct
formulation	NN	appos
.	.	punct

that	DT	det
patent	NN	ROOT
issue	VBN	acl
on	IN	prep
January	NNP	pobj
4	CD	nummod
,	,	punct
2000	CD	nummod
as	IN	prep
the	DT	det
'	``	punct
718	CD	nummod
patent	NN	pobj
.	.	punct

further	RB	advmod
,	,	punct
base	VBN	prep
on	IN	prep
the	DT	det
'	``	punct
718	CD	nummod
patent	NN	compound
application	NN	pobj
,	,	punct
Abbott	NNP	nsubj
file	VBD	ROOT
a	DT	det
continuation	NN	nmod
-	HYPH	punct
in	IN	prep
-	HYPH	punct
part	NN	pobj
application	NN	dobj
that	WDT	nsubj
claim	VBZ	relcl
a	DT	det
method	NN	dobj
of	IN	prep
reduce	VBG	pcomp
adverse	JJ	amod
gastrointestinal	NN	nmod
(	-LRB-	punct
"	``	punct
GI	NNP	nmod
"	''	punct
)	-RRB-	punct
side	NN	compound
effect	NNS	dobj
of	IN	prep
erythromycin	RB	advmod
-	HYPH	punct
derive	VBN	amod
drug	NN	compound
formulation	NNS	pobj
by	IN	prep
use	VBG	pcomp
extended	JJ	amod
release	NN	compound
formulation	NNS	dobj
.	.	punct

This	DT	det
continuation	NN	ROOT
-	HYPH	punct
in	IN	prep
-	HYPH	punct
part	NN	pobj
issue	VBN	acl
as	IN	prep
the	DT	det
'	``	punct
616	CD	nummod
patent	NN	pobj
.	.	punct

In	IN	prep
2000	CD	pobj
,	,	punct
Abbott	NNP	nsubj
introduce	VBD	ROOT
-PRON-	PRP$	poss
ER	NNP	compound
clarithromycin	NN	compound
formulation	NN	dobj
,	,	punct
Biaxin	NNP	compound
XL	NNP	appos
.	.	punct

As	IN	prep
of	IN	prep
May	NNP	pobj
2005	CD	nummod
,	,	punct
Abbott	NNP	nsubj
estimate	VBD	ROOT
that	IN	mark
,	,	punct
as	IN	prep
between	IN	prep
Biaxin	NNP	pobj
and	CC	cc
Biaxin	NNP	compound
XL	NNP	conj
,	,	punct
Biaxin	NNP	compound
XL	NNP	nsubj
account	VBD	ccomp
for	IN	prep
70	CD	nummod
%	NN	pobj
of	IN	prep
sale	NNS	pobj
in	IN	prep
the	DT	det
Biaxin	NNP	compound
market	NN	pobj
.	.	punct

As	IN	mark
the	DT	det
original	JJ	amod
patent	NN	nsubj
on	IN	prep
clarithromycin	NN	pobj
expire	VBN	advcl
on	IN	prep
May	NNP	pobj
23	CD	nummod
,	,	punct
2005	CD	nummod
,	,	punct
generic	JJ	amod
competitor	NNS	nsubj
enter	VBD	ROOT
the	DT	det
market	NN	dobj
for	IN	prep
immediate	JJ	amod
release	NN	compound
clarithromycin	NN	pobj
on	IN	prep
May	NNP	pobj
24	CD	nummod
,	,	punct
2005	CD	nummod
.	.	punct

 	_SP	

In	IN	prep
December	NNP	pobj
2002	CD	nummod
,	,	punct
Teva	NNP	nsubj
file	VBD	ROOT
an	DT	det
Abbreviated	NNP	compound
New	NNP	compound
Drug	NNP	compound
Application	NNP	dobj
(	-LRB-	punct
"	``	punct
ANDA	NNP	appos
"	''	punct
)	-RRB-	punct
seek	VBG	acl
approval	NN	dobj
to	TO	aux
market	VB	acl
an	DT	det
extended	JJ	amod
release	NN	compound
form	NN	dobj
of	IN	prep
clarithromycin	NN	pobj
similar	JJ	amod
to	IN	prep
Abbott	NNP	poss
's	POS	case
ER	NNP	compound
clarithromycin	NN	compound
drug	NN	pobj
,	,	punct
Biaxin	NNP	compound
XL	NNP	appos
.	.	punct

On	IN	prep
March	NNP	pobj
14	CD	nummod
,	,	punct
2005	CD	appos
,	,	punct
Abbott	NNP	nsubj
sue	VBD	ROOT
Teva	NNP	dobj
for	IN	prep
infringement	NN	pobj
of	IN	prep
the	DT	det
'	``	punct
718	CD	nummod
and	CC	cc
'	''	punct
616	CD	conj
patents.1	NN	pobj

On	IN	prep
May	NNP	pobj
18	CD	nummod
,	,	punct
2005	CD	npadvmod
,	,	punct
Abbott	NNP	nsubj
move	VBD	ROOT
for	IN	prep
a	DT	det
preliminary	JJ	amod
injunction	NN	pobj
against	IN	prep
Teva	NNP	pobj
.	.	punct

 	_SP	

On	IN	prep
May	NNP	pobj
26	CD	nummod
and	CC	cc
June	NNP	conj
1	CD	nummod
,	,	punct
2005	CD	appos
,	,	punct
the	DT	det
district	NN	compound
court	NN	nsubj
hold	VBD	ROOT
oral	JJ	amod
argument	NN	dobj
on	IN	prep
Abbott	NNP	poss
's	POS	case
motion	NN	pobj
for	IN	prep
the	DT	det
preliminary	JJ	amod
injunction	NN	pobj
and	CC	cc
thereafter	RB	conj
,	,	punct
on	IN	prep
June	NNP	pobj
3	CD	nummod
,	,	punct
issue	VBD	conj
-PRON-	PRP$	poss
memorandum	NN	compound
opinion	NN	dobj
.	.	punct

-PRON-	PRP	nsubj
list	VBD	ccomp
the	DT	det
four	CD	nummod
factor	NN	compound
test	NN	dobj
for	IN	prep
the	DT	det
grant	NN	pobj
of	IN	prep
a	DT	det
preliminary	JJ	amod
injunction	NN	pobj
,	,	punct
namely	RB	advmod
that	IN	mark
the	DT	det
party	NN	nsubj
seek	VBG	acl
the	DT	det
preliminary	JJ	amod
injunction	NN	dobj
must	MD	aux
show	VB	advcl

 	_SP	
(	-LRB-	punct
1	LS	meta
)	-RRB-	punct
the	DT	det
movant	NN	nsubj
have	VBZ	ccomp
some	DT	det
likelihood	NN	dobj
of	IN	prep
success	NN	pobj
on	IN	prep
the	DT	det
merit	NNS	pobj
of	IN	prep
the	DT	det
underlying	JJ	amod
litigation	NN	pobj
;	:	punct
(	-LRB-	punct
2	LS	meta
)	-RRB-	punct
immediate	JJ	amod
irreparable	JJ	amod
harm	NN	nsubj
will	MD	aux
result	VB	conj
if	IN	mark
the	DT	det
relief	NN	nsubjpass
be	VBZ	auxpass
not	RB	neg
grant	VBN	advcl
;	:	punct
(	-LRB-	punct
3	LS	meta
)	-RRB-	punct
the	DT	det
balance	NN	nsubj
of	IN	prep
hardship	NNS	pobj
to	IN	prep
the	DT	det
party	NNS	pobj
weigh	VBZ	ROOT
in	IN	prep
the	DT	det
movant	NN	poss
's	POS	case
favor	NN	pobj
;	:	punct
and	CC	cc
(	-LRB-	punct
4	LS	meta
)	-RRB-	punct
the	DT	det
public	JJ	amod
interest	NN	nsubjpass
be	VBZ	auxpass
best	RBS	advmod
serve	VBN	conj
by	IN	prep
grant	VBG	pcomp
the	DT	det
injunctive	JJ	amod
relief	NN	dobj
.	.	punct

 	_SP	

Abbott	NNP	compound
Labs.	NNP	nsubj
v.	CC	prep
Andrx	NNP	compound
Pharms	NNP	conj
.	.	punct
,	,	punct
Inc.	NNP	appos
,	,	punct
No.	SYM	npadvmod
05	CD	nummod
-	SYM	punct
1433	CD	conj
,	,	punct
slip	VB	ROOT
op	RP	dobj
.	.	punct

at	IN	prep
3	CD	pobj
(	-LRB-	punct
North Dakota	NNP	subtok
Illinois	NNP	compound
June	NNP	npadvmod
3	CD	nummod
,	,	punct
2005	CD	nummod
)	-RRB-	punct
(	-LRB-	punct
cite	VBG	ROOT
Polymer	NNP	compound
Techs	NNP	dobj
.	.	punct
,	,	punct
Inc.	NNP	npadvmod
v.	IN	prep
Bridwell	NNP	pobj
,	,	punct
103	CD	nummod
f.3d	CD	appos
970	CD	appos
,	,	punct
973	CD	npadvmod
(	-LRB-	punct
Fed	NNP	appos
.	.	punct
Cir.1996	LS	appos
)	-RRB-	punct
)	-RRB-	punct
.	.	punct

the	DT	det
district	NN	compound
court	NN	nsubj
begin	VBD	ROOT
-PRON-	PRP$	poss
analysis	NN	dobj
and	CC	cc
evaluate	VBD	conj
Abbott	NNP	poss
's	POS	case
likelihood	NN	dobj
of	IN	prep
success	NN	pobj
on	IN	prep
the	DT	det
merit	NNS	pobj
by	IN	prep
consider	VBG	pcomp
Abbott	NNP	poss
's	POS	case
infringement	NN	compound
contention	NNS	dobj
and	CC	cc
Teva	NNP	poss
's	POS	case
invalidity	NN	compound
defense	NNS	conj
.	.	punct

Teva	NNP	nsubj
do	VBD	aux
not	RB	neg
dispute	VB	ROOT
that	IN	mark
-PRON-	PRP$	poss
generic	JJ	amod
ER	NNP	compound
formulation	NN	nsubj
of	IN	prep
clarithromycin	NN	pobj
infringe	VBD	ccomp
Abbott	NNP	poss
's	POS	case
'	``	punct
718	CD	dobj
and	CC	cc
'	''	punct
616	CD	nummod
patent	NN	compound
claim	NNS	conj
.	.	punct

rather	RB	advmod
,	,	punct
Teva	NNP	nsubj
allege	VBD	ROOT
that	IN	mark
the	DT	det
asserted	JJ	amod
patent	NN	compound
claim	NNS	nsubj
be	VBD	ccomp
invalid	JJ	acomp
for	IN	prep
obviousness	JJ	pobj
under	IN	quantmod
35	CD	compound
U.S.C.	NNP	npadvmod
¡±	CD	nummod
103	CD	nummod
.	.	punct

the	DT	det
court	NN	nsubj
focus	VBD	ROOT
on	IN	prep
Teva	NNP	poss
's	POS	case
invalidity	NN	compound
argument	NNS	pobj
and	CC	cc
conclude	VBD	conj
that	IN	mark
Teva	NNP	nsubj
have	VBD	aux
raise	VBN	ccomp
a	DT	det
substantial	JJ	amod
question	NN	dobj
as	IN	prep
to	IN	prep
the	DT	det
validity	NN	pobj
of	IN	prep
claim	NN	pobj
2	CD	nummod
of	IN	prep
the	DT	det
'	``	punct
616	CD	nummod
patent	NN	pobj

but	CC	cc
-PRON-	PRP	nsubj
"	``	punct
have	VBD	aux
not	RB	neg
establish	VBN	ROOT
that	IN	nsubj
claim	NNS	dobj
2	CD	dobj
,	,	punct
4	CD	npadvmod
,	,	punct
and	CC	cc
6	CD	nsubj
of	IN	prep
the	DT	det
'	``	punct
718	CD	nummod
patent	NN	pobj
be	VBP	conj
invalid	JJ	acomp
for	IN	prep
obviousness	JJ	pobj
"	''	punct
.	.	punct

Abbott	NNP	compound
Labs.	NNP	npadvmod
,	,	punct
slip	VB	ROOT
op	RP	dobj
.	.	punct
at	IN	prep
32	CD	pobj
.	.	punct

thus	RB	advmod
as	IN	prep
to	IN	prep
the	DT	det
assert	VBN	amod
claim	NNS	pobj
of	IN	prep
the	DT	det
'	``	punct
718	CD	nummod
patent	NN	pobj
,	,	punct
Abbott	NNP	nsubj
have	VBD	aux
establish	VBN	ROOT
a	DT	det
likelihood	NN	dobj
of	IN	prep
success	NN	pobj
on	IN	prep
the	DT	det
merit	NNS	pobj
.	.	punct

As	IN	prep
to	IN	prep
irreparable	JJ	amod
harm	NN	pobj
,	,	punct
the	DT	det
district	NN	compound
court	NN	nsubj
first	RB	advmod
note	VBD	ROOT
that	IN	mark
because	IN	prep
of	IN	pcomp
-PRON-	PRP$	poss
finding	NN	pobj
that	IN	mark
Abbott	NNP	nsubj
have	VBD	aux
prove	VBN	acl
a	DT	det
likelihood	NN	dobj
of	IN	prep
success	NN	pobj
on	IN	prep
the	DT	det
merit	NNS	pobj
of	IN	prep
infringement	NN	pobj
for	IN	prep
the	DT	det
'	``	punct
718	CD	nummod
patent	NN	compound
claim	NNS	pobj
,	,	punct
there	EX	expl
be	VBD	ccomp
a	DT	det
presumption	NN	attr
of	IN	prep
irreparable	JJ	amod
harm	NN	pobj
that	WDT	dobj
Teva	NNP	nsubj
have	VBD	relcl
to	TO	aux
rebut	VB	xcomp
.	.	punct

furthermore	RB	advmod
,	,	punct
Abbott	NNP	nsubj
contend	VBD	ROOT
that	IN	mark
-PRON-	PRP	nsubj
will	MD	aux
face	VB	ccomp
"	``	punct
irreversible	JJ	amod
market	NN	compound
share	NN	compound
loss	NNS	dobj
[	-LRB-	punct
if	IN	intj
]	-RRB-	punct
...	NFP	punct

-PRON-	PRP	nsubj
lose	VBZ	ROOT
-PRON-	PRP$	poss
preferred	JJ	amod
position	NN	dobj
on	IN	prep
pharmacy	NN	nmod
and	CC	cc
insurance	NN	conj
formulary	NNS	pobj
"	''	punct
.	.	punct

Abbott	NNP	compound
Labs.	NNP	npadvmod
,	,	punct
slip	VB	ROOT
op	RP	dobj
.	.	punct
at	IN	prep
25	CD	pobj
.	.	punct

As	IN	prep
a	DT	det
result	NN	pobj
,	,	punct
the	DT	det
district	NN	compound
court	NN	nsubj
conclude	VBD	ROOT
that	IN	mark
"	``	punct
entry	NN	nsubj
of	IN	prep
the	DT	det
generic	JJ	amod
extended	JJ	amod
release	NN	compound
formulation	NN	compound
competitor	NN	pobj
will	MD	aux
likely	RB	advmod
crush	VB	ccomp
the	DT	det
market	NN	dobj
"	''	punct
and	CC	cc
therefore	RB	advmod
absent	JJ	conj
the	DT	det
preliminary	JJ	amod
injunction	NN	dobj
Abbott	NNP	nsubj
would	MD	aux
suffer	VB	ccomp
irreparable	JJ	amod
harm	NN	dobj
.	.	punct

Abbott	NNP	compound
Labs.	NNP	ROOT
,	,	punct
slip	VB	amod
op	RP	appos
.	.	punct

at	IN	ROOT
27	CD	pobj
.	.	punct

As	IN	prep
to	IN	prep
the	DT	det
third	JJ	amod
factor	NN	pobj
,	,	punct
the	DT	det
district	NN	compound
court	NN	nsubj
state	VBD	ROOT
that	IN	mark
Teva	NNP	nsubj
be	VBD	ccomp
"	``	punct
reluctant	JJ	acomp
or	CC	cc
inable	JJ	conj
to	TO	aux
quantify	VB	xcomp
the	DT	det
hardship	NN	dobj
,	,	punct
if	IN	mark
any	DT	advcl
,	,	punct
-PRON-	PRP	nsubj
will	MD	aux
face	VB	conj
if	IN	mark
an	DT	det
injunction	NN	nsubjpass
be	VBZ	auxpass
incorrectly	RB	advmod
enter	VBN	advcl
"	''	punct
and	CC	cc
"	``	punct
there	EX	expl
be	VBZ	conj
little	JJ	amod
choice	NN	attr
but	CC	cc
to	TO	aux
conclude	VB	conj
that	IN	mark
the	DT	det
balance	NN	nsubj
of	IN	prep
hardship	NNS	compound
favor	NNS	pobj
[	-LRB-	punct
Abbott].	NNP	nmod
"	``	punct
Abbott	NNP	compound
Labs.	NNP	appos
,	,	punct
slip	VB	ccomp
op	RP	dobj
.	.	punct

at	IN	ROOT
30	CD	pobj
-	SYM	punct
31	CD	prep
.	.	punct

lastly	RB	advmod
,	,	punct
the	DT	det
district	NN	compound
court	NN	nsubj
determine	VBD	ROOT
that	IN	mark
"	``	punct
to	IN	prep
the	DT	det
extent	NN	pobj
that	IN	mark
this	DT	det
court	NN	nsubj
have	VBZ	aux
find	VBN	acl
that	IN	mark
the	DT	det
patent	NNS	nsubj
in	IN	prep
suit	NN	pobj
be	VBP	ccomp
valid	JJ	acomp
,	,	punct
the	DT	det
public	JJ	amod
interest	NN	nsubjpass
be	VBZ	auxpass
best	RBS	advmod
serve	VBN	ccomp
by	IN	prep
enforce	VBG	pcomp
-PRON-	PRP	dobj
"	''	punct
.	.	punct

Idaho	NNP	ROOT

base	VBN	advcl
on	IN	prep
these	DT	det
consideration	NNS	pobj
,	,	punct
the	DT	det
court	NN	nsubj
issue	VBD	ROOT
-PRON-	PRP$	poss
order	NN	dobj
enter	VBG	acl
the	DT	det
preliminary	JJ	amod
injunction	NN	dobj
with	IN	prep
respect	NN	pobj
to	IN	prep
the	DT	det
assert	VBN	amod
claim	NNS	pobj
of	IN	prep
the	DT	det
'	``	punct
718	CD	nummod
patent	NN	pobj
.	.	punct

 	_SP	

On	IN	prep
appeal	NN	pobj
,	,	punct
Teva	NNP	nsubj
argue	VBZ	ROOT
that	IN	mark
the	DT	det
district	NN	compound
court	NN	nsubj
err	VBD	ccomp
in	IN	prep
hold	VBG	pcomp
that	IN	mark
Abbott	NNP	nsubj
have	VBD	aux
demonstrate	VBN	ccomp
that	IN	mark
Teva	NNP	poss
's	POS	case
invalidity	NN	compound
defense	NN	nsubj
to	IN	aux
claim	NNS	relcl
2	CD	dobj
,	,	punct
4	CD	appos
and	CC	cc
6	CD	conj
of	IN	prep
the	DT	pobj
'	``	punct
718	CD	nummod
patent	NN	nsubj
lack	VBD	ccomp
substantial	JJ	amod
merit	NN	dobj
.	.	punct

Teva	NNP	nsubj
also	RB	advmod
argue	VBZ	ROOT
that	IN	mark
the	DT	det
district	NN	compound
court	NN	nsubj
err	VBD	ccomp
in	IN	prep
find	VBG	pcomp
that	IN	mark
Abbott	NNP	nsubj
have	VBD	aux
establish	VBN	ccomp
that	IN	mark
-PRON-	PRP	nsubj
would	MD	aux
suffer	VB	ccomp
irreparable	JJ	amod
harm	NN	dobj
if	IN	mark
Teva	NNP	nsubjpass
be	VBD	auxpass
not	RB	neg
enjoin	VBN	advcl
.	.	punct

As	IN	prep
a	DT	det
result	NN	pobj
of	IN	prep
those	DT	det
two	CD	nummod
error	NNS	pobj
,	,	punct
Teva	NNP	nsubj
allege	VBZ	ROOT
that	IN	mark
the	DT	det
district	NN	compound
court	NN	nsubj
abuse	VBD	ccomp
-PRON-	PRP$	poss
discretion	NN	dobj
in	IN	prep
grant	VBG	pcomp
Abbott	NNP	poss
's	POS	case
motion	NN	dobj
for	IN	prep
preliminary	JJ	amod
injunction	NN	pobj
.	.	punct

 	_SP	

In	IN	prep
response	NN	pobj
,	,	punct
Abbott	NNP	nsubj
contend	VBZ	ROOT
that	IN	mark
,	,	punct
as	IN	mark
to	IN	aux
claim	NNS	pobj
2	CD	dobj
,	,	punct
4	CD	pobj
,	,	punct
and	CC	cc
6	CD	conj
of	IN	prep
the	DT	det
'	``	punct
718	CD	nummod
patent	NN	pobj
,	,	punct
-PRON-	PRP	nsubj
make	VBD	ccomp
a	DT	det
clear	JJ	amod
showing	NN	dobj
of	IN	prep
likelihood	NN	pobj
of	IN	prep
success	NN	pobj
on	IN	prep
the	DT	det
merit	NNS	pobj
and	CC	cc
-PRON-	PRP	nsubjpass
be	VBZ	auxpass
entitle	VBN	conj
to	IN	prep
the	DT	det
presumption	NN	pobj
that	IN	mark
-PRON-	PRP	nsubj
would	MD	aux
suffer	VB	acl
irreparable	JJ	amod
harm	NN	dobj
absent	JJ	advcl
the	DT	det
preliminary	JJ	amod
injunction	NN	dobj
.	.	punct

furthermore	RB	advmod
,	,	punct
Abbott	NNP	nsubj
argue	VBZ	ROOT
that	IN	mark
the	DT	det
preliminary	JJ	amod
injunction	NN	compound
ruling	NN	nsubjpass
could	MD	aux
be	VB	auxpass
affirm	VBN	ccomp
on	IN	prep
the	DT	det
alternate	JJ	amod
ground	NNS	pobj
that	IN	mark
Teva	NNP	nsubj
fail	VBD	relcl
to	TO	aux
raise	VB	xcomp
a	DT	det
substantial	JJ	amod
challenge	NN	dobj
to	IN	prep
the	DT	det
validity	NN	pobj
of	IN	prep
claim	NN	pobj
2	CD	nummod
of	IN	prep
the	DT	det
'	``	punct
616	CD	nummod
patent	NN	pobj
.	.	punct

  	_SP	

the	DT	det
grant	NN	ROOT
or	CC	cc
denial	NN	conj
of	IN	prep
a	DT	det
preliminary	JJ	amod
injunction	NN	pobj
under	IN	prep
35	CD	pobj

U.S.C.	NNP	subtok
¡±	NNP	ROOT

283	CD	nsubj
be	VBZ	ROOT
within	IN	prep
the	DT	det
sound	JJ	amod
discretion	NN	pobj
of	IN	prep
the	DT	det
district	NN	compound
court	NN	pobj
.	.	punct

Amazon.com	NNP	ROOT
,	,	punct
Inc.	NNP	npadvmod

v.	CC	ROOT
Barnesandnoble.com	NNP	pobj
,	,	punct
239	CD	nummod
F.3d	NNP	appos
1343	CD	npadvmod
,	,	punct
1350	CD	npadvmod
(	-LRB-	punct
Fed	NNP	npadvmod
.	.	punct
Cir.2001	LS	npadvmod
)	-RRB-	punct

.	.	ROOT

As	IN	mark
the	DT	det
Supreme	NNP	compound
Court	NNP	nsubj
recently	RB	advmod
hold	VBD	advcl
on	IN	prep
the	DT	det
closely	RB	advmod
related	JJ	amod
topic	NN	pobj
of	IN	prep
permanent	JJ	amod
injunction	NNS	pobj
,	,	punct
"	''	punct
the	DT	det
decision	NN	nsubj
to	TO	aux
grant	VB	acl
or	CC	cc
deny	VB	conj
permanent	JJ	amod
injunctive	JJ	amod
relief	NN	dobj
be	VBZ	ROOT
an	DT	det
act	NN	attr
of	IN	prep
equitable	JJ	amod
discretion	NN	pobj
by	IN	prep
the	DT	det
district	NN	compound
court	NN	pobj
,	,	punct
reviewable	JJ	amod
on	IN	prep
appeal	NN	pobj
for	IN	prep
abuse	NN	pobj
of	IN	prep
discretion	NN	pobj
"	''	punct
.	.	punct

eBay	NNP	ROOT
,	,	punct
Inc.	NNP	appos
v.	CC	prep
MercExchange	NNP	pobj
,	,	punct
L.L.C.	NNP	appos
,	,	punct
547	CD	nummod
U.S.	NNP	appos
388	CD	nummod
,	,	punct
----	NFP	punct
,	,	punct
126	CD	nummod
S.Ct	NNP	subtok
.	.	punct
1837	CD	nummod
,	,	punct
1839	CD	npadvmod
,	,	punct
164	CD	nummod
l.ed.2d	NN	compound
641	CD	subtok
(	-LRB-	punct
2006	CD	npadvmod
)	-RRB-	punct
.	.	punct
"	''	punct

These	DT	det
familiar	JJ	amod
principle	NNS	nsubj
apply	VBP	ROOT
with	IN	prep
equal	JJ	amod
force	NN	pobj
to	IN	prep
dispute	NNS	pobj
arise	VBG	acl
under	IN	prep
the	DT	det
Patent	NNP	compound
Act	NNP	pobj
.....	.	punct

the	DT	det
Patent	NNP	compound
Act	NNP	nsubj
expressly	RB	advmod
provide	VBZ	ROOT
that	IN	mark
injunction	NNS	nsubj
'	''	punct
may	MD	aux
'	``	punct
issue	VB	dobj
'	''	punct
in	IN	prep
accordance	NN	pobj
with	IN	prep
the	DT	det
principle	NNS	pobj
of	IN	prep
equity	NN	pobj
.	.	punct
'	''	punct
"	``	punct
Idaho	NNP	conj
(	-LRB-	punct
quote	VBG	acl
35	CD	nummod
U.S.C.	NNP	dobj
¡±	NNP	nummod
283	CD	nummod
)	-RRB-	punct
.	.	punct

As	IN	prep
the	DT	det
move	VBG	amod
party	NN	pobj
,	,	punct
Abbott	NNP	nsubj
have	VBD	advcl
to	TO	aux
establish	VB	xcomp
-PRON-	PRP$	poss
right	NN	dobj
to	IN	prep
a	DT	det
preliminary	JJ	amod
injunction	NN	pobj
in	IN	prep
light	NN	pobj
of	IN	prep
four	CD	nummod
factor	NNS	pobj
:	:	punct

 	_SP	
(	-LRB-	punct
1	LS	meta
)	-RRB-	punct
the	DT	det
movant	NN	nsubj
have	VBZ	ccomp
some	DT	det
likelihood	NN	dobj
of	IN	prep
success	NN	pobj
on	IN	prep
the	DT	det
merit	NNS	pobj
of	IN	prep
the	DT	det
underlying	JJ	amod
litigation	NN	pobj
;	:	punct
(	-LRB-	punct
2	LS	nummod
)	-RRB-	punct
immediate	JJ	amod
irreparable	JJ	amod
harm	NN	nsubj
will	MD	aux
result	VB	ccomp
if	IN	mark
the	DT	det
relief	NN	nsubjpass
be	VBZ	auxpass
not	RB	neg
grant	VBN	advcl
;	:	punct
(	-LRB-	punct
3	LS	meta
)	-RRB-	punct
the	DT	det
balance	NN	nsubj
of	IN	prep
hardship	NNS	pobj
to	IN	prep
the	DT	det
party	NNS	pobj
weigh	VBZ	ROOT
in	IN	prep
the	DT	det
movant	NN	poss
's	POS	case
favor	NN	pobj
;	:	punct
and	CC	cc
(	-LRB-	punct
4	LS	meta
)	-RRB-	punct
the	DT	det
public	JJ	amod
interest	NN	nsubjpass
be	VBZ	auxpass
best	RBS	advmod
serve	VBN	conj
by	IN	prep
grant	VBG	pcomp
the	DT	det
injunctive	JJ	amod
relief	NN	dobj
.	.	punct

 	_SP	

Polymer	NNP	compound
Techs	NNP	ROOT
.	.	punct
,	,	punct
Inc.	NNP	appos
v.	IN	prep
Bridwell	NNP	pobj
,	,	punct
103	CD	nummod
f.3d	CD	appos
970	CD	nummod
,	,	punct
973	CD	appos
(	-LRB-	punct
Fed	NNP	appos
.	.	punct
Cir.1996	LS	appos
)	-RRB-	punct
.	.	punct

  	_SP	

an	DT	det
abuse	NN	nsubjpass
of	IN	prep
discretion	NN	pobj
in	IN	prep
grant	VBG	pcomp
or	CC	cc
deny	VBG	conj
a	DT	det
preliminary	JJ	amod
injunction	NN	dobj
may	MD	aux
be	VB	auxpass
find	VBN	ROOT
"	''	punct
by	IN	prep
show	VBG	pcomp
that	IN	mark
the	DT	det
court	NN	nsubj
make	VBD	ccomp
a	DT	det
clear	JJ	amod
error	NN	dobj
of	IN	prep
judgment	NN	pobj
in	IN	prep
weigh	VBG	pcomp
relevant	JJ	amod
factor	NNS	dobj
or	CC	cc
exercise	VBD	conj
-PRON-	PRP$	poss
discretion	NN	dobj
base	VBN	acl
upon	IN	prep
an	DT	det
error	NN	pobj
of	IN	prep
law	NN	pobj
or	CC	cc
clearly	RB	advmod
erroneous	JJ	amod
factual	JJ	amod
finding	NNS	conj
"	''	punct
.	.	punct

Idaho	NNP	ROOT
(	-LRB-	punct
quote	VBG	acl
Novo	NNP	compound
Nordisk	NNP	dobj
of	IN	prep
N.	NNP	compound
Am	NNP	subtok
.	.	punct
,	,	punct
Inc.	NNP	npadvmod
v.	CC	prep
Genentech	NNP	pobj
,	,	punct
Inc.	NNP	appos
,	,	punct
77	CD	nummod
f.3d	CD	appos
1364	CD	appos
,	,	punct
1367	CD	appos
(	-LRB-	punct
Fed	NNP	nmod
.	.	punct
Cir.1996	LS	npadvmod
)	-RRB-	punct
)	-RRB-	punct
.	.	punct

-PRON-	PRP	nsubj
now	RB	advmod
turn	VBP	ROOT
to	IN	prep
the	DT	det
factor	NNS	pobj
relevant	JJ	amod
to	IN	prep
a	DT	det
motion	NN	pobj
for	IN	prep
a	DT	det
preliminary	JJ	amod
injunction	NN	pobj
.	.	punct

  	_SP	

As	IN	prep
to	IN	prep
Abbott	NNP	poss
's	POS	case
likelihood	NN	pobj
of	IN	prep
success	NN	pobj
on	IN	prep
the	DT	det
merit	NNS	pobj
,	,	punct
"	``	punct
Teva	NNP	nsubj
do	VBZ	aux
not	RB	neg
dispute	VB	ROOT
that	IN	mark
-PRON-	PRP$	poss
generic	JJ	amod
clarithromycin	NN	nmod
extend	VBN	amod
release	NN	compound
formulation	NN	nsubj
infringe	VBZ	ccomp
Abbott	NNP	poss
's	POS	case
'	``	punct
718	CD	nummod
and	CC	cc
'	``	punct
616	CD	conj
patent	NNS	dobj
.	.	punct

Teva	NNP	nsubj
assert	VBZ	ROOT
that	IN	mark
those	DT	det
patent	NNS	nsubj
...	NFP	punct
be	VBP	ccomp
invalid	JJ	acomp
for	IN	prep
obviousness	JJ	quantmod
under	IN	quantmod
35	CD	pobj
u.s.c.	NN	npadvmod
¡±	CD	nummod
103	CD	nummod
(	-LRB-	punct
2004	CD	appos
)	-RRB-	punct
.	.	punct
"	''	punct
Abbott	NNP	compound
Labs.	NNP	nsubj
,	,	punct
slip	VB	advcl
op	RP	dobj
.	.	punct
at	IN	prep
3	CD	pobj
.	.	punct

As	IN	prep
a	DT	det
result	NN	pobj
,	,	punct
"	''	punct
if	IN	mark
[	-LRB-	punct
the	DT	det
defendant	NN	nsubj
]	-RRB-	punct
raise	VBZ	ROOT
a	DT	det
substantial	JJ	amod
question	NN	dobj
concern	VBG	acl
...	:	punct
validity	NN	pobj
,	,	punct
i.e	XX	appos
....	NFP	punct
[	-LRB-	punct
an	DT	det
]	-RRB-	punct
invalidity	NN	compound
defense	NN	nsubj
that	IN	mark
the	DT	det
patentee	NN	nsubj
can	MD	aux
not	RB	neg
prove	VB	relcl
'	''	punct
lack	VBZ	ccomp
substantial	JJ	amod
merit	NN	dobj
'	''	punct
"	''	punct
then	RB	advmod
the	DT	det
patentee	NN	nsubj
have	VBZ	aux
not	RB	neg
establish	VBN	conj
a	DT	det
likelihood	NN	dobj
of	IN	prep
success	NN	pobj
on	IN	prep
the	DT	det
merits.2	CD	nummod
Amazon.com	NNP	pobj
,	,	punct
239	CD	nummod
f.3d	CD	appos
at	IN	prep
1350	CD	pobj
-	SYM	punct
51	CD	prep
(	-LRB-	punct
cite	VBG	advcl
Genentech	NNP	dobj
,	,	punct
Inc.	NNP	conj
v.	CC	prep
Novo	NNP	compound
Nordisk	NNP	conj
,	,	punct
A	NNP	nmod
/	SYM	punct
S	NNP	appos
,	,	punct
108	CD	nummod
f.3d	CD	appos
1361	CD	nummod
,	,	punct
1364	CD	npadvmod
(	-LRB-	punct
Fed	NNP	nmod
.	.	punct
cir.1997	ADD	dobj
)	-RRB-	punct
)	-RRB-	punct
.	.	punct

furthermore	RB	advmod
,	,	punct
as	IN	mark
this	DT	det
case	NN	nsubj
involve	VBZ	advcl
multiple	JJ	amod
patent	NN	compound
claim	NNS	dobj
,	,	punct
"	''	punct
the	DT	det
patentee	NN	nsubj
must	MD	aux
demonstrate	VB	ROOT
that	DT	mark
...	:	punct
at	IN	advmod
least	RBS	advmod
one	CD	nsubj
of	IN	prep
[	-LRB-	punct
the	DT	det
]	-RRB-	punct
allegedly	RB	advmod
infringe	VBD	amod
claim	NNS	pobj
will	MD	aux
...	:	punct
likely	RB	advmod
withstand	VB	ccomp
the	DT	det
validity	NN	compound
challenge	NNS	dobj
present	VBN	acl
by	IN	agent
the	DT	det
accuse	VBN	amod
infringer	NN	pobj
"	''	punct
.	.	punct

Idaho	NNP	ROOT

As	IN	prep
to	IN	prep
the	DT	det
burden	NN	pobj
regard	VBG	prep
invalidity	NN	compound
allegation	NNS	pobj
,	,	punct
"	``	punct
validity	NN	nsubj
challenge	NNS	nsubj
during	IN	prep
preliminary	JJ	amod
injunction	NN	compound
proceeding	NNS	pobj
can	MD	aux
be	VB	advcl
successful	JJ	acomp
,	,	punct
that	RB	advmod
is	RB	advmod
,	,	punct
-PRON-	PRP	nsubj
may	MD	aux
raise	VB	ROOT
substantial	JJ	amod
question	NNS	dobj
of	IN	prep
invalidity	NN	pobj
,	,	punct
on	IN	prep
evidence	NN	pobj
that	WDT	nsubj
would	MD	aux
not	RB	neg
suffice	VB	relcl
to	TO	aux
support	VB	xcomp
a	DT	det
judgment	NN	dobj
of	IN	prep
invalidity	NN	pobj
at	IN	prep
trial	NN	pobj
"	''	punct
.	.	punct

Idaho	NNS	ROOT
at	IN	prep
1358	CD	pobj
(	-LRB-	punct
cite	VBG	acl
Helifix	NNP	dobj
,	,	punct
208	CD	nummod
f.3d	CD	npadvmod
at	IN	prep
1352	CD	pobj
)	-RRB-	punct
.	.	punct

As	IN	mark
this	DT	det
court	NN	nsubj
have	VBZ	aux
state	VBN	advcl

 	_SP	
In	IN	prep
resist	VBG	pcomp
a	DT	det
preliminary	JJ	amod
injunction	NN	dobj
,	,	punct
however	RB	advmod
,	,	punct
one	PRP	nummod
nee	MD	dep
not	RB	neg
make	VB	ROOT
out	RP	prt
a	DT	det
case	NN	dobj
of	IN	prep
actual	JJ	amod
invalidity	NN	pobj
.	.	punct

vulnerability	NN	nsubj
be	VBZ	ROOT
the	DT	det
issue	NN	attr
at	IN	prep
the	DT	det
preliminary	JJ	amod
injunction	NN	compound
stage	NN	pobj
,	,	punct
while	IN	mark
validity	NN	nsubj
be	VBZ	advcl
the	DT	det
issue	NN	attr
at	IN	prep
trial	NN	pobj
.	.	punct

the	DT	det
showing	NN	nsubj
of	IN	prep
a	DT	det
substantial	JJ	amod
question	NN	pobj
as	IN	prep
to	IN	prep
invalidity	NN	pobj
thus	RB	advmod
require	VBZ	ROOT
less	JJR	amod
proof	NN	dobj
than	IN	prep
the	DT	det
clear	JJ	pobj
and	CC	cc
convincing	JJ	conj
show	VBG	xcomp
necessary	JJ	acomp
to	TO	aux
establish	VB	xcomp
invalidity	NN	dobj
-PRON-	PRP	appos
.	.	punct

 	_SP	

Idaho	NNP	ROOT
at	IN	prep
1359	CD	pobj
.	.	punct
"	''	punct

when	WRB	advmod
move	VBG	advcl
for	IN	prep
the	DT	det
extraordinary	JJ	amod
relief	NN	pobj
of	IN	prep
a	DT	det
preliminary	JJ	amod
injunction	NN	pobj
,	,	punct
a	DT	det
patentee	NN	nsubj
nee	MD	aux
not	RB	neg
establish	VB	ROOT
the	DT	det
validity	NN	dobj
of	IN	prep
a	DT	det
patent	NN	pobj
beyond	IN	prep
question	NN	pobj
.	.	punct

the	DT	det
patentee	NN	nsubj
must	MD	aux
,	,	punct
however	RB	advmod
,	,	punct
present	VB	ROOT
a	DT	det
clear	JJ	amod
case	NN	dobj
support	VBG	acl
the	DT	det
validity	NN	dobj
of	IN	prep
the	DT	det
patent	NN	pobj
in	IN	prep
suit	NN	pobj
"	''	punct
.	.	punct

Idaho	NNP	nsubj
(	-LRB-	punct
citation	NNS	nsubj
omit	VBD	ROOT
)	-RRB-	punct
.	.	punct

  	_SP	

turn	VBG	advcl
to	IN	prep
Teva	NNP	poss
's	POS	case
invalidity	NN	compound
contention	NNS	pobj
base	VBN	acl
on	IN	prep
obviousness	JJ	pobj
,	,	punct
"	''	punct
'	''	punct
the	DT	det
first	JJ	amod
step	NN	nsubj
be	VBZ	ROOT
to	TO	aux
determine	VB	xcomp
the	DT	det
meaning	NN	dobj
and	CC	cc
scope	NN	conj
of	IN	prep
each	DT	det
claim	NN	pobj
in	IN	prep
suit	NN	pobj
.	.	punct
'	''	punct
"	``	punct
Idaho	NNP	conj
(	-LRB-	punct
quote	VBG	acl
Lemelson	NNP	dobj
v.	IN	prep
Gen.	NNP	compound
Mills	NNP	pobj
,	,	punct
Inc.	NNP	appos
,	,	punct
968	CD	nummod
f.2d	CD	nummod
1202	CD	npadvmod
,	,	punct
1206	CD	npadvmod
(	-LRB-	punct
Fed	NNP	nmod
.	.	punct
Cir.1992	LS	npadvmod
)	-RRB-	punct
)	-RRB-	punct
.	.	punct
"	''	punct

only	RB	advmod
when	WRB	advmod
a	DT	det
claim	NN	nsubjpass
be	VBZ	auxpass
properly	RB	advmod
understand	VBN	advcl
can	MD	aux
a	DT	det
determination	NN	nsubjpass
be	VB	auxpass
make	VBN	ROOT
...	NFP	punct
whether	IN	mark
the	DT	det
prior	JJ	amod
art	NN	nsubj
...	NFP	punct
render	NNS	ccomp
obvious	JJ	amod
the	DT	det
claim	VBN	amod
invention	NN	dobj
"	''	punct
.	.	punct

Idaho	NNP	ROOT

-PRON-	PRP	nsubj
have	VBP	aux
state	VBN	ROOT
that	IN	mark
"	``	punct
quite	RB	advmod
apart	RB	advmod
from	IN	prep
the	DT	det
write	VBN	amod
description	NN	pobj
and	CC	cc
the	DT	det
prosecution	NN	compound
history	NN	conj
,	,	punct
the	DT	det
claim	NNS	nsubj
-PRON-	PRP	appos
provide	VBP	ccomp
substantial	JJ	amod
guidance	NN	dobj
as	IN	prep
to	IN	prep
the	DT	det
meaning	NN	pobj
of	IN	prep
particular	JJ	amod
claim	NN	compound
term	NNS	pobj
"	''	punct
.	.	punct

phillip	NNS	ROOT
v.	IN	prep
AWH	NNP	compound
Corp.	NNP	pobj
,	,	punct
415	CD	nummod
f.3d	CD	appos
1303	CD	nummod
,	,	punct
1314	CD	npadvmod
(	-LRB-	punct
Fed	NNP	appos
.	.	punct
Cir.2005	LS	dobj
)	-RRB-	punct
.	.	punct
"	''	punct

first	RB	advmod
,	,	punct
-PRON-	PRP	nsubj
look	VBP	ROOT
to	IN	prep
the	DT	det
word	NNS	pobj
of	IN	prep
the	DT	det
claim	NNS	pobj
-PRON-	PRP	npadvmod
,	,	punct
both	DT	preconj
assert	VBD	acl
and	CC	cc
nonasserte	VBN	conj
,	,	punct
to	TO	aux
define	VB	acl
the	DT	det
scope	NN	dobj
of	IN	prep
the	DT	det
patented	JJ	amod
invention	NN	pobj
"	''	punct
.	.	punct

Vitronics	NNP	compound
Corp.	NNP	ROOT
v.	IN	prep
Conceptronic	NNP	nmod
,	,	punct
Inc.	NNP	pobj
,	,	punct
90	CD	nummod
f.3d	CD	appos
1576	CD	nummod
,	,	punct
1582	CD	npadvmod
(	-LRB-	punct
Fed	NNP	nmod
.	.	punct
Cir.1996	LS	appos
)	-RRB-	punct
.	.	punct

where	WRB	advmod
claim	NN	compound
term	NNS	nsubj
be	VBP	advcl
ambiguous	JJ	acomp
or	CC	cc
dispute	VBN	conj
,	,	punct
then	RB	advmod
-PRON-	PRP	nsubj
turn	VBP	ROOT
to	IN	prep
the	DT	det
specification	NN	pobj
as	IN	mark
"	``	punct
the	DT	det
specification	NN	nsubj
'	''	punct
be	VBZ	advcl
always	RB	advmod
highly	RB	advmod
relevant	JJ	acomp
to	IN	prep
the	DT	det
claim	NN	compound
construction	NN	compound
analysis	NN	pobj
.	.	punct

usually	RB	advmod
,	,	punct
-PRON-	PRP	nsubj
be	VBZ	ccomp
dispositive	JJ	acomp
;	:	punct
-PRON-	PRP	nsubj
be	VBZ	ROOT
the	DT	det
single	JJ	amod
good	JJS	amod
guide	NN	attr
to	IN	prep
the	DT	det
meaning	NN	pobj
of	IN	prep
a	DT	det
dispute	VBN	amod
term	NN	pobj
.	.	punct
'	''	punct
"	``	punct
phillip	NNS	attr
,	,	punct
415	CD	nummod
f.3d	CD	appos
at	IN	prep
1315	CD	pobj
(	-LRB-	punct
quote	VBG	acl
Vitronics	NNP	dobj
,	,	punct
90	CD	nummod
f.3d	CD	npadvmod
at	IN	prep
1582	CD	pobj
)	-RRB-	punct
.	.	punct

 	_SP	

Once	IN	mark
the	DT	det
scope	NN	nsubj
of	IN	prep
the	DT	det
claim	NNS	pobj
be	VBP	auxpass
determine	VBN	advcl
,	,	punct
the	DT	det
actual	JJ	amod
obviousness	JJ	amod
determination	NN	nsubj
under	IN	prep
35	CD	nummod
u.s.c.	NN	pobj
¡±	CD	nummod
103	CD	nummod
begin	VBZ	ROOT
.	.	punct

recently	RB	advmod
this	DT	det
court	NN	nsubj
re	VBD	subtok
-	VBD	subtok
iterate	VBD	ROOT
the	DT	det
proper	JJ	amod
standard	NNS	dobj
for	IN	prep
make	VBG	pcomp
determination	NNS	dobj
under	IN	prep
¡±	CD	pobj
103	CD	nummod
.	.	punct

In	IN	prep
re	NN	pobj
Kahn	NNP	pobj
,	,	punct
441	CD	nummod
f.3d	CD	nummod
977	CD	nummod
(	-LRB-	punct
Fed	NNP	pobj
.	.	punct
Cir.2006	LS	ROOT
)	-RRB-	punct
.	.	punct

first	RB	advmod
,	,	punct
the	DT	det
court	NN	nsubj

 	_SP	
determine	VBZ	ROOT
the	DT	det
scope	NN	dobj
and	CC	cc
content	NN	conj
of	IN	prep
the	DT	det
prior	JJ	amod
art	NN	pobj
,	,	punct
and	CC	cc
ascertain	VBZ	conj
the	DT	det
difference	NNS	dobj
between	IN	prep
the	DT	det
prior	JJ	amod
art	NN	pobj
and	CC	cc
the	DT	det
claim	NNS	conj
at	IN	prep
issue	NN	pobj
,	,	punct
and	CC	cc
resolve	VBZ	conj
the	DT	det
level	NN	dobj
of	IN	prep
ordinary	JJ	amod
skill	NN	pobj
in	IN	prep
the	DT	det
pertinent	JJ	amod
art	NN	pobj
.	.	punct

Against	IN	prep
this	DT	det
background	NN	pobj
,	,	punct
the	DT	det
[	-LRB-	punct
court	NN	nsubj
]	-RRB-	punct
determine	VBZ	ROOT
whether	IN	mark
the	DT	det
subject	JJ	amod
matter	NN	nsubj
would	MD	aux
have	VB	aux
be	VBN	ccomp
obvious	JJ	acomp
to	IN	prep
a	DT	det
person	NN	pobj
of	IN	prep
ordinary	JJ	amod
skill	NN	pobj
in	IN	prep
the	DT	det
art	NN	pobj
at	IN	prep
the	DT	det
time	NN	pobj
of	IN	prep
the	DT	det
assert	VBN	amod
invention	NN	pobj
.	.	punct

 	_SP	

Idaho	NNP	ROOT
at	IN	prep
985	CD	pobj
(	-LRB-	punct
cite	VBG	acl
Dann	NNP	dobj
v.	IN	prep
Johnston	NNP	pobj
,	,	punct
425	CD	nummod
U.S.	NNP	npadvmod
219	CD	nummod
,	,	punct
226	CD	appos
,	,	punct
96	CD	nummod
S.Ct	NNP	subtok
.	.	punct
1393	CD	appos
,	,	punct
47	CD	nummod
l.ed.2d	NN	nmod
692	CD	nummod
(	-LRB-	punct
1976	CD	appos
)	-RRB-	punct
and	CC	cc
Graham	NNP	conj
v.	IN	prep
John	NNP	compound
Deere	NNP	compound
Co.	NNP	conj
,	,	punct
383	CD	nummod
U.S.	NNP	conj
1	CD	nummod
,	,	punct
13	CD	nummod
-	SYM	punct
14	CD	prep
,	,	punct
86	CD	nummod
S.Ct	NNP	subtok
.	.	punct

684	CD	ROOT
,	,	punct
15	CD	nummod
l.ed.2d	NN	nmod
545	CD	nummod
(	-LRB-	punct
1966	CD	npadvmod
)	-RRB-	punct
)	-RRB-	punct
.	.	punct

In	IN	prep
make	VBG	pcomp
this	DT	det
determination	NN	dobj
,	,	punct
-PRON-	PRP	nsubj
note	VBD	ROOT
in	IN	prep
Kahn	NNP	pobj
that	IN	mark
"	``	punct
most	JJS	amod
invention	NNS	nsubj
arise	VBP	ccomp
from	IN	prep
a	DT	det
combination	NN	pobj
of	IN	prep
old	JJ	amod
element	NNS	pobj
and	CC	cc
each	DT	det
element	NN	nsubjpass
may	MD	aux
often	RB	advmod
be	VB	auxpass
find	VBN	conj
in	IN	prep
the	DT	det
prior	JJ	amod
art	NN	pobj
"	''	punct
.	.	punct

Idaho	NNS	ROOT
at	IN	prep
986	CD	pobj
.	.	punct

the	DT	det
prior	JJ	amod
art	NN	nsubjpass
that	WDT	nsubjpass
be	VBZ	auxpass
consider	VBN	relcl
be	VBZ	auxpass
draw	VBN	ROOT
from	IN	prep
reference	NNS	pobj
"	''	punct
either	CC	preconj
in	IN	prep
the	DT	det
field	NN	pobj
of	IN	prep
the	DT	det
applicant	NN	poss
's	POS	case
endeavor	NN	pobj
or	CC	cc
be	VBZ	conj
reasonably	RB	advmod
pertinent	JJ	acomp
to	IN	prep
the	DT	det
problem	NN	pobj
with	IN	prep
which	WDT	pobj
the	DT	det
inventor	NN	nsubj
be	VBD	relcl
concern	VBN	acomp
"	''	punct
.	.	punct

Idaho	NNS	ROOT
at	IN	prep
987	CD	pobj
.	.	punct

 	_SP	

however	RB	advmod
,	,	punct
mere	JJ	amod
identification	NN	nsubj
in	IN	prep
the	DT	det
prior	JJ	amod
art	NN	pobj
of	IN	prep
each	DT	det
element	NN	pobj
be	VBZ	ROOT
insufficient	JJ	acomp
to	TO	aux
defeat	VB	xcomp
the	DT	det
patentability	NN	dobj
of	IN	prep
the	DT	det
combine	VBN	amod
subject	NN	amod
matter	NN	pobj
as	IN	prep
a	DT	det
whole	NN	pobj
.	.	punct

rather	RB	advmod
,	,	punct
a	DT	det
party	NN	nsubj
allege	VBG	csubj
invalidity	NN	dobj
due	IN	prep
to	IN	pcomp
obviousness	JJ	pobj
must	MD	aux
articulate	VB	ROOT
the	DT	det
reason	NNS	dobj
one	CD	nsubjpass
of	IN	prep
ordinary	JJ	amod
skill	NN	pobj
in	IN	prep
the	DT	det
art	NN	pobj
would	MD	aux
have	VB	aux
be	VBN	auxpass
motivate	VBN	relcl
to	TO	aux
select	VB	xcomp
the	DT	det
reference	NNS	dobj
and	CC	cc
to	TO	aux
combine	VB	conj
-PRON-	PRP	dobj
to	TO	aux
render	VB	xcomp
the	DT	det
claim	VBN	amod
invention	NN	nsubj
obvious	JJ	ccomp
.	.	punct

 	_SP	

Idaho	NNP	ROOT
at	IN	prep
986	CD	pobj
.	.	punct

 	_SP	

This	DT	det
'	``	punct
motivation	NN	nmod
-	HYPH	punct
suggestion	NN	compound
-	HYPH	punct
teaching	NN	nmod
'	''	punct
test	NN	nsubj
ask	VBZ	ROOT
not	RB	neg
merely	RB	advmod
what	WP	dobj
the	DT	det
reference	NNS	nsubj
disclose	VBP	ccomp
,	,	punct
but	CC	cc
whether	IN	mark
a	DT	det
person	NN	nsubj
of	IN	prep
ordinary	JJ	amod
skill	NN	pobj
in	IN	prep
the	DT	det
art	NN	pobj
,	,	punct
possess	VBN	advcl
with	IN	prep
the	DT	det
understanding	NNS	pobj
and	CC	cc
knowledge	NN	conj
reflect	VBN	acl
in	IN	prep
the	DT	det
prior	JJ	amod
art	NN	pobj
,	,	punct
and	CC	cc
motivate	VBN	conj
by	IN	agent
the	DT	det
general	JJ	amod
problem	NN	pobj
face	VBG	acl
the	DT	det
inventor	NN	dobj
,	,	punct
would	MD	aux
have	VB	aux
be	VBN	auxpass
lead	VBN	conj
to	TO	aux
make	VB	xcomp
the	DT	det
combination	NN	nsubj
recite	VBN	ccomp
in	IN	prep
the	DT	det
claim	NNS	pobj
.	.	punct

 	_SP	

Idaho	NNP	ROOT
at	IN	prep
988	CD	pobj
.	.	punct

 	_SP	

In	IN	prep
analyze	VBG	pcomp
Teva	NNP	poss
's	POS	case
obviousness	JJ	amod
contention	NNS	dobj
as	IN	mark
to	IN	aux
claim	NNS	advcl
2	CD	dobj
,	,	punct
4	CD	npadvmod
,	,	punct
and	CC	cc
6	CD	conj
of	IN	prep
the	DT	det
'	``	punct
718	CD	nummod
patent	NN	pobj
and	CC	cc
Abbott	NNP	poss
's	POS	case
alternative	JJ	amod
ground	NNS	conj
for	IN	prep
affirm	VBG	pcomp
the	DT	det
preliminary	JJ	amod
injunction	NN	dobj
under	IN	prep
claim	NN	pobj
2	CD	nummod
of	IN	prep
'	CD	punct
616	CD	nummod
patent	NN	pobj
,	,	punct
-PRON-	PRP	nsubj
separate	VBP	ROOT
the	DT	det
analysis	NN	dobj
into	IN	prep
two	CD	nummod
part	NNS	pobj
.	.	punct

claim	NN	nsubjpass
2	CD	nummod
and	CC	cc
4	CD	conj
of	IN	prep
the	DT	det
'	``	punct
718	CD	nummod
patent	NN	pobj
be	VBP	auxpass
closely	RB	advmod
related	JJ	ROOT
and	CC	cc
be	VBP	auxpass
address	VBN	conj
first	RB	advmod
.	.	punct

Claim	NNP	nsubjpass
6	CD	nummod
of	IN	prep
the	DT	det
'	``	punct
718	CD	nummod
patent	NN	pobj
and	CC	cc
claim	NN	conj
2	CD	dobj
of	IN	prep
the	DT	det
'	``	punct
616	CD	nummod
patent	NN	pobj
be	VBP	auxpass
deal	VBN	ROOT
with	IN	prep
next	JJ	advmod
.	.	punct

For	IN	prep
each	DT	det
pair	NN	pobj
of	IN	prep
claim	NNS	pobj
,	,	punct
-PRON-	PRP	nsubj
construe	VBP	ROOT
the	DT	det
claim	NNS	dobj
and	CC	cc
-PRON-	PRP	nsubj
determine	VBP	conj
if	IN	mark
the	DT	det
allegation	NNS	nsubj
raise	VBP	ccomp
substantial	JJ	amod
question	NNS	dobj
of	IN	prep
obviousness	NN	pobj
.	.	punct

  	_SP	

-PRON-	PRP	nsubj
begin	VBP	ROOT
by	IN	prep
examine	VBG	pcomp
claim	NN	dobj
2	CD	nummod
and	CC	cc
4	CD	conj
of	IN	prep
the	DT	det
'	``	punct
718	CD	nummod
patent	NN	pobj
and	CC	cc
the	DT	det
district	NN	compound
court	NN	poss
's	POS	case
analysis	NN	conj
regard	VBG	prep
these	DT	det
claim	NNS	pobj
.	.	punct

claim	NN	nsubj
2	CD	nummod
of	IN	prep
the	DT	det
'	``	punct
718	CD	nummod
patent	NN	pobj
claims3	NN	appos

 	_SP	
a	DT	det
pharmaceutical	JJ	amod
composition	NN	appos
for	IN	prep
extended	JJ	amod
release	NN	pobj
of	IN	prep
an	DT	det
erythromycin	JJ	amod
derivative	NN	pobj
in	IN	prep
the	DT	det
gastrointestinal	JJ	amod
environment	NN	pobj
,	,	punct
comprise	VBG	acl

 	_SP	
an	DT	det
erythromycin	JJ	amod
derivative	JJ	dobj
and	CC	cc

 	_SP	
from	IN	prep
about	IN	quantmod
5	CD	pobj
to	IN	prep
about	IN	quantmod
50	CD	nummod
%	NN	pobj
by	IN	prep
weight	NN	pobj
of	IN	prep
a	DT	det
pharmaceutically	RB	advmod
acceptable	JJ	amod
polymer	NN	pobj
,	,	punct
wherein	WRB	advmod
the	DT	det
polymer	NN	nsubj
be	VBZ	ROOT
a	DT	det
hydrophilic	JJ	amod
water	NN	npadvmod
-	HYPH	punct
soluble	JJ	amod
polymer	NN	attr
,	,	punct
so	IN	mark
that	IN	mark
when	WRB	advmod
ingest	VBN	advcl
orally	RB	advmod
,	,	punct
the	DT	det
composition	NN	nsubj
induce	VBZ	advcl
statistically	RB	advmod
significantly	RB	advmod
low	JJR	amod
mean	JJ	amod
fluctuation	NN	compound
index	NN	dobj
in	IN	prep
the	DT	det
plasma	NN	pobj
than	IN	prep
an	DT	det
immediate	JJ	amod
release	NN	compound
composition	NN	pobj
of	IN	prep
the	DT	det
erythromycin	JJ	amod
derivative	JJ	pobj
while	IN	mark
maintain	VBG	advcl
bioavailability	NN	dobj
substantially	RB	advmod
equivalent	JJ	amod
to	IN	prep
that	DT	pobj
of	IN	prep
the	DT	det
immediate	JJ	amod
release	NN	compound
composition	NN	pobj
of	IN	prep
the	DT	det
erythromycin	JJ	amod
derivative	JJ	pobj
.	.	punct

 	_SP	
'	POS	punct
718	CD	nummod
patent	NN	attr
,	,	punct
col.	NN	conj
11	CD	nummod
,	,	punct
will	UH	intj
.	.	punct

28	CD	ROOT
-	SYM	punct
40	CD	prep
.	.	punct

In	IN	prep
short	JJ	amod
,	,	punct
claim	NN	nsubj
2	CD	dobj
have	VBZ	ROOT
three	CD	nummod
basic	JJ	amod
element	NNS	dobj
.	.	punct

first	RB	advmod
,	,	punct
the	DT	det
extended	JJ	amod
release	NN	compound
composition	NN	nsubj
include	VBZ	ROOT
an	DT	det
erythromycin	JJ	amod
derivative	JJ	dobj
.	.	punct

second	JJ	advmod
,	,	punct
-PRON-	PRP	nsubj
include	VBZ	ROOT
a	DT	det
polymer	NN	dobj
.	.	punct

third	RB	advmod
,	,	punct
the	DT	det
claim	NN	nsubj
include	VBZ	ROOT
specific	JJ	amod
pharmacokinetic	JJ	amod
parameter	NNS	dobj
that	IN	dobj
the	DT	det
erythromycin	JJ	amod
derivative	JJ	nmod
and	CC	cc
polymer	NN	conj
composition	NN	nsubj
must	MD	aux
meet	VB	relcl
.	.	punct

 	_SP	

similarly	RB	advmod
,	,	punct
claim	NN	ROOT
4	CD	nummod
claim	NNS	dobj

 	_SP	
a	DT	det
pharmaceutical	JJ	amod
composition	NN	dobj
for	IN	prep
extended	JJ	amod
release	NN	pobj
of	IN	prep
an	DT	det
erythromycin	JJ	amod
derivative	NN	pobj
in	IN	prep
the	DT	det
gastrointestinal	JJ	amod
environment	NN	pobj
,	,	punct
comprise	VBG	advcl

 	_SP	
an	DT	det
erythromycin	JJ	amod
derivative	JJ	dobj
and	CC	cc

 	_SP	
from	IN	conj
about	IN	quantmod
5	CD	pobj
to	IN	prep
about	IN	quantmod
50	CD	nummod
%	NN	pobj
by	IN	prep
weight	NN	pobj
of	IN	prep
a	DT	det
pharmaceutically	RB	advmod
acceptable	JJ	amod
polymer	NN	pobj
,	,	punct

 	_SP	
so	IN	mark
that	IN	mark
upon	IN	prep
oral	JJ	amod
ingestion	NN	pobj
,	,	punct
maximum	JJ	amod
peak	NN	compound
concentration	NNS	nsubj
of	IN	prep
the	DT	det
erythromycin	JJ	amod
derivative	NN	pobj
be	VBP	advcl
low	JJR	acomp
than	IN	prep
those	DT	pobj
produce	VBN	acl
by	IN	agent
an	DT	det
immediate	JJ	amod
release	NN	compound
pharmaceutical	NN	compound
composition	NN	pobj
,	,	punct
and	CC	cc
area	NN	nsubj
under	IN	prep
the	DT	det
concentration	NN	compound
-	HYPH	punct
time	NN	compound
curve	NN	pobj
and	CC	cc
the	DT	det
minimum	JJ	amod
plasma	NN	compound
concentration	NN	conj
be	VBP	conj
substantially	RB	advmod
equivalent	JJ	acomp
to	IN	prep
that	DT	pobj
of	IN	prep
the	DT	det
immediate	JJ	amod
release	NN	compound
pharmaceutical	NN	compound
composition	NN	pobj
.	.	punct

 	_SP	
'	POS	punct
718	CD	nummod
patent	NN	dobj
,	,	punct
col.	NN	conj
11	CD	nummod
,	,	punct
will	UH	intj
.	.	punct

48	CD	ROOT
-	SYM	punct
58	CD	prep
.	.	punct

As	IN	mark
can	MD	aux
be	VB	auxpass
see	VBN	advcl
,	,	punct
claim	NN	conj
4	CD	dobj
also	RB	advmod
have	VBZ	ROOT
three	CD	nummod
basic	JJ	amod
element	NNS	dobj
:	:	punct
the	DT	det
erythromycin	JJ	amod
derivative	NN	appos
,	,	punct
the	DT	det
polymer	NN	conj
,	,	punct
and	CC	cc
specific	JJ	conj
(	-LRB-	punct
but	CC	cc
different	JJ	conj
from	IN	prep
claim	NN	pobj
2	CD	nummod
)	-RRB-	punct
pharmacokinetic	JJ	amod
parameter	NNS	appos
.	.	punct

 	_SP	

From	IN	prep
the	DT	det
specification	NN	pobj
,	,	punct
the	DT	det
district	NN	compound
court	NN	nsubj
define	VBD	ccomp
erythromycin	JJ	amod
derivative	JJ	dobj
in	IN	prep
both	DT	det
claim	NNS	pobj
as	IN	prep
mean	VBG	pcomp
"	''	punct
'	``	punct
erythromycin	JJ	nsubj
have	VBG	xcomp
no	DT	det
substituent	NN	amod
group	NNS	dobj
,	,	punct
or	CC	cc
have	VBG	conj
conventional	JJ	amod
substituent	NN	amod
group	NNS	dobj
,	,	punct
in	IN	prep
organic	JJ	amod
synthesis	NN	pobj
,	,	punct
in	IN	prep
place	NN	pobj
of	IN	prep
a	DT	det
hydrogen	NN	compound
atom	NN	pobj
of	IN	prep
the	DT	det
hydroxy	NN	amod
group	NNS	pobj
and/or	CC	punct
a	DT	det
methyl	NN	compound
group	NN	dobj
of	IN	prep
the	DT	det
3'-dimethylamino	CD	nummod
group	NN	pobj
,	,	punct
which	WDT	nsubjpass
be	VBZ	auxpass
prepare	VBN	relcl
accord	VBG	prep
to	IN	prep
the	DT	det
conventional	JJ	amod
manner	NN	pobj
.	.	punct
'	''	punct
"	``	punct
Abbott	NNP	compound
Labs.	NNP	nsubj
,	,	punct
slip	VB	ROOT
op	RP	dobj
.	.	punct

at	IN	ROOT
10	CD	pobj
(	-LRB-	punct
quote	VBG	pobj
'	``	punct
718	CD	nummod
patent	NN	dobj
,	,	punct
col.	NN	npadvmod
3	CD	nummod
,	,	punct
will	UH	intj
.	.	punct
34	CD	npadvmod
-	SYM	punct
39	CD	prep
)	-RRB-	punct
.	.	punct

notably	RB	advmod
,	,	punct
this	DT	det
definition	NN	nsubj
of	IN	prep
erythromycin	JJ	amod
derivative	JJ	pobj
include	VBZ	ROOT
clarithromycin	NN	dobj
but	CC	cc
exclude	NNS	conj
azithromycin	RB	advmod
,	,	punct
a	DT	det
related	JJ	amod
macrolide	NN	amod
antibiotic	NN	appos
sell	VBN	acl
by	IN	agent
Pfizer	NNP	pobj
as	IN	prep
the	DT	det
drug	NN	pobj
Zithromax	NNP	appos
.	.	punct

 	_SP	

then	RB	advmod
,	,	punct
construe	VBG	advcl
"	``	punct
pharmaceutically	RB	advmod
acceptable	JJ	amod
polymer	NN	dobj
,	,	punct
"	''	punct
the	DT	det
district	NN	compound
court	NN	nsubj
again	RB	advmod
properly	RB	advmod
turn	VBD	ROOT
to	IN	prep
the	DT	det
'	``	punct
718	CD	nummod
patent	NN	compound
specification	NN	pobj
.	.	punct

the	DT	det
specification	NN	nsubj
describe	VBZ	ROOT
this	DT	dobj
as	IN	prep
"	``	punct
a	DT	det
water	NN	npadvmod
-	HYPH	punct
soluble	JJ	amod
hydrophilic	JJ	compound
polymer	NN	pobj
select	VBN	acl
from	IN	prep
the	DT	det
group	NN	pobj
consist	VBG	acl
of	IN	prep
polyvinylpyrrolidine	NN	pobj
,	,	punct
hydroxypropyl	JJ	amod
cellulose	NN	conj
,	,	punct
hydroxypropylmethyl	RB	advmod
cellulose	NN	conj
,	,	punct
methyl	NN	compound
cellulose	NN	conj
,	,	punct
vinyl	NN	nmod
acetate	VB	nmod
/	SYM	punct
crotonic	VB	amod
acid	NN	compound
copolymer	NNS	conj
,	,	punct
methacrylic	NN	nsubj
acid	NNS	conj
copolymer	NNS	dobj
,	,	punct
maleic	NN	compound
anhydride	NN	compound
/	SYM	punct
methyl	NN	compound
vinyl	NN	appos
either	CC	preconj
copolymer	NNS	conj
and	CC	cc
derivative	NNS	conj
and	CC	cc
mixture	NNS	conj
thereof	RB	advmod
"	''	punct
.	.	punct

Idaho	NNP	ROOT
(	-LRB-	punct
quote	VBG	parataxis
'	``	punct
718	CD	nummod
patent	NN	dobj
,	,	punct
col.	NN	npadvmod
col.	NN	npadvmod
)	-RRB-	punct
.	.	punct

furthermore	RB	advmod
,	,	punct
the	DT	det
specification	NN	nsubj
describe	VBZ	ROOT
the	DT	det
"	``	punct
'	``	punct
more	RBR	advmod
preferable	JJ	amod
'	''	punct
"	''	punct
polymer	NN	dobj
as	IN	prep
hydroxypropylmethyl	RB	advmod
cellulose	NN	pobj
(	-LRB-	punct
"	``	punct
HPMC	NNP	appos
"	''	punct
)	-RRB-	punct
.	.	punct

Idaho	NNP	ROOT
(	-LRB-	punct
quote	VBG	parataxis
'	``	punct
718	CD	nummod
patent	NN	dobj
,	,	punct
col.	NN	npadvmod
)	-RRB-	punct
.	.	punct

 	_SP	

the	DT	det
district	NN	compound
court	NN	nsubj
also	RB	advmod
construe	VBD	ROOT
the	DT	det
more	RBR	advmod
technical	JJ	amod
limitation	NNS	dobj
in	IN	prep
the	DT	det
claim	NNS	pobj
.	.	punct

In	IN	prep
claim	NN	pobj
4	CD	nummod
the	DT	det
pharmacokinetic	JJ	amod
limitation	NNS	nsubj
require	VBP	ROOT
that	IN	mark

 	_SP	
upon	IN	prep
oral	JJ	amod
ingestion	NN	pobj
,	,	punct
maximum	JJ	amod
peak	NN	compound
concentration	NNS	conj
of	IN	prep
the	DT	det
erythromycin	JJ	amod
derivative	NN	pobj
be	VBP	ccomp
low	JJR	acomp
than	IN	prep
those	DT	pobj
produce	VBN	acl
by	IN	agent
an	DT	det
immediate	JJ	amod
release	NN	compound
pharmaceutical	NN	compound
composition	NN	pobj
,	,	punct
and	CC	cc
area	NN	nsubj
under	IN	prep
the	DT	det
concentration	NN	compound
-	HYPH	punct
time	NN	compound
curve	NN	pobj
and	CC	cc
the	DT	det
minimum	JJ	amod
plasma	NN	compound
concentration	NN	conj
be	VBP	conj
substantially	RB	advmod
equivalent	JJ	acomp
to	IN	prep
that	DT	pobj
of	IN	prep
the	DT	det
immediate	JJ	amod
release	NN	compound
pharmaceutical	NN	compound
composition	NN	pobj
.	.	punct

 	_SP	

the	DT	det
district	NN	compound
court	NN	nsubj
elaborate	VBN	ROOT
on	IN	prep
this	DT	det
language	NN	pobj
by	IN	prep
state	VBG	pcomp
that	IN	mark

 	_SP	
this	DT	nsubj
mean	VBZ	ccomp
that	IN	mark
the	DT	det
concentration	NN	compound
-	HYPH	punct
time	NN	compound
curve	NN	nsubj
represent	VBG	acl
the	DT	det
concentration	NN	dobj
of	IN	prep
drug	NN	pobj
in	IN	prep
blood	NN	compound
plasma	NN	pobj
will	MD	aux
be	VB	ccomp
flat	JJR	acomp
and	CC	cc
low	JJR	conj
for	IN	prep
the	DT	det
extended	JJ	amod
release	NN	compound
formulation	NN	pobj
than	IN	prep
for	IN	prep
the	DT	det
immediate	JJ	amod
release	NN	compound
formulation	NN	pobj
,	,	punct
but	CC	cc
will	MD	aux
have	VB	conj
an	DT	det
area	NN	dobj
under	IN	prep
the	DT	det
curve	NN	pobj
(	-LRB-	punct
"	``	punct
AUC	NNP	appos
"	''	punct
)	-RRB-	punct
that	WDT	nsubj
be	VBZ	relcl
substantially	RB	advmod
equivalent	JJ	acomp
to	IN	prep
that	DT	pobj
of	IN	prep
-PRON-	PRP$	poss
immediate	JJ	amod
release	NN	compound
corollary	JJ	pobj
.	.	punct

At	IN	prep
the	DT	det
same	JJ	amod
time	NN	pobj
,	,	punct
the	DT	det
minimum	JJ	amod
plasma	NN	compound
concentration	NN	nsubj
for	IN	prep
the	DT	det
extended	JJ	amod
release	NN	compound
formulation	NN	pobj
will	MD	aux
be	VB	ROOT
substantially	RB	advmod
the	DT	det
same	JJ	attr
as	IN	prep
that	DT	pobj
of	IN	prep
the	DT	det
immediate	JJ	amod
release	NN	compound
formulation	NN	pobj
,	,	punct
mean	VBG	advcl
that	IN	mark
the	DT	det
drug	NN	nsubj
will	MD	aux
be	VB	ccomp
present	JJ	acomp
in	IN	prep
the	DT	det
blood	NN	pobj
at	IN	prep
the	DT	det
same	JJ	amod
minimum	JJ	amod
level	NN	pobj
at	IN	prep
all	DT	det
time	NNS	pobj
for	IN	prep
both	CC	preconj
the	DT	det
immediate	JJ	amod
release	NN	pobj
and	CC	cc
extended	JJ	amod
release	NN	compound
formulation	NNS	conj
.	.	punct

 	_SP	

the	DT	det
district	NN	compound
court	NN	nsubj
do	VBD	aux
not	RB	neg
address	VB	ROOT
the	DT	det
pharmacokinetic	JJ	amod
limitation	NNS	dobj
of	IN	prep
claim	NN	pobj
2	CD	dobj
explicitly	RB	advmod
.	.	punct

below	RB	advmod
,	,	punct
in	IN	prep
-PRON-	PRP$	poss
analysis	NN	pobj
,	,	punct
-PRON-	PRP	nsubj
turn	VBP	ROOT
to	IN	prep
the	DT	det
specification	NN	pobj
to	TO	aux
aid	VB	xcomp
in	IN	prep
define	VBG	pcomp
the	DT	det
pharmacokinetic	JJ	amod
parameter	NNS	dobj
of	IN	prep
claim	NN	pobj
2	CD	dobj
.	.	punct

 	_SP	

In	IN	prep
make	VBG	pcomp
-PRON-	PRP$	poss
invalidity	NN	compound
contention	NNS	dobj
,	,	punct
Teva	NNP	nsubj
point	VBD	ROOT
to	IN	prep
a	DT	det
number	NN	pobj
of	IN	prep
prior	JJ	amod
art	NN	compound
reference	NNS	pobj
.	.	punct

These	DT	nsubj
include	VBD	ROOT
publish	VBN	amod
Patent	NNP	compound
Cooperation	NNP	compound
Treaty	NNP	compound
application	NN	compound
WO	NNP	dobj

95/30422	CD	punct
(	-LRB-	punct
"	``	punct
the	DT	det
'	''	punct
422	CD	nummod
publication	NN	ROOT
"	''	punct
)	-RRB-	punct
.	.	punct

-PRON-	PRP	nsubj
pertain	VBD	ROOT
to	IN	prep
control	VBN	amod
-	HYPH	punct
release	NN	compound
dosage	NN	compound
form	NNS	pobj
of	IN	prep
azithromycin	NN	pobj
with	IN	prep
HPMC	NNP	pobj
that	IN	mark
,	,	punct
among	IN	prep
other	JJ	amod
thing	NNS	pobj
,	,	punct
be	VBD	auxpass
mean	VBN	ccomp
to	TO	aux
address	VB	xcomp
the	DT	det
GI	NNP	compound
side	NN	compound
effect	NNS	dobj
of	IN	prep
azithromycin	NN	pobj
.	.	punct

 	_SP	

Teva	NNP	nsubj
also	RB	advmod
point	VBD	ROOT
to	IN	prep
Abbott	NNP	poss
's	POS	case
own	JJ	amod
U.S.	NNP	compound
patent	NN	compound
No.	SYM	pobj
5,705,190	CD	nummod
(	-LRB-	punct
"	``	punct
'	``	punct
190	CD	nummod
patent	NN	dobj
"	''	punct
)	-RRB-	punct
which	WDT	nsubj
disclose	VBD	relcl
a	DT	det
control	VBN	amod
release	NN	compound
pharmaceutical	NN	amod
formulation	NN	dobj
of	IN	prep
clarithromycin	NN	pobj
combine	VBN	acl
with	IN	prep
a	DT	det
water	NN	npadvmod
soluble	JJ	amod
alginate	NN	compound
salt	NN	pobj
.	.	punct

furthermore	RB	advmod
,	,	punct
Teva	NNP	nsubj
also	RB	advmod
cite	VBD	ROOT
a	DT	det
number	NN	dobj
of	IN	prep
other	JJ	amod
prior	JJ	amod
art	NN	compound
reference	NNS	pobj
include	VBG	prep
textbook	NNS	pobj
and	CC	cc
government	NN	nmod
and	CC	cc
trade	NN	conj
publication	NNS	conj
that	WDT	nsubj
discuss	VBD	relcl
control	VBN	amod
release	NN	compound
pharmaceutical	NNS	dobj
.	.	punct

the	DT	det
district	NN	compound
court	NN	nsubj
characterize	VBD	ROOT
these	DT	det
more	JJR	advmod
general	JJ	amod
source	NNS	dobj
as	IN	prep
"	``	punct
source	NNS	pobj
in	IN	prep
the	DT	det
prior	JJ	amod
art	NN	pobj
discuss	VBG	acl
extended	JJ	amod
release	NN	compound
formulation	NNS	dobj
and	CC	cc
seek	VBG	conj
way	NNS	dobj
to	TO	aux
develop	VB	relcl
formulation	NNS	dobj
that	WDT	nsubj
achieve	VBD	relcl
desirable	JJ	amod
pharmacokinetic	JJ	amod
goal	NNS	dobj
"	''	punct
.	.	punct

Idaho	NNP	nsubj

 	_SP	
consider	VBG	advcl
-PRON-	PRP$	poss
tentative	JJ	amod
claim	NN	compound
construction	NN	dobj
and	CC	cc
after	IN	conj
review	VBG	pcomp
these	DT	det
prior	JJ	amod
art	NN	compound
reference	NNS	dobj
,	,	punct
the	DT	det
district	NN	compound
court	NN	nsubj
determine	VBD	ROOT
that	IN	mark

 	_SP	
Teva	NNP	nsubj
have	VBZ	aux
fail	VBN	ccomp
to	TO	aux
raise	VB	xcomp
a	DT	det
substantial	JJ	amod
question	NN	dobj
as	IN	prep
to	IN	prep
the	DT	det
validity	NN	pobj
of	IN	prep
Abbott	NNP	poss
's	POS	case
claim	NN	pobj
2	CD	appos
and	CC	cc
4	CD	conj
.	.	punct

the	DT	det
prior	JJ	amod
art	NN	nsubj
cite	VBN	acl
by	IN	agent
Teva	NNP	pobj
disclose	VBZ	ROOT
discrete	JJ	amod
portion	NNS	dobj
of	IN	prep
the	DT	det
assert	VBN	amod
claim	NNS	pobj
,	,	punct
but	CC	cc
Teva	NNP	nsubj
fail	VBZ	conj
to	TO	aux
demonstrate	VB	xcomp
that	IN	mark
this	DT	nsubj
would	MD	aux
be	VB	ccomp
sufficient	JJ	acomp
to	TO	aux
give	VB	xcomp
a	DT	det
person	NN	dobj
of	IN	prep
ordinary	JJ	amod
skill	NN	pobj
in	IN	prep
the	DT	det
art	NN	pobj
a	DT	det
reasonable	JJ	amod
expectation	NN	dobj
of	IN	prep
success	NN	pobj
.	.	punct

Teva	NNP	poss
's	POS	case
prior	JJ	amod
art	NN	compound
reference	NNS	nsubj
reveal	VBP	ROOT
that	IN	mark
use	VBG	csubj
HPMC	NNP	dobj
be	VBD	ccomp
a	DT	det
logical	JJ	amod
line	NN	attr
of	IN	prep
inquiry	NN	pobj
but	CC	cc
the	DT	det
dissimilarity	NNS	conj
between	IN	prep
the	DT	det
drug	NNS	pobj
with	IN	prep
which	WDT	pobj
HPMC	NNP	nsubj
have	VBD	aux
be	VBN	relcl
successfully	RB	advmod
combine	VBN	acomp
and	CC	cc
clarithromycin	JJ	compound
defeat	NN	conj

Teva	NNP	poss
's	POS	case
claim	NN	ROOT
of	IN	prep
obviousness	JJ	pobj
....	.	punct

Abbott	NNP	nsubj
have	VBZ	aux
provide	VBN	ROOT
ample	JJ	amod
evidence	NN	dobj
that	IN	mark
-PRON-	PRP$	poss
invention	NN	nsubj
be	VBD	acl
not	RB	neg
obvious	JJ	acomp
and	CC	cc
that	IN	mark
there	EX	expl
be	VBD	conj
many	JJ	amod
other	JJ	amod
extended	JJ	amod
release	NN	compound
formulation	NNS	attr
know	VBN	acl
in	IN	prep
the	DT	det
prior	JJ	amod
art	NN	pobj
.	.	punct

 	_SP	

Abbott	NNP	compound
Labs.	NNP	ROOT
,	,	punct
slip	VB	amod
op	RP	appos
.	.	punct

at	IN	ROOT
17	CD	pobj
-	SYM	punct
18	CD	prep
.	.	punct

 	_SP	

On	IN	prep
appeal	NN	pobj
,	,	punct
-PRON-	PRP	nsubj
begin	VBP	ROOT
,	,	punct
as	IN	mark
do	VBD	advcl
the	DT	det
district	NN	compound
court	NN	nsubj
,	,	punct
with	IN	prep
the	DT	det
claim	NNS	pobj
.	.	punct

-PRON-	PRP	nsubj
agree	VBP	ROOT
with	IN	prep
the	DT	det
district	NN	compound
court	NN	poss
's	POS	case
preliminary	JJ	amod
claim	NN	compound
construction	NN	pobj
as	IN	prep
to	IN	prep
"	``	punct
erythromycin	JJ	amod
derivative	JJ	pobj
"	''	punct
and	CC	cc
"	``	punct
pharmaceutically	RB	advmod
acceptable	JJ	amod
polymer	NN	conj
"	''	punct
in	IN	prep
both	DT	det
claim	NNS	pobj
2	CD	appos
and	CC	cc
4	CD	conj
.	.	punct

furthermore	RB	advmod
,	,	punct
-PRON-	PRP	nsubj
agree	VBP	ROOT
with	IN	prep
the	DT	det
district	NN	compound
court	NN	poss
's	POS	case
elaboration	NN	pobj
on	IN	prep
the	DT	det
pharmacokinetic	JJ	amod
parameter	NNS	pobj
of	IN	prep
claim	NN	pobj
4	CD	npadvmod
.	.	punct

In	IN	prep
short	JJ	amod
,	,	punct
the	DT	det
parameter	NNS	nsubj
of	IN	prep
claim	NN	pobj
4	CD	appos
require	VBP	ccomp
three	CD	nummod
thing	NNS	dobj
:	:	punct

 	_SP	
[	-LRB-	punct
1	CD	nummod
]	-RRB-	punct
maximum	JJ	amod
peak	NN	compound
concentration	NNS	nsubj
of	IN	prep
the	DT	det
erythromycin	JJ	amod
derivative	NN	pobj
be	VBP	ccomp
low	JJR	acomp
than	IN	prep
those	DT	pobj
produce	VBN	acl
by	IN	agent
an	DT	det
immediate	JJ	amod
release	NN	compound
pharmaceutical	NN	compound
composition	NN	pobj
,	,	punct
[	-LRB-	punct
2	CD	nummod
]	-RRB-	punct
area	NN	nsubj
under	IN	prep
the	DT	det
concentration	NN	compound
-	HYPH	punct
time	NN	compound
curve	NN	pobj
be	VBP	ccomp
substantially	RB	advmod
equivalent	JJ	acomp
to	IN	prep
that	DT	pobj
of	IN	prep
the	DT	det
immediate	JJ	amod
release	NN	compound
pharmaceutical	NN	compound
composition	NN	pobj
and	CC	cc
,	,	punct
[	-LRB-	punct
3	LS	meta
]	-RRB-	punct
the	DT	det
minimum	JJ	amod
plasma	NN	compound
concentration	NN	nsubj
be	VBP	ROOT
substantially	RB	advmod
equivalent	JJ	acomp
to	IN	prep
that	DT	pobj
of	IN	prep
the	DT	det
immediate	JJ	amod
release	NN	compound
pharmaceutical	NN	compound
composition	NN	pobj
.	.	punct

 	_SP	
'	POS	punct
718	CD	nummod
patent	NN	nsubj
,	,	punct
col.	NN	conj
11	CD	nummod
,	,	punct
will	UH	intj
.	.	punct

48	CD	ROOT
-	SYM	punct
58	CD	prep
.	.	punct

In	IN	prep
order	NN	pobj
to	TO	aux
more	RBR	advmod
fully	RB	advmod
understand	VB	acl
these	DT	det
specific	JJ	amod
parameter	NNS	dobj
,	,	punct
-PRON-	PRP	nsubj
turn	VBP	ROOT
to	IN	prep
the	DT	det
specification	NN	pobj
.	.	punct

-PRON-	PRP	nsubj
define	VBZ	ROOT
a	DT	det
number	NN	dobj
of	IN	prep
the	DT	det
relevant	JJ	amod
pharmacokinetic	JJ	amod
parameter	NNS	pobj
use	VBN	acl
in	IN	prep
these	DT	det
claim	NNS	pobj
.	.	punct

the	DT	det
specification	NN	nsubj
define	VBZ	ROOT
the	DT	det
"	``	punct
maximum	JJ	amod
plasma	NN	compound
concentration	NN	dobj
of	IN	prep
the	DT	det
erythromycin	JJ	amod
derivative	JJ	pobj
,	,	punct
produce	VBN	acl
by	IN	agent
the	DT	det
ingestion	NN	pobj
of	IN	prep
the	DT	det
composition	NN	pobj
of	IN	prep
the	DT	det
invention	NN	pobj
or	CC	cc
the	DT	det
IR	NNP	compound
comparator	NN	conj
"	''	punct
as	IN	prep
CMax	NNP	pobj
.	.	punct
'	''	punct
718	CD	nummod
patent	NN	dobj
,	,	punct
col.	NN	conj
3	CD	nummod
,	,	punct
will	UH	intj
.	.	punct

13	CD	ROOT
-	SYM	punct
15	CD	prep
.	.	punct

likewise	RB	advmod
,	,	punct
the	DT	det
minimum	JJ	amod
plasma	NN	compound
concentration	NN	nsubjpass
be	VBZ	auxpass
define	VBN	ROOT
as	IN	prep
CMin	NNP	pobj
.	.	punct
'	''	punct
718	CD	nummod
patent	NN	dobj
,	,	punct
col.	NN	conj
3	CD	nummod
,	,	punct
will	UH	intj
.	.	punct

15	CD	ROOT
-	SYM	punct
19	CD	prep
.	.	punct

the	DT	det
specification	NN	nsubj
define	VBZ	ROOT
the	DT	det
area	NN	dobj
under	IN	prep
the	DT	det
curve	NN	pobj
,	,	punct
AUC	NNP	appos
,	,	punct
"	''	punct
as	IN	prep
the	DT	det
area	NN	pobj
under	IN	prep
the	DT	det
plasma	NN	compound
concentration	NN	compound
-	HYPH	punct
time	NN	compound
curve	NN	pobj
,	,	punct
as	IN	mark
calculate	VBN	advcl
by	IN	agent
the	DT	det
trapezoidal	JJ	amod
rule	NN	pobj
over	IN	prep
the	DT	det
complete	JJ	amod
24-hour	JJ	nummod
interval	NN	pobj
for	IN	prep
all	PDT	predet
the	DT	det
formulation	NNS	pobj
"	''	punct
.	.	punct
'	''	punct
718	CD	nummod
patent	NN	dobj
,	,	punct
col.	NN	conj
3	CD	nummod
,	,	punct
will	UH	intj
.	.	punct

26	CD	ROOT
-	SYM	punct
29	CD	prep
.	.	punct

From	IN	prep
these	DT	det
definition	NNS	pobj
give	VBN	acl
in	IN	prep
the	DT	det
specification	NN	pobj
,	,	punct
-PRON-	PRP	nsubj
can	MD	aux
describe	VB	ROOT
the	DT	det
three	CD	nummod
pharmacokinetic	JJ	amod
limitation	NNS	dobj
of	IN	prep
claim	NN	pobj
4	CD	nummod
as	IN	quantmod
cmax_er	NN	pobj
<	XX	npadvmod
CMax_IR	NNP	npadvmod
,	,	punct
AUCER	NNP	nmod
=	SYM	punct
AUCIR	NNP	conj
,	,	punct
and	CC	cc
cmin_er	NN	punct
=	SYM	punct

cmin_ir.4	CD	ROOT

 	_SP	

As	IN	mark
to	TO	aux
claim	VB	advcl
2	CD	dobj
,	,	punct
the	DT	det
district	NN	compound
court	NN	nsubj
do	VBD	aux
not	RB	neg
explicitly	RB	advmod
discuss	VB	ROOT
that	DT	det
claim	NN	poss
's	POS	case
pharmacokinetic	JJ	amod
parameter	NNS	dobj
.	.	punct

nonetheless	RB	advmod
,	,	punct
just	RB	advmod
as	IN	mark
with	IN	prep
claim	NN	pobj
4	CD	nummod
,	,	punct
the	DT	det
parameter	NNS	nsubjpass
in	IN	prep
claim	NN	pobj
2	CD	nummod
be	VBP	auxpass
define	VBN	ROOT
in	IN	prep
the	DT	det
specification	NN	pobj
.	.	punct

Claim	NNP	nsubj
2	CD	nummod
require	VBZ	ROOT
that	IN	mark

 	_SP	
the	DT	det
composition	NN	nsubj
[	-LRB-	punct
1	CD	meta
]	-RRB-	punct
induce	NNS	ccomp
statistically	RB	advmod
significantly	RB	advmod
low	JJR	amod
mean	JJ	amod
fluctuation	NN	compound
index	NN	dobj
in	IN	prep
the	DT	det
plasma	NN	pobj
than	IN	prep
an	DT	det
immediate	JJ	amod
release	NN	compound
composition	NN	pobj
of	IN	prep
the	DT	det
erythromycin	JJ	amod
derivative	JJ	pobj
while	IN	prep
[	-LRB-	punct
2	CD	meta
]	-RRB-	punct
maintain	VBG	pcomp
bioavailability	NN	dobj
substantially	RB	advmod
equivalent	JJ	amod
to	IN	prep
that	DT	pobj
of	IN	prep
the	DT	det
immediate	JJ	amod
release	NN	compound
composition	NN	pobj
of	IN	prep
the	DT	det
erythromycin	JJ	amod
derivative	JJ	pobj
.	.	punct

 	_SP	

the	DT	det
specification	NN	nsubj
define	VBZ	ROOT
the	DT	det
"	``	punct
degree	NN	dobj
of	IN	prep
fluctuation	NN	pobj
"	''	punct
or	CC	cc
DFL	NNP	conj
as	IN	prep
DFL	NNP	pobj
=	NNP	punct
(	-LRB-	punct
CMax	NNP	compound
-	HYPH	punct
CMin	NNP	punct
)	-RRB-	punct
/CAv	NFP	npadvmod
,	,	punct
'	''	punct
718	CD	nummod
patent	NN	conj
,	,	punct
col.	NN	conj
.	.	punct

CAv	NNS	nsubj
be	VBZ	ROOT
the	DT	det
average	JJ	amod
concentration	NN	attr
of	IN	prep
the	DT	det
drug	NN	pobj
over	IN	prep
a	DT	det
twenty	CD	compound
-	HYPH	punct
four	CD	nummod
hour	NN	compound
interval	NN	pobj
,	,	punct
'	''	punct
718	CD	nummod
patent	NN	appos
,	,	punct
col.	NN	conj
3	CD	nummod
,	,	punct
will	UH	intj
.	.	punct

19	CD	ROOT
-	SYM	punct
22	CD	prep
,	,	punct
and	CC	cc
generally	RB	advmod
be	VBZ	auxpass
define	VBN	conj
as	IN	prep
CAv	NNS	pobj
=	SYM	punct

AUC	NNP	ROOT
/	SYM	punct
£n	LS	nummod
where	WRB	advmod
£n	LS	relcl
>	XX	npadvmod
>	XX	npadvmod

>	XX	ROOT

>	XX	ROOT

>	XX	ROOT

>	XX	ROOT

>	XX	det
>	XX	nsubj
be	VBZ	ROOT
twenty	CD	compound
-	HYPH	punct
four	CD	nummod
hour	NNS	attr
.	.	punct

see	VB	ROOT
Shargel	NNP	dobj
&	CC	cc
Yu	NNP	conj
,	,	punct
Applied	NNP	compound
Biopharmaceutics	NNP	conj
and	CC	cc
Pharmacokinetics	NNP	conj

252	CD	ROOT
(	-LRB-	punct
3d	CD	compound
ed.1993	NNP	appos
)	-RRB-	punct
.	.	punct

the	DT	det
'	``	punct
718	CD	nummod
patent	NN	compound
specification	NN	nsubj
define	VBZ	ROOT
"	``	punct
bioavailability	NN	dobj
"	''	punct
as	IN	prep
the	DT	det
log	NN	npadvmod
-	HYPH	punct
transform	VBN	amod
AUC	NNP	pobj
.	.	punct
'	''	punct

718	CD	nummod
patent	NN	ROOT
,	,	punct
col.	NN	conj
.	.	punct

base	VBN	prep
on	IN	prep
this	DT	det
logarithm	NN	npadvmod
-	HYPH	punct
base	VBN	amod
definition	NN	pobj
,	,	punct
-PRON-	PRP	nsubj
follow	VBZ	ROOT
that	IN	mark
,	,	punct
at	IN	prep
a	DT	det
minimum	NN	pobj
,	,	punct
where	WRB	advmod
AUCER	NNP	nsubj
=	SYM	punct
AUCIR	NNP	pcomp
then	RB	advmod
the	DT	det
two	CD	nummod
composition	NNS	nsubj
would	MD	aux
have	VB	ccomp
substantially	RB	advmod
equivalent	JJ	amod
bioavailability	NN	dobj
.	.	punct

thus	RB	advmod
,	,	punct
sufficient	JJ	amod
condition	NNS	nsubj
for	IN	prep
satisfy	VBG	pcomp
claim	NN	dobj
2	CD	poss
's	POS	case
pharmacokinetic	JJ	amod
parameter	NNS	nsubj
be	VBP	ROOT
that	DT	attr
:	:	punct
dfler	VB	nmod
<	XX	nmod
DFLIR	NNP	appos
and	CC	cc
AUCER	NNP	nmod
=	SYM	punct
AUCIR	NNP	conj
.	.	punct

 	_SP	

-PRON-	PRP	nsubj
now	RB	advmod
turn	VBP	ROOT
to	IN	prep
the	DT	det
relevant	JJ	amod
prior	JJ	amod
art	NN	pobj
and	CC	cc
begin	VB	conj
by	IN	prep
focus	VBG	pcomp
on	IN	prep
the	DT	det
invalidity	NN	compound
allegation	NNS	pobj
surround	VBG	acl
claim	NN	dobj
4	CD	nummod
.	.	punct

As	IN	mark
describe	VBN	advcl
above	RB	advmod
,	,	punct
the	DT	det
prior	JJ	amod
art	NN	nsubj
include	VBZ	ROOT
the	DT	det
'	``	punct
190	CD	nummod
patent	NN	dobj
own	VBN	acl
by	IN	agent
Abbott	NNP	pobj
.	.	punct

the	DT	det
patent	NN	nmod
,	,	punct
inter	JJ	compound
alia	NNS	ROOT
,	,	punct
describe	NNS	conj
and	CC	cc
claim	VBZ	compound
composition	NNS	conj
of	IN	prep
clarithromycin	NN	pobj
in	IN	prep
an	DT	det
alginate	NN	compound
matrix	NN	pobj
.	.	punct

Abbott	NNP	nsubj
-PRON-	PRP	appos
describe	VBZ	ROOT
that	IN	mark
"	``	punct
the	DT	det
formulation	NNS	nsubjpass
be	VBP	auxpass
administer	VBN	ccomp
once	RB	advmod
a	DT	det
day	NN	npadvmod
and	CC	cc
be	VBP	auxpass
direct	VBN	conj
towards	IN	prep
increase	VBG	pcomp
the	DT	det
bioavailability	NN	dobj
of	IN	prep
the	DT	det
active	JJ	amod
ingredient	NN	pobj
so	IN	mark
that	IN	mark
-PRON-	PRP	nsubj
be	VBZ	advcl
bioequivalent	JJ	acomp
with	IN	prep
the	DT	det
current	JJ	amod
immediate	JJ	amod
release	NN	pobj
,	,	punct
twice	PDT	advmod
a	DT	det
-	HYPH	punct
day	NN	compound
composition	NNS	appos
.	.	punct
"	''	punct
'	``	punct
190	CD	nummod
patent	NN	dobj
,	,	punct
col.	NN	conj
1	CD	nummod
,	,	punct
will	UH	intj
.	.	punct

43	CD	ROOT
-	SYM	punct
47	CD	prep
.	.	punct

several	JJ	amod
disclosure	NNS	ROOT
in	IN	prep
this	DT	det
patent	NN	compound
merit	NN	compound
attention	NN	pobj
.	.	punct

claim	NN	nsubj
4	CD	nummod
of	IN	prep
the	DT	det
'	``	punct
190	CD	nummod
patent	NN	compound
claim	NNS	pobj
"	''	punct
a	DT	det
control	VBN	amod
release	NN	appos
,	,	punct
solid	JJ	amod
pharmaceutical	JJ	compound
composition	NN	appos
...	:	punct
comprise	VBG	ROOT
:	:	punct
a	DT	det
therapeutically	RB	advmod
effective	JJ	amod
amount	NN	dobj
of	IN	prep
a	DT	det
macrolide	NN	pobj
...	.	punct
[	-LRB-	punct
and	CC	cc
]	-RRB-	punct
a	DT	det
water	NN	npadvmod
-	HYPH	punct
soluble	JJ	amod
alginate	NN	compound
salt	NN	conj
....	.	punct
"	''	punct

furthermore	RB	advmod
,	,	punct
claim	NN	ROOT
5	CD	dobj
of	IN	prep
the	DT	det
'	``	punct
190	CD	nummod
patent	NN	compound
claim	NNS	pobj
"	''	punct
the	DT	det
composition	NN	dobj
of	IN	prep
claim	NN	pobj

4	CD	ROOT
wherein	WRB	advmod

the	DT	det
macrolide	NN	nsubj
be	VBZ	ROOT
clarithromycin	JJ	attr
"	''	punct
.	.	punct

thus	RB	advmod
,	,	punct
the	DT	det
'	``	punct
190	CD	nummod
patent	NN	nsubj
disclose	VBZ	ROOT
an	DT	det
extended	JJ	amod
release	NN	compound
formulation	NN	dobj
of	IN	prep
clarithromycin	NN	compound
wherein	WRB	pobj
the	DT	det
polymer	NN	nsubjpass
use	VBN	acl
be	VBZ	auxpass
alginate	NN	relcl
as	IN	mark
oppose	VBN	advcl
to	IN	prep
the	DT	det
polymer	NNS	pobj
like	IN	prep
HPMC	NNP	pobj
claim	VBD	advcl
in	IN	prep
the	DT	det
'	``	punct
718	CD	nummod
patent	NN	pobj
.	.	punct

 	_SP	

the	DT	det
'	``	punct
190	CD	nummod
patent	NN	nsubj
also	RB	advmod
disclose	VBZ	ROOT
particular	JJ	amod
pharmacokinetic	JJ	amod
parameter	NNS	dobj
for	IN	prep
-PRON-	PRP$	poss
control	VBN	amod
release	NN	compound
clarithromycin	NN	pobj
and	CC	cc
alginate	NN	conj
composition	NNS	dobj
.	.	punct

For	IN	prep
example	NN	pobj
,	,	punct
as	IN	mark
point	VBN	advcl
out	RP	prt
by	IN	agent
Teva	NNP	pobj
,	,	punct
a	DT	det
side	NN	nmod
-	HYPH	punct
by	IN	prep
-	HYPH	punct
side	NN	pobj
comparison	NN	appos
of	IN	prep
Formula	NNP	compound
C	NNP	pobj
of	IN	prep
the	DT	det
'	``	punct
190	CD	nummod
patent	NN	pobj
with	IN	prep
an	DT	det
IR	NNP	compound
formulation	NN	pobj
show	VBZ	ROOT
that	IN	mark
Formula	NNP	compound
C	NNP	nsubj
exhibit	VBD	ccomp
a	DT	det
low	JJR	amod
CMax	NNP	dobj
(	-LRB-	punct
2.00	CD	nummod
£gg	NN	nmod
/	SYM	punct
ml	NN	appos
)	-RRB-	punct
than	IN	prep
the	DT	det
immediate	JJ	amod
release	NN	compound
formulation	NN	pobj
(	-LRB-	punct
2.28	CD	nummod
£gg	NN	quantmod
/	SYM	punct
ml	NN	appos
)	-RRB-	punct
and	CC	cc
substantially	RB	advmod
equivalent	JJ	amod
AUC	NNP	conj
(	-LRB-	punct
28.69	CD	appos
range	VBG	acl
from	IN	prep
24.61	CD	pobj
to	IN	prep
32.74	CD	pobj
£gg	NN	prep
h	NN	nmod
/	SYM	punct
ml	NN	pobj
vs.	IN	prep
32.16	CD	pobj
range	VBG	acl
from	IN	prep
25.66	CD	pobj
to	IN	prep
42.70	CD	nummod
£ggh	NN	nmod
/	SYM	punct
mL	NNP	pobj
)	-RRB-	punct
and	CC	cc
substantially	RB	advmod
equivalent	JJ	conj

CMin	NNP	ROOT
(	-LRB-	punct
0.66	CD	appos
range	VBG	acl
from	IN	prep
0.37	CD	quantmod
to	IN	quantmod
0.91	CD	nummod
£gg	NN	nmod
/	SYM	punct
ml	NN	pobj
vs.	IN	prep
0.72	CD	pobj
range	VBG	acl
from	IN	prep
.54	CD	pobj
to	IN	prep
1.05	CD	nummod
£g	NN	nmod
g	NN	nmod
/	SYM	punct
ml	NN	pobj
)	-RRB-	punct
.	.	punct
'	''	punct

190	CD	nummod
patent	NN	ROOT
,	,	punct
col.	NN	conj
7	CD	nummod
,	,	punct
table	NN	conj
2	CD	nummod
.	.	punct

thus	RB	advmod
,	,	punct
Teva	NNP	nsubj
make	VBZ	ROOT
substantial	JJ	amod
argument	NNS	dobj
that	IN	mark
the	DT	det
'	``	punct
190	CD	nummod
patent	NN	nsubj
disclose	VBZ	acl
a	DT	det
clarithromycin	NN	compound
composition	NN	dobj
with	IN	prep
alginate	NN	pobj
(	-LRB-	punct
as	IN	mark
oppose	VBN	ccomp
to	IN	prep
a	DT	det
polymer	NN	pobj
like	IN	prep
HPMC	NNP	pobj
)	-RRB-	punct
that	WDT	nsubj
arguably	RB	advmod
have	VBZ	advcl
the	DT	det
pharmacokinetic	JJ	amod
parameter	NNS	dobj
require	VBN	acl
in	IN	prep
claim	NN	pobj
4	CD	nummod
of	IN	prep
the	DT	det
'	``	punct
718	CD	nummod
patent	NN	pobj
.	.	punct

 	_SP	

Of	IN	prep
the	DT	det
claim	NN	compound
limitation	NNS	pobj
in	IN	prep
claim	NN	pobj
4	CD	nummod
of	IN	prep
the	DT	det
'	``	punct
718	CD	nummod
patent	NN	pobj
,	,	punct
the	DT	det
'	``	punct
190	CD	nummod
patent	NN	nsubj
do	VBZ	aux
not	RB	neg
disclose	VB	ROOT
the	DT	det
claim	VBN	amod
polymer	NNS	dobj
of	IN	prep
the	DT	det
'	``	punct
718	CD	nummod
patent	NN	pobj
.	.	punct

the	DT	det
'	``	punct
190	CD	nummod
patent	NN	nsubj
only	RB	advmod
disclose	VBZ	ROOT
the	DT	det
use	NN	dobj
of	IN	prep
alginate	NN	pobj
in	IN	prep
make	VBG	pcomp
control	VBN	amod
release	NN	compound
formulation	NNS	dobj
.	.	punct

other	JJ	amod
prior	JJ	amod
art	NN	nsubj
,	,	punct
though	RB	advmod
,	,	punct
do	VBZ	aux
disclose	VB	ROOT
extend	VBN	amod
release	NN	compound
formulation	NNS	dobj
with	IN	prep
pharmaceutically	RB	advmod
acceptable	JJ	amod
polymer	NNS	pobj
like	IN	prep
HPMC	NNP	pobj
.	.	punct

For	IN	prep
example	NN	pobj
,	,	punct
the	DT	det
'	``	punct
422	CD	nummod
publication	NN	nsubj
file	VBN	acl
by	IN	agent
Pfizer	NNP	compound
Inc.	NNP	pobj
,	,	punct
disclose	VBZ	ROOT
control	VBN	amod
-	HYPH	punct
release	NN	compound
dosage	NN	compound
form	NNS	dobj
of	IN	prep
azithromycin	NN	pobj
.	.	punct

In	IN	prep
particular	JJ	amod
,	,	punct
the	DT	det
application	NN	nsubj
disclose	VBD	ROOT
control	VBN	amod
release	NN	compound
formulation	NNS	dobj
create	VBN	acl
from	IN	prep
combine	VBG	pcomp
azithromycin	NN	dobj
with	IN	prep
HPMC	NNP	pobj
.	.	punct

Abbott	NNP	compound
Labs.	NNP	ROOT
,	,	punct
slip	VB	amod
op	RP	appos
.	.	punct

at	IN	ROOT
14	CD	pobj
.	.	punct

 	_SP	

On	IN	prep
appeal	NN	pobj
,	,	punct
Teva	NNP	nsubj
argue	VBZ	ROOT
that	IN	mark
,	,	punct
base	VBN	prep
on	IN	prep
the	DT	det
'	NN	punct
422	CD	nummod
publication	NN	pobj
,	,	punct
a	DT	det
person	NN	nsubj
of	IN	prep
ordinary	JJ	amod
skill	NN	pobj
in	IN	prep
the	DT	det
art	NN	pobj
would	MD	aux
replace	VB	ccomp
the	DT	det
alginate	NN	dobj
of	IN	prep
the	DT	det
'	``	punct
190	CD	nummod
patent	NN	pobj
with	IN	prep
HPMC	NNP	pobj
because	IN	mark
the	DT	det
'	``	punct
422	CD	nummod
publication	NN	nsubj
disclose	VBD	advcl
use	VBG	xcomp
HPMC	NNP	dobj
with	IN	prep
azithromycin	NN	pobj
,	,	punct
a	DT	det
compound	NN	npadvmod
relate	VBN	amod
to	IN	prep
clarithromycin	NN	pobj
.	.	punct

In	IN	prep
response	NN	pobj
,	,	punct
Abbott	NNP	nsubj
point	VBZ	ROOT
out	RP	prt
that	IN	mark
most	JJS	amod
invention	NNS	nsubj
arise	VBP	ccomp
from	IN	prep
a	DT	det
combination	NN	pobj
of	IN	prep
old	JJ	amod
element	NNS	pobj
and	CC	cc
that	IN	mark
"	``	punct
identification	NN	nsubj
in	IN	prep
the	DT	det
prior	JJ	amod
art	NN	pobj
of	IN	prep
each	DT	det
individual	JJ	amod
part	NN	pobj
claim	VBD	conj
be	VBZ	ccomp
insufficient	JJ	acomp
to	TO	aux
defeat	VB	xcomp
patentability	NN	dobj
of	IN	prep
the	DT	det
whole	JJ	pobj
claim	VBN	amod
invention	NN	dobj
"	''	punct
.	.	punct

Abbott	NNP	compound
Labs.	NNP	npadvmod
,	,	punct
slip	VB	ROOT
op	RP	dobj
.	.	punct

at	IN	ROOT
15	CD	pobj
(	-LRB-	punct
quote	VBG	pcomp
in	RP	prep
re	IN	compound
Kotzab	NNP	pobj
,	,	punct
217	CD	nummod
f.3d	CD	appos
1365	CD	nummod
,	,	punct
1370	CD	appos
(	-LRB-	punct
Fed	NNP	nmod
.	.	punct
Cir.2000	LS	parataxis
)	-RRB-	punct
)	-RRB-	punct
.	.	punct

 	_SP	

As	IN	mark
mention	VBN	advcl
above	RB	advmod
,	,	punct
there	EX	expl
must	MD	aux
be	VB	ROOT
some	DT	det
motivation	NN	attr
,	,	punct
suggestion	NN	conj
,	,	punct
or	CC	cc
teaching	NN	conj
of	IN	prep
the	DT	det
desirability	NN	pobj
of	IN	prep
make	VBG	pcomp
the	DT	det
specific	JJ	amod
compound	NN	dobj
.	.	punct

Abbott	NNP	nsubj
argue	VBZ	ROOT
that	IN	mark
such	PDT	predet
a	DT	det
motivation	NN	nsubj
be	VBZ	aux
lack	VBG	ccomp
here	RB	advmod
because	IN	mark
the	DT	det
compound	NNS	nsubj
azithromycin	VBP	amod
and	CC	cc
clarithromycin	NN	conj
be	VBP	advcl
so	RB	advmod
different	JJ	acomp
that	IN	mark
the	DT	det
'	``	punct
422	CD	nummod
publication	NN	nsubj
would	MD	aux
not	RB	neg
reasonably	RB	advmod
motivate	VB	ccomp
a	DT	det
person	NN	dobj
of	IN	prep
skill	NN	pobj
in	IN	prep
the	DT	det
art	NN	pobj
to	TO	aux
interchange	VB	advcl
the	DT	det
component	NNS	dobj
of	IN	prep
the	DT	det
formulation	NNS	pobj
in	IN	prep
the	DT	det
'	NN	punct
422	CD	nummod
publication	NN	pobj
with	IN	prep
those	DT	pobj
of	IN	prep
the	DT	det
'	``	punct
190	CD	nummod
patent	NN	pobj
with	IN	prep
a	DT	det
reasonable	JJ	amod
expectation	NN	pobj
of	IN	prep
success	NN	pobj
.	.	punct

the	DT	det
district	NN	compound
court	NN	nsubj
agree	VBD	ROOT
with	IN	prep
Abbott	NNP	pobj
and	CC	cc
find	VBD	conj
that	IN	mark
because	IN	prep
of	IN	pcomp
the	DT	det
chemical	NN	amod
and	CC	cc
metabolic	NN	conj
difference	NNS	pobj
between	IN	prep
azithromycin	NN	pobj
and	CC	cc
clarithromycin	NN	conj
,	,	punct
"	''	punct
a	DT	det
person	NN	nsubj
of	IN	prep
ordinary	JJ	amod
skill	NN	pobj
in	IN	prep
the	DT	det
art	NN	pobj
would	MD	aux
not	RB	neg
have	VB	aux
have	VBN	ccomp
a	DT	det
reasonable	JJ	amod
expectation	NN	dobj
that	IN	mark
the	DT	det
azithromycin	NN	amod
formulation	NN	nsubj
in	IN	prep
the	DT	det
'	NN	punct
422	CD	nummod
publication	NN	pobj
...	:	punct
would	MD	aux
lead	VB	relcl
to	IN	prep
the	DT	det
feature	NNS	pobj
claim	VBN	acl
in	IN	prep
the	DT	det
'	``	punct
718	CD	nummod
patent	NN	pobj
"	''	punct
.	.	punct

Idaho	NNS	ROOT
at	IN	prep
16	CD	pobj
.	.	punct

-PRON-	PRP	nsubj
be	VBZ	ROOT
in	IN	prep
this	DT	det
conclusion	NN	pobj
that	IN	mark
the	DT	det
district	NN	compound
court	NN	nsubj
err	VBD	ccomp
.	.	punct

 	_SP	

the	DT	det
district	NN	compound
court	NN	nsubj
conclude	VBD	ROOT
that	IN	mark
Teva	NNP	nsubj
have	VBD	aux
not	RB	neg
raise	VBN	ccomp
a	DT	det
substantial	JJ	amod
question	NN	dobj
that	IN	mark
a	DT	det
person	NN	nsubj
of	IN	prep
ordinary	JJ	amod
skill	NN	pobj
in	IN	prep
the	DT	det
art	NN	pobj
would	MD	aux
have	VB	aux
have	VBN	acl
a	DT	det
reasonable	JJ	amod
expectation	NN	dobj
of	IN	prep
success	NN	pobj
in	IN	prep
make	VBG	pcomp
the	DT	det
claim	VBN	amod
invention	NN	dobj
.	.	punct

the	DT	det
prior	JJ	amod
art	NN	nsubj
,	,	punct
however	RB	advmod
,	,	punct
especially	RB	advmod
Abbott	NNP	poss
's	POS	case
own	JJ	amod
'	CD	punct
190	CD	nummod
patent	NN	nsubj
,	,	punct
contradict	VBZ	ROOT
that	DT	det
conclusion	NN	dobj
.	.	punct

As	IN	mark
argue	VBN	advcl
by	IN	agent
Teva	NNP	pobj
,	,	punct
another	DT	det
claim	NN	ROOT
from	IN	prep
the	DT	det
'	``	punct
190	CD	nummod
patent	NN	compound
merit	VBZ	pobj
close	JJ	amod
attention	NN	appos
.	.	punct

not	RB	preconj
only	RB	advmod
do	VBZ	dep
the	DT	det
'	``	punct
190	CD	nummod
patent	NN	compound
claim	NN	nsubj
composition	NNS	dobj
with	IN	prep
clarithromycin	NN	pobj
,	,	punct
but	CC	cc
claim	NN	conj
14	CD	dobj
of	IN	prep
the	DT	det
'	``	punct
190	CD	nummod
patent	NN	compound
claim	NNS	pobj
"	''	punct
the	DT	det
composition	NN	dobj
of	IN	prep
claim	NN	pobj
4	CD	nummod
,	,	punct
wherein	WRB	advmod
the	DT	det
macrolide	NN	nsubjpass
be	VBZ	auxpass
select	VBN	ROOT
from	IN	prep
the	DT	det
group	NN	pobj
consist	VBG	acl
of	IN	prep
erythromycin	NN	amod
,	,	punct
dirithromycin	NN	pobj
,	,	punct
azithromycin	NN	conj
,	,	punct
roxithromycin	NN	conj
,	,	punct
and	CC	cc
ABT-229	NNP	conj
"	''	punct
.	.	punct

This	DT	det
claim	NN	nsubj
be	VBZ	ROOT
relevant	JJ	acomp
because	IN	mark
-PRON-	PRP	nsubj
describe	VBZ	advcl
Abbott	NNP	poss
's	POS	case
own	JJ	amod
view	NN	dobj
of	IN	prep
the	DT	det
ordinary	JJ	amod
skill	NN	pobj
in	IN	prep
the	DT	det
art	NN	pobj
at	IN	prep
the	DT	det
time	NN	pobj
-PRON-	PRP	nsubj
file	VBD	relcl
the	DT	det
application	NN	dobj
that	WDT	nsubj
lead	VBD	relcl
to	IN	prep
the	DT	det
'	``	punct
190	CD	nummod
patent	NN	pobj
and	CC	cc
-PRON-	PRP	nsubj
do	VBZ	conj
so	RB	advmod
not	RB	neg
by	IN	prep
what	WP	dobj
the	DT	det
'	``	punct
190	CD	nummod
patent	NN	compound
disclose	NNS	pobj
but	CC	cc
by	IN	conj
what	WP	dobj
-PRON-	PRP	nsubj
do	VBZ	aux
not	RB	neg
disclose	VB	pcomp
.	.	punct

claim	NN	ROOT
4	CD	nummod
and	CC	cc
14	CD	conj
of	IN	prep
the	DT	det
'	``	punct
190	CD	nummod
patent	NN	compound
cover	NN	compound
composition	NNS	pobj
that	WDT	nsubj
include	VBP	relcl
azithromycin	NN	dobj
or	CC	cc
clarithromycin	JJ	conj
.	.	punct

Despite	IN	prep
these	DT	det
claim	NNS	pobj
to	IN	prep
varied	JJ	amod
composition	NNS	pobj
,	,	punct
the	DT	det
specification	NN	nsubj
only	RB	advmod
explicitly	RB	advmod
describe	VBZ	ROOT
composition	NNS	dobj
make	VBN	acl
from	IN	prep
clarithromycin	NN	pobj
.	.	punct

-PRON-	PRP	nsubj
presume	VBP	ROOT
that	IN	mark
Abbott	NNP	nsubj
file	VBD	ccomp
and	CC	cc
prosecute	VBD	conj
the	DT	det
'	``	punct
190	CD	nummod
patent	NN	dobj
representing	NN	acl
that	DT	nsubj
claim	NN	relcl
14	CD	dobj
of	IN	prep
the	DT	det
'	``	punct
190	CD	nummod
patent	NN	compound
satisfie	NNS	dobj
the	DT	det
write	VBN	amod
description	NN	dobj
and	CC	cc
enablement	NN	amod
requirement	NNS	conj
of	IN	prep
35	CD	nummod
U.S.C.	NNP	pobj
¡±	NNP	punct
112	CD	nummod
.	.	punct

see	VB	ROOT
Amgen	NNP	compound
Inc.	NNP	dobj
v.	CC	prep
Hoechst	NNP	nmod
Marion	NNP	nmod
Roussel	NNP	nmod
,	,	punct
Inc.	NNP	pobj
,	,	punct
314	CD	nummod
f.3d	CD	appos
1313	CD	appos
(	-LRB-	punct
Fed	NNP	nmod
.	.	punct
Cir.2003	NFP	parataxis
)	-RRB-	punct
(	-LRB-	punct
"	``	punct
-PRON-	PRP	nsubj
hold	VBP	ccomp
a	DT	det
presumption	NN	nsubj
arise	VBZ	ccomp
that	IN	mark
both	CC	predet
the	DT	det
claim	VBN	amod
and	CC	cc
unclaimed	JJ	conj
disclosure	NNS	nsubjpass
in	IN	prep
a	DT	det
prior	JJ	amod
art	NN	compound
patent	NN	pobj
be	VBP	auxpass
enable	VBN	ccomp
"	''	punct
.	.	punct
)	-RRB-	punct
.	.	punct

Because	IN	mark
the	DT	det
'	``	punct
190	CD	nummod
patent	NN	nsubj
explicitly	RB	advmod
disclose	VBZ	advcl
only	RB	advmod
clarithromycin	NN	npadvmod
control	VBN	amod
release	NN	compound
composition	NNS	dobj
,	,	punct
yet	CC	cc
claim	NNS	conj
azithromycin	NN	amod
composition	NNS	dobj
,	,	punct
-PRON-	PRP	nsubj
conclude	VBP	ROOT
that	IN	mark
Abbott	NNP	nsubj
have	VBZ	aux
represent	VBN	ccomp
to	IN	prep
the	DT	det
U.S.	NNP	nmod
Patent	NNP	nmod
and	CC	cc
Trademark	NNP	conj
Office	NNP	pobj
(	-LRB-	punct
"	``	punct
PTO	NNP	appos
"	''	punct
)	-RRB-	punct
that	IN	mark
the	DT	det
difference	NNS	nsubj
between	IN	prep
clarithromycin	NN	pobj
and	CC	cc
azithromycin	NN	conj
be	VBD	ccomp
such	JJ	acomp
that	IN	mark
azithromycin	NN	nsubjpass
could	MD	aux
be	VB	auxpass
substitute	VBN	ccomp
into	IN	prep
a	DT	det
control	VBN	amod
release	NN	compound
clarithromycin	NN	compound
composition	NN	pobj
by	IN	agent
a	DT	det
person	NN	pobj
of	IN	prep
ordinary	JJ	amod
skill	NN	pobj
in	IN	prep
the	DT	det
art	NN	pobj
without	IN	prep
undue	JJ	amod
experimentation	NN	pobj
.	.	punct

see	VB	advcl
Invitrogen	NNP	compound
Corp.	NNP	dobj
v.	IN	prep
Clontech	NNP	compound
Labs.	NNP	pobj
,	,	punct
Inc.	NNP	appos
,	,	punct
429	CD	nummod
f.3d	CD	appos
1052	CD	nummod
,	,	punct
1070	CD	npadvmod
-	SYM	punct
71	CD	prep
(	-LRB-	punct
Fed	NNP	nmod
.	.	punct
Cir.2005	LS	ccomp
)	-RRB-	punct
(	-LRB-	punct
"	``	punct
section	NN	nsubj
112	CD	nummod
require	VBZ	ROOT
that	IN	mark
the	DT	det
patent	NN	compound
specification	NN	nsubj
enable	VBP	ccomp
those	DT	dobj
skilled	JJ	amod
in	IN	prep
the	DT	det
art	NN	pobj
to	TO	aux
make	VB	acl
and	CC	cc
use	VB	conj
the	DT	det
full	JJ	amod
scope	NN	dobj
of	IN	prep
the	DT	det
claim	VBN	amod
invention	NN	pobj
without	IN	prep
undue	JJ	amod
experimentation	NN	pobj
....	.	punct
the	DT	det
scope	NN	nsubj
of	IN	prep
enablement	NN	pobj
,	,	punct
in	IN	prep
turn	NN	pobj
,	,	punct
be	VBZ	ccomp
that	IN	attr
which	WDT	nsubjpass
be	VBZ	auxpass
disclose	VBN	ccomp
in	IN	prep
the	DT	det
specification	NN	pobj
plus	CC	cc
the	DT	det
scope	NN	conj
of	IN	prep
what	WP	nsubjpass
would	MD	aux
be	VB	auxpass
know	VBN	pcomp
to	IN	prep
one	CD	pobj
of	IN	prep
ordinary	JJ	amod
skill	NN	pobj
in	IN	prep
the	DT	det
art	NN	pobj
without	IN	prep
undue	JJ	amod
experimentation	NN	pobj
"	''	punct
.	.	punct
)	-RRB-	punct
.	.	punct

As	IN	prep
a	DT	det
result	NN	pobj
,	,	punct
base	VBN	prep
on	IN	prep
Abbott	NNP	poss
's	POS	case
own	JJ	amod
'	CD	punct
190	CD	nummod
patent	NN	pobj
,	,	punct
there	EX	expl
exist	VBZ	ROOT
a	DT	det
substantial	JJ	amod
argument	NN	dobj
that	IN	mark
a	DT	det
person	NN	nsubjpass
of	IN	prep
ordinary	JJ	amod
skill	NN	pobj
in	IN	prep
the	DT	det
art	NN	pobj
would	MD	aux
be	VB	auxpass
motivate	VBN	acl
to	TO	aux
combine	VB	xcomp
the	DT	det
'	NN	punct
422	CD	nummod
publication	NN	dobj
,	,	punct
namely	RB	advmod
the	DT	det
use	NN	appos
of	IN	prep
HPMC	NNP	pobj
in	IN	prep
extended	JJ	amod
release	NN	compound
macrolide	NN	compound
composition	NNS	pobj
,	,	punct
with	IN	prep
the	DT	det
'	``	punct
190	CD	nummod
patent	NN	pobj
with	IN	prep
a	DT	det
reasonable	JJ	amod
expectation	NN	pobj
of	IN	prep
success	NN	pobj
.	.	punct

 	_SP	

furthermore	RB	advmod
,	,	punct
the	DT	det
district	NN	compound
court	NN	nsubj
also	RB	advmod
err	VBD	ROOT
by	IN	prep
focus	VBG	pcomp
on	IN	prep
the	DT	det
drug	NNS	poss
'	POS	case
chemical	NN	amod
dissimilarity	NNS	pobj
,	,	punct
while	IN	mark
not	RB	neg
properly	RB	advmod
account	VBG	advcl
for	IN	prep
-PRON-	PRP$	poss
similarity	NNS	pobj
.	.	punct

-PRON-	PRP	nsubj
appear	VBZ	ROOT
to	TO	aux
have	VB	aux
focus	VBN	xcomp
on	IN	prep
the	DT	det
presence	NN	pobj
of	IN	prep
difference	NNS	pobj
per	IN	prep
se	FW	pcomp
,	,	punct
rather	RB	advmod
than	IN	cc
on	IN	prep
those	DT	det
difference	NNS	pobj
that	WDT	nsubj
would	MD	aux
be	VB	relcl
relevant	JJ	acomp
vel	FW	advmod
non	NN	intj
to	IN	prep
one	CD	pobj
of	IN	prep
ordinary	JJ	amod
skill	NN	pobj
in	IN	prep
the	DT	det
art	NN	pobj
.	.	punct

For	IN	prep
example	NN	pobj
,	,	punct
the	DT	det
court	NN	nsubj
appear	VBZ	ROOT
to	TO	aux
have	VB	aux
be	VBN	auxpass
influence	VBN	xcomp
by	IN	agent
Abbott	NNP	poss
's	POS	case
expert	NN	pobj
,	,	punct
Dr.	NNP	compound
Banker	NNP	appos
,	,	punct
who	WP	nsubj
point	VBD	relcl
out	RP	prt
that	IN	mark
the	DT	det
half	JJ	amod
-	HYPH	punct
life	NN	nsubj
of	IN	prep
azithromycin	NN	pobj
be	VBZ	ccomp
long	JJR	acomp
than	IN	prep
that	DT	pobj
of	IN	prep
clarithromycin	NN	pobj
.	.	punct

Dr.	NNP	compound
Banker	NNP	nsubj
also	RB	advmod
note	VBD	ROOT
that	IN	mark
clarithromycin	NN	nsubj
exhibit	VBZ	ccomp
an	DT	det
extensive	JJ	amod
"	``	punct
first	JJ	amod
-	HYPH	punct
pass	NN	nmod
"	''	punct
metabolism	NN	dobj
to	IN	prep
an	DT	det
active	JJ	amod
metabolite	NN	pobj
,	,	punct
whereas	IN	mark
azithromycin	NN	nsubj
do	VBZ	advcl
not	RB	neg
.	.	punct

however	RB	advmod
,	,	punct
the	DT	det
court	NN	nsubj
appear	VBZ	ROOT
to	TO	aux
have	VB	aux
inexplicably	RB	advmod
discount	VBN	xcomp
the	DT	det
testimony	NN	dobj
of	IN	prep
Dr.	NNP	compound
Lee	NNP	pobj
.	.	punct

As	IN	mark
Dr.	NNP	compound
Lee	NNP	nsubj
note	VBD	advcl
,	,	punct
because	IN	mark
the	DT	det
drug	NN	nsubjpass
be	VBZ	auxpass
transform	VBN	ccomp
into	IN	prep
an	DT	det
active	JJ	amod
metabolite	NN	pobj
,	,	punct
"	''	punct
a	DT	det
person	NN	nsubj
skilled	JJ	amod
in	IN	prep
the	DT	det
art	NN	pobj
would	MD	aux
have	VB	aux
expect	VBN	ROOT
that	IN	mark
clarithromycin	NN	nsubj
would	MD	aux
work	VB	ccomp
even	RB	advmod
better	RBR	advmod
than	IN	prep
azithromycin	NN	amod
in	IN	prep
an	DT	det
extended	JJ	amod
release	NN	compound
formulation	NN	pobj
"	''	punct
.	.	punct

address	VBG	advcl
the	DT	det
drug	NNS	poss
'	POS	case
difference	NNS	dobj
in	IN	prep
half	JJ	amod
-	HYPH	punct
life	NN	pobj
and	CC	cc
metabolism	NN	conj
,	,	punct
Dr.	NNP	compound
Lee	NNP	nsubj
conclude	VBD	ROOT
that	IN	mark
"	``	punct
these	DT	det
characteristic	NNS	nsubj
further	RB	advmod
support	VBP	ccomp
the	DT	det
expectation	NN	dobj
that	IN	mark
a	DT	det
person	NN	nsubj
of	IN	prep
ordinary	JJ	amod
skill	NN	pobj
in	IN	prep
the	DT	det
art	NN	pobj
would	MD	aux
have	VB	acl
motivation	NN	dobj
and	CC	cc
a	DT	det
reasonable	JJ	amod
expectation	NN	conj
of	IN	prep
success	NN	pobj
in	IN	prep
make	VBG	pcomp
a	DT	det
successful	JJ	amod
ER	NNP	compound
formulation	NN	dobj
of	IN	prep
clarithromycin	NN	pobj
....	.	punct
"	''	punct
(	-LRB-	punct
emphasis	NN	nsubj
add	VBN	parataxis
)	-RRB-	punct
.	.	punct

 	_SP	

In	IN	prep
light	NN	pobj
of	IN	prep
the	DT	det
record	NN	pobj
,	,	punct
Teva	NNP	nsubj
have	VBZ	aux
raise	VBN	ROOT
a	DT	det
substantial	JJ	amod
question	NN	dobj
that	WDT	nsubj
claim	NN	relcl
4	CD	dobj
be	VBZ	acl
vulnerable	JJ	acomp
to	IN	prep
allegation	NNS	pobj
of	IN	prep
invalidity	NN	pobj
.	.	punct

the	DT	det
'	``	punct
190	CD	nummod
patent	NN	nsubj
-PRON-	PRP	appos
demonstrate	VBZ	ROOT
that	IN	mark
Abbott	NNP	nsubj
have	VBZ	aux
represent	VBN	ccomp
to	IN	prep
the	DT	det
pto	NN	pobj
and	CC	cc
the	DT	det
public	NN	conj
in	IN	prep
general	JJ	amod
that	IN	mark
a	DT	det
person	NN	nsubj
of	IN	prep
ordinary	JJ	amod
skill	NN	pobj
in	IN	prep
the	DT	det
art	NN	pobj
can	MD	aux
expect	VB	ccomp
to	TO	aux
successfully	RB	advmod
substitute	VB	xcomp
azithromycin	NN	dobj
into	IN	prep
a	DT	det
clarithromycin	NN	npadvmod
control	VBN	amod
release	NN	compound
composition	NN	pobj
without	IN	prep
undue	JJ	amod
experimentation	NN	pobj
.	.	punct

 	_SP	

Claim	NNP	nsubj
2	CD	nummod
present	VBZ	ROOT
a	DT	det
slightly	RB	advmod
different	JJ	amod
analysis	NN	dobj
.	.	punct

the	DT	det
prior	JJ	amod
art	NN	nsubjpass
and	CC	cc
the	DT	det
obviousness	JJ	amod
discussion	NN	conj
from	IN	prep
claim	NN	pobj
4	CD	appos
could	MD	aux
be	VB	auxpass
apply	VBN	ROOT
directly	RB	advmod
to	TO	aux
claim	VB	advcl
2	CD	dobj
but	CC	cc
for	IN	conj
the	DT	det
difference	NNS	pobj
in	IN	prep
pharmacokinetic	JJ	amod
limitation	NNS	pobj
.	.	punct

Upon	IN	prep
inspection	NN	pobj
,	,	punct
the	DT	det
'	``	punct
422	CD	nummod
publication	NN	nsubj
and	CC	cc
the	DT	det
'	``	punct
190	CD	nummod
patent	NN	compound
disclose	NN	compound
composition	NNS	conj
satisfy	VBG	acl
the	DT	det
pharmacokinetic	JJ	amod
limitation	NNS	dobj
of	IN	prep
claim	NN	pobj
2	CD	nummod
and	CC	cc
therefore	RB	advmod
the	DT	det
obviousness	JJ	amod
argument	NNS	nsubj
from	IN	prep
above	RB	prep
do	VBP	aux
apply	VB	ROOT
and	CC	cc
provide	VB	conj
a	DT	det
substantial	JJ	amod
argument	NN	dobj
as	IN	prep
to	IN	prep
the	DT	det
invalidity	NN	pobj
of	IN	prep
claim	NN	pobj
2	CD	nummod
.	.	punct

As	IN	mark
discuss	VBN	advcl
above	RB	advmod
,	,	punct
where	WRB	advmod
two	CD	nummod
composition	NNS	nsubj
have	VBP	ccomp
similar	JJ	amod
auc	NNS	dobj
,	,	punct
these	DT	det
composition	NNS	nsubj
have	VBP	ROOT
similar	JJ	amod
bioavailability	NN	dobj
.	.	punct

the	DT	det
'	``	punct
190	CD	nummod
patent	NN	compound
disclose	VBZ	compound
composition	NNS	ROOT
with	IN	prep
similar	JJ	amod
AUC	NNP	pobj
's	POS	case
and	CC	cc
therefore	RB	advmod
there	EX	expl
exist	VBZ	conj
a	DT	det
substantial	JJ	amod
argument	NN	dobj
that	IN	mark
-PRON-	PRP	nsubj
disclose	VBZ	acl
composition	NNS	dobj
with	IN	prep
substantially	RB	advmod
equivalent	JJ	amod
bioavailability	NN	pobj
.	.	punct
'	''	punct

190	CD	nummod
patent	NN	ROOT
,	,	punct
col.	NN	conj
7	CD	nummod
,	,	punct
table	NN	conj
2	CD	nummod
.	.	punct

thus	RB	advmod
,	,	punct
the	DT	det
'	``	punct
190	CD	nummod
patent	NN	compound
disclose	NNS	compound
composition	NNS	ROOT
that	WDT	nsubj
satisfy	VBP	relcl
the	DT	det
second	NN	dobj
of	IN	prep
the	DT	det
pharmacokinetic	JJ	amod
limitation	NNS	pobj
of	IN	prep
claim	NN	pobj
2	CD	npadvmod
.	.	punct

furthermore	RB	advmod
,	,	punct
although	IN	mark
the	DT	det
'	``	punct
190	CD	nummod
patent	NN	nsubj
do	VBZ	aux
not	RB	neg
explicitly	RB	advmod
disclose	VB	advcl
composition	NNS	dobj
with	IN	prep
a	DT	det
low	JJR	amod
fluctuation	NN	compound
index	NN	pobj
,	,	punct
the	DT	det
'	``	punct
190	CD	nummod
patent	NN	appos
,	,	punct
nonetheless	RB	advmod
,	,	punct
do	VBZ	ROOT
so	RB	advmod
implicitly	RB	advmod
.	.	punct

By	IN	prep
compare	VBG	pcomp
the	DT	det
disclose	VBN	amod
pharmacokinetic	JJ	amod
parameter	NNS	dobj
from	IN	prep
the	DT	det
'	``	punct
190	CD	nummod
patent	NN	pobj
,	,	punct
a	DT	det
substantial	JJ	amod
argument	NN	nsubj
exist	VBZ	ROOT
that	IN	mark
the	DT	det
'	``	punct
190	CD	nummod
patent	NN	nsubj
also	RB	advmod
disclose	VBZ	ccomp
composition	NNS	compound
satisfy	VBG	ccomp
DFLER	NNP	nmod
<	XX	nmod
DFLIR	NNP	dobj
.	.	punct

As	IN	mark
discuss	VBN	advcl
above	RB	advmod
,	,	punct
the	DT	det
'	``	punct
190	CD	nummod
patent	NN	nsubj
disclose	VBZ	ROOT
pharmacokinetic	JJ	amod
parameter	NNS	dobj
that	WDT	nsubj
satisfy	VBP	nsubj
claim	NN	ccomp
4	CD	dobj
.	.	punct

In	IN	prep
other	JJ	amod
word	NNS	pobj
,	,	punct
the	DT	det
'	``	punct
190	CD	nummod
patent	NN	nsubj
disclose	VBZ	ROOT
a	DT	det
composition	NN	dobj
that	IN	nsubj
satisfie	NNS	relcl
:	:	punct

cmax_er	NN	punct
<	XX	punct
CMax_IR	NNP	ROOT
,	,	punct
AUCER	NNP	nmod
=	SYM	punct
AUCIR	NNP	conj
,	,	punct
and	CC	cc

cmin_er	NN	ROOT
=	SYM	punct

cmin_ir	UH	ROOT
.	.	punct

By	IN	prep
examine	VBG	pcomp
the	DT	det
definition	NNS	dobj
give	VBN	acl
in	IN	prep
the	DT	det
specification	NN	pobj
,	,	punct
-PRON-	PRP	nsubj
conclude	VBP	ROOT
that	IN	mark
the	DT	det
disclose	VBN	amod
composition	NN	nsubj
from	IN	prep
the	DT	det
'	``	punct
190	CD	nummod
patent	NN	pobj
also	RB	advmod
implicitly	RB	advmod
satisfy	VBZ	ccomp
the	DT	det
condition	NN	dobj
from	IN	prep
claim	NN	pobj
2	CD	nummod
that	IN	nsubj
DFLER	NNP	nmod
<	XX	nmod
DFLIR	NNP	ccomp
.	.	punct

By	IN	prep
subtract	VBG	pcomp
claim	NN	dobj
4	CD	poss
's	POS	case
third	JJ	amod
condition	NN	dobj
from	IN	prep
the	DT	det
first	JJ	pobj
,	,	punct
one	PRP	nsubj
can	MD	aux
infer	VB	ROOT
that	IN	mark
the	DT	det
composition	NN	nsubj
from	IN	prep
the	DT	det
'	``	punct
190	CD	nummod
patent	NN	pobj
also	RB	advmod
satisfy	VBZ	ccomp
CMaxER	NNP	nmod
-	HYPH	punct
CMinER	NNP	nmod
<	XX	nmod
CMaxIR	NNP	compound
-	HYPH	punct
CMinIR	NNP	dobj
.	.	punct

This	DT	det
inequality	NN	nsubj
,	,	punct
with	IN	prep
the	DT	det
definition	NN	pobj
of	IN	prep
the	DT	det
fluctuation	NN	compound
index	NN	pobj
,	,	punct
and	CC	cc
with	IN	conj
the	DT	det
second	JJ	amod
limitation	NN	pobj
from	IN	prep
claim	NN	pobj
4	CD	nummod
,	,	punct
establish	VBZ	ROOT
that	IN	dobj
:	:	punct

 	_SP	

DFLER=	NNP	ROOT

CMaxER	NNP	compound
-	HYPH	punct
CMinER	NNP	nmod
/	SYM	punct
CAvER	NNP	ROOT

=	SYM	punct
CMaxER	NNP	nmod
-	HYPH	punct
CMinER	NNP	nmod
/	SYM	punct
AUCER	NNP	ROOT
/	SYM	punct

£n	VBZ	ROOT
<	XX	npadvmod
CMaxIR	NNP	compound
-	HYPH	punct
CMinIR	NNP	nmod
/	SYM	punct
AUCIR	NNP	nmod
/	SYM	punct
£n	NN	pobj

=	SYM	punct
CMaxIR	NNP	compound
-	HYPH	punct
CMinIR	NNP	nmod
/	SYM	punct
CAvIR	NNP	ROOT
=	SYM	punct
DFLIR	NNP	amod

 	_SP	

In	IN	prep
other	JJ	amod
word	NNS	pobj
,	,	punct
because	IN	mark
the	DT	det
'	``	punct
190	CD	nummod
patent	NN	nsubj
disclose	VBD	ccomp
a	DT	det
composition	NN	dobj
satisfy	VBG	acl
the	DT	det
pharmacokinetic	JJ	amod
limitation	NNS	dobj
of	IN	prep
claim	NN	pobj
4	CD	nummod
,	,	punct
the	DT	det
'	``	punct
190	CD	nummod
patent	NN	nsubj
also	RB	advmod
disclose	VBD	ROOT
composition	NNS	dobj
that	WDT	nsubj
satisfy	VBP	relcl
DFLER	NNP	nmod
<	XX	nmod
DFLIR	NNP	dobj
and	CC	cc
be	VBP	conj
substantially	RB	advmod
bioequivalent.5	IN	attr

thus	RB	advmod
,	,	punct
the	DT	det
obviousness	JJ	amod
argument	NNS	nsubjpass
relate	VBG	acl
to	IN	prep
the	DT	det
'	``	punct
190	CD	nummod
patent	NN	pobj
and	CC	cc
the	DT	det
'	``	punct
422	CD	nummod
publication	NN	conj
make	VBN	acl
above	RB	oprd
for	IN	prep
claim	NN	pobj
4	CD	nummod
can	MD	aux
be	VB	auxpass
apply	VBN	ROOT
in	IN	prep
similar	JJ	amod
fashion	NN	pobj
to	TO	aux
claim	VB	advcl
2	CD	dobj
.	.	punct

As	IN	prep
a	DT	det
result	NN	pobj
,	,	punct
Teva	NNP	nsubj
have	VBZ	aux
also	RB	advmod
raise	VBN	ROOT
substantial	JJ	amod
question	NNS	dobj
as	IN	prep
to	IN	prep
the	DT	det
validity	NN	pobj
of	IN	prep
claim	NN	pobj
2	CD	nummod
.	.	punct

 	_SP	

-PRON-	PRP	nsubj
now	RB	advmod
turn	VBP	ccomp
to	TO	aux
claim	VB	xcomp
6	CD	dobj
of	IN	prep
the	DT	det
'	``	punct
718	CD	nummod
patent	NN	pobj
and	CC	cc
claim	NN	conj
2	CD	dobj
of	IN	prep
'	CD	punct
616	CD	nummod
patent.6	CD	pobj
In	IN	prep
-PRON-	PRP$	poss
analysis	NN	pobj
,	,	punct
the	DT	det
district	NN	nsubj
begin	VBD	ROOT
by	IN	prep
look	VBG	pcomp
to	IN	prep
the	DT	det
claim	NNS	pobj
.	.	punct

claim	NN	nsubj
2	CD	nummod
of	IN	prep
the	DT	det
'	``	punct
616	CD	nummod
patent	NN	compound
set	NNS	pobj
forth	RB	advmod

 	_SP	
a	DT	det
method	NN	appos
of	IN	prep
reduce	VBG	pcomp
gastrointestinal	JJ	amod
adverse	JJ	amod
side	NN	compound
effect	NNS	dobj
comprise	VBG	acl
administer	VBG	xcomp
an	DT	det
effective	JJ	amod
amount	NN	dobj
of	IN	prep
an	DT	det
extended	JJ	amod
release	NN	compound
pharmaceutical	NN	compound
composition	NN	pobj
comprise	VBG	acl
an	DT	det
erythromycin	JJ	amod
derivative	NN	dobj
and	CC	cc
a	DT	det
pharmaceutically	RB	advmod
acceptable	JJ	amod
polymer	NN	conj
,	,	punct
wherein	WRB	advmod
the	DT	det
erythromycin	JJ	amod
derivative	NN	nsubj
be	VBZ	ROOT
clarithromycin	JJ	acomp
.	.	punct

 	_SP	
'	''	punct
616	CD	nummod
patent	NN	attr
,	,	punct
col.	NN	conj
12	CD	nummod
,	,	punct
will	UH	intj
.	.	punct

39	CD	ROOT
-	SYM	punct
46	CD	prep
.	.	punct

For	IN	prep
these	DT	det
claim	NNS	pobj
,	,	punct
"	''	punct
erythromycin	JJ	amod
derivative	JJ	nsubjpass
"	''	punct
and	CC	cc
"	``	punct
pharmaceutically	RB	advmod
acceptable	JJ	amod
polymer	NN	conj
"	''	punct
be	VBP	auxpass
construe	VBN	ROOT
as	IN	mark
-PRON-	PRP	nsubjpass
be	VBP	auxpass
construe	VBN	advcl
in	IN	prep
claim	NNS	pobj
2	CD	nummod
and	CC	cc
4	CD	conj
of	IN	prep
the	DT	det
'	``	punct
718	CD	nummod
patent	NN	pobj
discuss	VBN	acl
above	RB	advmod
.	.	punct

As	IN	mark
to	TO	aux
claim	VB	advcl
2	CD	dobj
,	,	punct
the	DT	det
district	NN	compound
court	NN	nsubj
rely	VBD	ROOT
on	IN	prep
the	DT	det
plain	JJ	amod
meaning	NN	pobj
of	IN	prep
"	``	punct
reduce	VBG	pcomp
gastrointestinal	JJ	amod
adverse	JJ	amod
side	NN	compound
effect	NNS	dobj
"	''	punct
.	.	punct

 	_SP	

At	IN	prep
the	DT	det
district	NN	compound
court	NN	pobj
,	,	punct
Teva	NNP	nsubj
argue	VBD	ROOT
that	IN	mark

 	_SP	
well	RB	advmod
before	IN	prep
the	DT	det
invention	NN	pobj
of	IN	prep
the	DT	det
patent	NN	pobj
,	,	punct
adverse	JJ	amod
gastrointestinal	JJ	amod
effect	NNS	nsubjpass
be	VBD	auxpass
widely	RB	advmod
know	VBN	ccomp
as	IN	prep
side	NN	compound
effect	NNS	pobj
of	IN	prep
both	CC	preconj
erythromycin	JJ	pobj
and	CC	cc
clarithromycin	NN	conj
and	CC	cc
,	,	punct
to	IN	prep
a	DT	det
less	JJR	amod
degree	NN	pobj
,	,	punct
azithromycin	NN	conj
.	.	punct

In	IN	prep
addition	NN	pobj
,	,	punct
person	NNS	nsubj
skilled	JJ	amod
in	IN	prep
the	DT	det
art	NN	pobj
know	VBD	ROOT
that	IN	det
one	CD	nummod
way	NN	nsubj
to	TO	aux
reduce	VB	relcl
these	DT	det
gastrointestinal	JJ	amod
effect	NNS	dobj
be	VBD	ccomp
to	TO	aux
formulate	VB	xcomp
the	DT	det
drug	NN	dobj
in	IN	prep
a	DT	det
polymer	NN	compound
matrix	NN	pobj
,	,	punct
e.g.	RB	advmod
,	,	punct
an	DT	det
extended	JJ	amod
release	NN	compound
formulation	NN	dobj
.	.	punct

the	DT	det
GI	NNP	compound
side	NN	compound
effect	NNS	nsubjpass
of	IN	prep
clarithromycin	NN	pobj
be	VBD	auxpass
know	VBN	ROOT
to	TO	aux
be	VB	xcomp
dependent	JJ	acomp
on	IN	prep
the	DT	det
drug	NN	compound
concentration	NN	pobj
in	IN	prep
the	DT	det
blood	NN	pobj
.	.	punct

moreover	RB	advmod
,	,	punct
the	DT	det
'	``	punct
422	CD	nummod
[	-LRB-	punct
publication	NN	nsubj
]	-RRB-	punct
for	IN	prep
extended	JJ	amod
release	NN	compound
azithromycin	NN	pobj
disclose	VBN	ROOT
that	IN	dobj
extend	VBN	amod
release	NN	compound
composition	NNS	pobj
of	IN	prep
that	DT	det
closely	RB	advmod
-	HYPH	punct
relate	VBN	amod
compound	NN	npadvmod
reduce	VBD	amod
gastrointestinal	JJ	amod
side	NN	compound
effect	NNS	pobj
.	.	punct

 	_SP	

Abbott	NNP	compound
Labs.	NNP	ROOT
,	,	punct
slip	VB	amod
op	RP	appos
.	.	punct

at	IN	ROOT
21	CD	pobj
.	.	punct

In	IN	prep
contrast	NN	pobj
,	,	punct
Abbott	NNP	nsubj
argue	VBD	parataxis
,	,	punct
inter	JJ	compound
alia	NNS	ROOT
,	,	punct
that	IN	mark
"	``	punct
the	DT	det
gastrointestinal	JJ	amod
side	NN	compound
effect	NNS	nsubj
of	IN	prep
different	JJ	amod
active	JJ	amod
pharmaceutical	JJ	amod
agent	NNS	pobj
be	VBP	ccomp
so	RB	advmod
distinct	JJ	acomp
that	IN	mark
the	DT	det
pharmacokinetic	JJ	amod
property	NNS	nsubj
of	IN	prep
a	DT	det
formulation	NN	pobj
with	IN	prep
one	CD	nummod
drug	NN	pobj
be	VBP	ccomp
not	RB	neg
predictive	JJ	acomp
of	IN	prep
a	DT	det
similar	JJ	amod
formulation	NN	pobj
with	IN	prep
another	DT	det
drug	NN	pobj
"	''	punct
.	.	punct

Idaho	NNP	ROOT

 	_SP	

After	IN	prep
review	VBG	pcomp
the	DT	det
prior	JJ	amod
art	NN	dobj
,	,	punct
the	DT	det
district	NN	compound
court	NN	nsubj
conclude	VBD	ROOT
that	IN	mark

 	_SP	
Abbott	NNP	nsubj
have	VBZ	aux
fail	VBN	ccomp
to	TO	aux
meet	VB	xcomp
-PRON-	PRP$	poss
burden	NN	dobj
of	IN	prep
demonstrating	NN	pcomp
that	IN	mark
Teva	NNP	poss
's	POS	case
opposition	NN	nsubj
lack	VBZ	ccomp
substantial	JJ	amod
merit	NN	dobj
.	.	punct

This	DT	det
court	NN	nsubj
find	VBZ	ROOT
that	IN	mark
the	DT	det
prior	JJ	amod
art	NN	nsubj
,	,	punct
specifically	RB	advmod
the	DT	det
discussion	NNS	appos
in	IN	prep
industry	NN	compound
treatise	NNS	pobj
and	CC	cc
medical	JJ	amod
journal	NNS	conj
of	IN	prep
formulation	NNS	pobj
that	WDT	nsubj
reduce	VBD	relcl
GI	NNP	compound
irritation	NN	dobj
,	,	punct
the	DT	det
teaching	NNS	appos
of	IN	prep
the	DT	det
'	``	punct
422	CD	nummod
[	-LRB-	punct
publication	NN	pobj
]	-RRB-	punct
,	,	punct
and	CC	cc
the	DT	det
reference	NN	compound
material	NN	conj
in	IN	prep
the	DT	det
Physicians	NNPS	poss
'	POS	case
Desk	NNP	compound
Reference	NNP	pobj
regard	VBG	prep
side	NN	compound
effect	NNS	pobj
,	,	punct
would	MD	aux
lead	VB	ccomp
a	DT	det
person	NN	dobj
of	IN	prep
ordinary	JJ	amod
skill	NN	pobj
in	IN	prep
the	DT	det
art	NN	pobj
to	TO	aux
expect	VB	advcl
that	IN	mark
an	DT	det
extended	JJ	amod
release	NN	compound
formulation	NN	nsubj
of	IN	prep
clarithromycin	NN	pobj
would	MD	aux
reduce	VB	ccomp
adverse	JJ	amod
GI	NNP	compound
side	NN	compound
effect	NNS	dobj
.	.	punct

 	_SP	

Idaho	NNP	ROOT
at	IN	prep
22	CD	pobj
.	.	punct

 	_SP	

Claim	NNP	ROOT
6	CD	nummod
of	IN	prep
the	DT	det
'	``	punct
718	CD	nummod
patent	NN	compound
claim	NNS	pobj

 	_SP	
an	DT	det
extended	JJ	amod
release	NN	compound
pharmaceutical	NN	compound
composition	NN	appos
comprise	VBG	acl
an	DT	det
erythromycin	JJ	amod
derivative	NN	dobj
and	CC	cc
a	DT	det
pharmaceutically	RB	advmod
acceptable	JJ	amod
polymer	NN	conj
,	,	punct
the	DT	det
composition	NN	appos
have	VBG	acl
an	DT	det
improve	VBN	amod
taste	NN	compound
profile	NN	dobj
as	IN	prep
compare	VBN	prep
to	IN	prep
the	DT	det
immediate	JJ	amod
release	NN	compound
formulation	NN	pobj
.	.	punct

 	_SP	
'	POS	punct
718	CD	nummod
patent	NN	conj
,	,	punct
col.	NN	conj
12	CD	nummod
,	,	punct
will	UH	intj
.	.	punct

23	CD	ROOT
-	SYM	punct
27	CD	prep
.	.	punct

As	IN	mark
to	TO	aux
claim	VB	advcl
6	CD	dobj
,	,	punct
the	DT	det
district	NN	compound
court	NN	nsubj
specifically	RB	advmod
construe	VBD	ROOT
the	DT	det
term	NN	dobj
"	``	punct
taste	NN	compound
profile	NN	appos
"	''	punct
note	VBG	xcomp
that	IN	mark
the	DT	det
specification	NN	nsubj
of	IN	prep
the	DT	det
'	``	punct
718	CD	nummod
patent	NN	compound
describe	NNS	pobj
"	``	punct
taste	NN	compound
profile	NN	appos
"	''	punct
in	IN	prep
parenthesis	NNS	pobj
immediately	RB	advmod
follow	VBG	ccomp
the	DT	det
word	NNS	dobj
"	``	punct
taste	NN	compound
perversion	NN	dobj
"	''	punct
.	.	punct
'	''	punct
718	CD	nummod
patent	NN	dobj
,	,	punct
col.	NN	conj
9	CD	nummod
,	,	punct
will	UH	intj
.	.	punct

23	CD	ROOT
-	SYM	punct
24	CD	prep
.	.	punct

the	DT	det
specification	NN	nsubj
define	VBZ	ROOT
"	``	punct
taste	NN	compound
perversion	NN	dobj
"	''	punct
as	IN	prep
"	``	punct
the	DT	det
perception	NN	pobj
of	IN	prep
a	DT	det
bitter	JJ	amod
metallic	JJ	amod
taste	NN	pobj
normally	RB	advmod
associate	VBN	acl
with	IN	prep
the	DT	det
erythromycin	JJ	amod
derivative	NNS	pobj
,	,	punct
particularly	RB	advmod
,	,	punct
with	IN	prep
clarithromycin	NN	pobj
"	''	punct
.	.	punct
'	''	punct
718	CD	nummod
patent	NN	dobj
,	,	punct
col.	NN	conj
3	CD	nummod
,	,	punct
will	UH	intj
.	.	punct

53	CD	ROOT
-	SYM	punct
55	CD	prep
.	.	punct

base	VBN	prep
on	IN	prep
this	DT	det
usage	NN	pobj
in	IN	prep
the	DT	det
specification	NN	pobj
,	,	punct
the	DT	det
district	NN	compound
court	NN	nsubj
conclude	VBD	ROOT
that	IN	mark
"	``	punct
taste	NN	ccomp
perversion	NN	dobj
"	''	punct
and	CC	cc
"	``	punct
taste	NN	compound
profile	NN	nsubjpass
"	''	punct
be	VBP	auxpass
"	``	punct
use	VBN	conj
synonymously	RB	advmod
"	''	punct
.	.	punct

Abbott	NNP	compound
Labs.	NNP	npadvmod
,	,	punct
slip	VB	ROOT
op	RP	dobj
.	.	punct
at	IN	prep
19	CD	pobj
.	.	punct

 	_SP	

At	IN	prep
the	DT	det
district	NN	compound
court	NN	pobj
,	,	punct
Teva	NNP	nsubj
argue	VBD	ROOT
that	IN	mark
"	``	punct
-PRON-	PRP	nsubjpass
be	VBD	auxpass
know	VBN	ccomp
that	IN	mark
clarithromycin	NN	nsubj
cause	VBN	ccomp
taste	NN	compound
perversion	NN	dobj
and	CC	cc
this	DT	nsubj
create	VBD	conj
a	DT	det
motivation	NN	dobj
for	IN	mark
formulator	NNS	nsubj
to	TO	aux
try	VB	advcl
to	TO	aux
create	VB	xcomp
an	DT	det
extended	JJ	amod
release	NN	compound
formulation	NN	dobj
that	WDT	nsubj
would	MD	aux
have	VB	relcl
an	DT	det
improve	VBN	amod
taste	NN	compound
profile	NN	dobj
.	.	punct

As	IN	prep
support	NN	pobj
,	,	punct
Teva	NNP	nsubj
cite	VBD	ROOT
a	DT	det
1993	CD	nummod
article	NN	dobj
write	VBN	acl
by	IN	agent
Abbott	NNP	compound
researcher	NNS	pobj
,	,	punct
discuss	VBG	advcl
the	DT	det
pharmacokinetic	NNS	dobj
of	IN	prep
single-	NN	nmod
and	CC	cc
multiple	JJ	amod
-	HYPH	punct
dose	NN	compound
clarithromycin	NN	pobj
"	''	punct
.	.	punct

Idaho	NNS	ROOT
at	IN	prep
19	CD	pobj
(	-LRB-	punct
citation	NNS	nsubj
omit	VBN	parataxis
)	-RRB-	punct
.	.	punct

furthermore	RB	advmod
,	,	punct
Teva	NNP	nsubj
also	RB	advmod
rely	VBD	ROOT
on	IN	prep
Pfizer	NNP	poss
's	POS	case
'	''	punct
422	CD	nummod
publication	NN	pobj
which	WDT	nsubj
,	,	punct
as	IN	mark
discuss	VBN	advcl
above	RB	advmod
,	,	punct
disclose	VBD	relcl
extended	JJ	amod
release	NN	compound
formulation	NNS	dobj
for	IN	prep
amelioration	NN	pobj
of	IN	prep
other	JJ	amod
macrolide	NN	npadvmod
relate	VBN	amod
side	NN	compound
effect	NNS	pobj
.	.	punct

Abbott	NNP	nsubj
argue	VBD	ROOT
that	IN	mark
only	RB	advmod
-PRON-	PRP$	poss
own	JJ	amod
study	NN	nsubj
by	IN	prep
-PRON-	PRP$	poss
researcher	NNS	pobj
mention	VBD	ccomp
taste	NN	compound
perversion	NN	dobj
.	.	punct

the	DT	det
other	JJ	amod
reference	NNS	nsubj
,	,	punct
like	IN	prep
the	DT	det
'	``	punct
422	CD	nummod
publication	NN	pobj
,	,	punct
either	CC	preconj
describe	VB	ROOT
other	JJ	amod
non	JJ	subtok
-	JJ	subtok
taste	VB	amod
relate	VBN	amod
side	NN	compound
effect	NNS	dobj
or	CC	cc
-PRON-	PRP	nsubj
describe	VBP	conj
"	``	punct
taste	NN	compound
mask	VBG	dobj
"	''	punct
rather	RB	advmod
than	IN	cc
"	``	punct
taste	NN	conj
perversion	NN	dobj
"	''	punct
.	.	punct

Idaho	NNP	ROOT

furthermore	RB	advmod
,	,	punct
as	IN	prep
to	IN	prep
-PRON-	PRP$	poss
one	CD	nummod
study	NN	pobj
,	,	punct
Abbott	NNP	nsubj
argue	VBD	ROOT
that	IN	mark
the	DT	det
mere	JJ	amod
fact	NN	nsubj
that	IN	mark
taste	NN	compound
perversion	NN	nsubjpass
be	VBZ	auxpass
mention	VBN	acl
do	VBZ	aux
not	RB	neg
make	VB	ccomp
claim	NN	nsubj
6	CD	nummod
obvious	JJ	ccomp
and	CC	cc
,	,	punct
additionally	RB	advmod
,	,	punct
that	IN	mark
Teva	NNP	nsubj
have	VBD	aux
not	RB	neg
even	RB	advmod
show	VBN	ccomp
evidence	NN	dobj
that	IN	nsubj
taste	NN	acl
perversion	NN	dobj
be	VBZ	ccomp
dose	NN	attr
dependent	JJ	amod
.	.	punct

 	_SP	

After	IN	prep
weigh	VBG	pcomp
the	DT	det
prior	JJ	amod
art	NN	dobj
,	,	punct
the	DT	det
district	NN	compound
court	NN	nsubj

 	_SP	
agree	VBD	ROOT
with	IN	prep
Abbott	NNP	pobj
that	IN	mark
Teva	NNP	nsubj
have	VBZ	aux
not	RB	neg
meet	VBN	ccomp
-PRON-	PRP$	poss
burden	NN	dobj
of	IN	prep
raise	VBG	pcomp
a	DT	det
substantial	JJ	amod
question	NN	dobj
as	IN	prep
to	IN	prep
the	DT	det
validity	NN	pobj
of	IN	prep
claim	NN	pobj
6	CD	nummod
.	.	punct

Teva	NNP	nsubj
rely	VBZ	ROOT
primarily	RB	advmod
on	IN	prep
only	RB	advmod
one	CD	nummod
study	NN	pobj
,	,	punct
cite	VBD	acl
apparently	RB	advmod
in	IN	prep
only	RB	advmod
one	CD	nummod
article	NN	pobj
,	,	punct
that	WDT	nsubj
mention	NNS	nsubj
taste	VBP	ccomp
perversion	NN	dobj
as	IN	prep
a	DT	det
know	VBN	amod
side	NN	compound
effect	NN	pobj
of	IN	prep
clarithromycin	NN	pobj
,	,	punct
and	CC	cc
even	RB	advmod
then	RB	advmod
,	,	punct
in	IN	prep
only	RB	advmod
one	CD	pobj
of	IN	prep
thirty	CD	compound
-	HYPH	punct
eight	CD	nummod
research	NN	compound
subject	NNS	pobj
.	.	punct

This	DT	det
court	NN	nsubj
find	VBZ	ROOT
that	IN	mark
Teva	NNP	nsubj
have	VBZ	aux
fail	VBN	ccomp
to	TO	aux
provide	VB	xcomp
sufficient	JJ	amod
evidence	NN	dobj
to	TO	aux
demonstrate	VB	acl
that	DT	det
improve	VBN	amod
taste	NN	compound
profile	NN	dobj
as	IN	prep
a	DT	det
result	NN	pobj
of	IN	prep
an	DT	det
extended	JJ	amod
release	NN	compound
formulation	NN	pobj
of	IN	prep
clarithromycin	NN	pobj
would	MD	aux
have	VB	aux
be	VBN	ccomp
obvious	JJ	acomp
to	IN	prep
an	DT	det
ordinary	JJ	amod
person	NN	pobj
skilled	JJ	amod
in	IN	prep
the	DT	det
art	NN	pobj
.	.	punct

 	_SP	

Idaho	NNP	ROOT
at	IN	prep
20	CD	pobj
.	.	punct

 	_SP	

the	DT	det
district	NN	compound
court	NN	nsubj
conclude	VBD	ROOT
that	IN	mark
Teva	NNP	nsubj
fail	VBD	ccomp
to	TO	aux
raise	VB	xcomp
a	DT	det
substantial	JJ	amod
question	NN	dobj
as	IN	mark
to	TO	aux
claim	VB	advcl
6	CD	dobj
of	IN	prep
the	DT	det
'	``	punct
718	CD	nummod
patent	NN	pobj
but	CC	cc
the	DT	det
district	NN	compound
court	NN	nsubj
find	VBD	conj
Teva	NNP	nsubj
have	VBD	aux
raise	VBN	ccomp
a	DT	det
substantial	JJ	amod
question	NN	dobj
as	IN	prep
to	IN	prep
the	DT	det
validity	NN	pobj
of	IN	prep
claim	NN	pobj
2	CD	nummod
of	IN	prep
the	DT	det
'	``	punct
616	CD	nummod
patent	NN	pobj
.	.	punct

 	_SP	

the	DT	det
district	NN	compound
court	NN	nsubj
properly	RB	advmod
construe	VBD	ROOT
the	DT	det
claim	NNS	dobj
for	IN	prep
the	DT	det
purpose	NNS	pobj
of	IN	prep
the	DT	det
preliminary	JJ	amod
injunction	NN	pobj
.	.	punct
"	''	punct

erythromycin	JJ	compound
derivative	NN	nsubjpass
"	''	punct
and	CC	cc
"	``	punct
pharmaceutically	RB	advmod
acceptable	JJ	amod
polymer	NN	conj
"	''	punct
be	VBP	auxpass
construe	VBN	ROOT
as	IN	advmod
above	RB	advmod
.	.	punct

furthermore	RB	advmod
,	,	punct
for	IN	prep
claim	NN	pobj
2	CD	nummod
of	IN	prep
the	DT	det
'	``	punct
616	CD	nummod
patent	NN	pobj
,	,	punct
reduce	VBG	csubjpass
gastrointestinal	JJ	amod
side	NN	compound
effect	NNS	dobj
be	VBZ	auxpass
give	VBN	ROOT
-PRON-	PRP$	poss
plain	JJ	amod
meaning	NN	dobj
while	IN	mark
for	IN	prep
claim	NN	pobj
6	CD	nummod
of	IN	prep
the	DT	det
'	``	punct
718	CD	nummod
patent	NN	pobj
,	,	punct
"	''	punct
taste	NN	compound
profile	NN	nsubjpass
"	''	punct
be	VBZ	auxpass
read	VBN	advcl
as	IN	advmod
synonymous	JJ	oprd
with	IN	prep
"	``	punct
taste	NN	compound
perversion	NN	pobj
"	''	punct
.	.	punct

 	_SP	

-PRON-	PRP	nsubj
now	RB	advmod
turn	VBP	ROOT
to	IN	prep
the	DT	det
obviousness	JJ	amod
contention	NNS	pobj
base	VBN	acl
on	IN	prep
the	DT	det
above	JJ	amod
construction	NN	pobj
of	IN	prep
claim	NN	pobj
2	CD	pobj
and	CC	cc
6	CD	conj
.	.	punct

even	RB	advmod
though	IN	mark
claim	NN	nsubj
2	CD	npadvmod
be	VBZ	advcl
a	DT	det
method	NN	compound
claim	NN	attr
and	CC	cc
claim	VBP	conj
6	CD	nsubj
be	VBZ	ccomp
a	DT	det
composition	NN	attr
,	,	punct
-PRON-	PRP	nsubj
both	DT	appos
deal	VBP	ROOT
with	IN	prep
ER	NNP	compound
composition	NNS	pobj
of	IN	prep
erythromycin	JJ	amod
derivative	NNS	pobj
combine	VBN	acl
with	IN	prep
pharmaceutically	RB	advmod
acceptable	JJ	amod
polymer	NNS	pobj
that	WDT	nsubj
can	MD	aux
improve	VB	relcl
adverse	JJ	amod
side	NN	compound
effect	NNS	dobj
compare	VBN	prep
to	IN	prep
the	DT	det
IR	NNP	compound
composition	NNS	pobj
.	.	punct

As	IN	prep
a	DT	det
result	NN	pobj
,	,	punct
the	DT	det
obviousness	JJ	amod
analysis	NN	nsubj
be	VBZ	ROOT
quite	RB	advmod
similar	JJ	acomp
for	IN	prep
both	DT	det
claim	NNS	pobj
.	.	punct

Claim	NNP	nmod
2	CD	nummod
address	NNS	ROOT
reduce	VBG	acl
adverse	JJ	amod
GI	NNP	compound
side	NN	compound
effect	NNS	dobj
while	IN	mark
claim	NN	advcl
6	CD	nummod
address	NNS	dobj
improve	VBG	acl
the	DT	det
taste	NN	compound
profile	NN	dobj
.	.	punct

 	_SP	

These	DT	det
two	CD	nummod
claim	NNS	nsubj
have	VBP	ROOT
three	CD	nummod
major	JJ	amod
component	NNS	dobj
.	.	punct

-PRON-	PRP	nsubj
require	VBP	ROOT
an	DT	det
erythromycin	JJ	amod
derivative	JJ	dobj
,	,	punct
a	DT	det
polymer	NN	conj
,	,	punct
and	CC	cc
-PRON-	PRP	nsubj
each	DT	appos
recite	JJ	conj
improvement	NN	dobj
of	IN	prep
a	DT	det
side	NN	compound
effect	NN	pobj
(	-LRB-	punct
taste	NN	parataxis
perversion	NN	dobj
for	IN	prep
claim	NN	pobj
6	CD	nummod
of	IN	prep
the	DT	det
'	``	punct
718	CD	nummod
patent	NN	nmod
and	CC	cc
GI	NNP	compound
side	NN	compound
effect	NNS	pobj
for	IN	prep
claim	NN	pobj
2	CD	nummod
of	IN	prep
the	DT	det
'	``	punct
616	CD	nummod
patent	NN	pobj
)	-RRB-	punct
.	.	punct

follow	VBG	prep
the	DT	det
discussion	NN	pobj
above	RB	prep
of	IN	prep
claim	NN	pobj
2	CD	pobj
and	CC	cc
4	CD	conj
of	IN	prep
the	DT	det
'	``	punct
718	CD	nummod
patent	NN	pobj
,	,	punct
there	EX	expl
be	VBP	ROOT
substantial	JJ	amod
argument	NNS	attr
that	IN	mark
an	DT	det
extended	JJ	amod
release	NN	compound
formulation	NN	nsubj
with	IN	prep
an	DT	det
erythromycin	JJ	amod
derivative	NN	pobj
and	CC	cc
an	DT	det
acceptable	JJ	amod
polymer	NN	conj
would	MD	aux
have	VB	aux
be	VBN	acl
obvious	JJ	acomp
in	IN	prep
light	NN	pobj
of	IN	prep
the	DT	det
prior	JJ	amod
art.7	NN	pobj

the	DT	det
validity	NN	ROOT
of	IN	prep
claim	NN	pobj
2	CD	nummod
and	CC	cc
claim	VBP	conj
6	CD	nummod
likely	JJ	amod
hinge	NNS	dobj
on	IN	prep
the	DT	det
extra	JJ	amod
limitation	NNS	pobj
regard	VBG	prep
the	DT	det
claim	VBN	amod
improve	VBN	amod
side	NN	compound
-	HYPH	punct
effect	NNS	pobj
.	.	punct

In	IN	prep
-PRON-	PRP$	poss
brief	NN	pobj
on	IN	prep
appeal	NN	pobj
,	,	punct
Abbott	NNP	nsubj
contend	VBZ	ROOT
that	IN	mark
"	``	punct
the	DT	det
invention	NNS	nsubj
of	IN	prep
the	DT	det
patent	NNS	pobj
in	IN	prep
suit	NN	pobj
decrease	VB	ccomp
the	DT	det
incidence	NN	dobj
and	CC	cc
severity	NN	conj
of	IN	prep
two	CD	nummod
primary	JJ	amod
side	NN	compound
effect	NNS	pobj
of	IN	prep
clarithromycin	NN	pobj
:	:	punct
taste	NN	acl
perversion	NN	dobj
and	CC	cc
gastrointestinal	JJ	amod
distress	NN	conj
....	.	punct

These	DT	det
discovery	NNS	nsubj
form	VBP	ROOT
the	DT	det
basis	NN	dobj
of	IN	prep
claim	NN	pobj
6	CD	nummod
of	IN	prep
the	DT	det
'	``	punct
718	CD	nummod
patent	NN	pobj
and	CC	cc
claim	NN	conj
2	CD	dobj
of	IN	prep
the	DT	det
'	``	punct
616	CD	nummod
patent	NN	pobj
respectively	RB	advmod
"	''	punct
.	.	punct

As	IN	prep
to	IN	prep
such	JJ	amod
claim	NNS	pobj
,	,	punct
this	DT	det
court	NN	nsubj
have	VBZ	aux
state	VBN	ROOT
that	IN	mark
"	``	punct
when	WRB	advmod
unexpected	JJ	amod
result	NNS	nsubjpass
be	VBP	auxpass
use	VBN	advcl
as	IN	prep
evidence	NN	pobj
of	IN	prep
nonobviousness	NN	pobj
,	,	punct
the	DT	det
result	NNS	nsubjpass
must	MD	aux
be	VB	auxpass
show	VBN	ccomp
to	TO	aux
be	VB	xcomp
unexpected	JJ	acomp
compare	VBN	prep
with	IN	prep
the	DT	det
close	JJS	amod
prior	JJ	amod
art	NN	pobj
"	''	punct
.	.	punct

In	IN	ROOT
re	NN	pobj
Baxter	NNP	compound
Travenol	NNP	compound
Labs.	NNP	pobj
,	,	punct
952	CD	nummod
f.2d	CD	compound
388	CD	nummod
,	,	punct
392	CD	appos
(	-LRB-	punct
Fed	NNP	nmod
.	.	punct
Cir.1991	LS	pobj
)	-RRB-	punct
(	-LRB-	punct
cite	VBG	pcomp
In	IN	prep
re	IN	compound
De	NNP	compound
Blauwe	NNP	pobj
,	,	punct
736	CD	nummod
f.2d	CD	nummod
699	CD	appos
,	,	punct
705	CD	appos
(	-LRB-	punct
Fed	NNP	appos
.	.	punct
cir.1984	ADD	amod
)	-RRB-	punct
)	-RRB-	punct
.	.	punct

 	_SP	

the	DT	det
prior	JJ	amod
art	NN	nsubj
and	CC	cc
Abbott	NNP	poss
's	POS	case
own	JJ	amod
statement	NNS	conj
in	IN	prep
-PRON-	PRP$	poss
brief	NNS	pobj
indicate	VBP	ROOT
that	IN	mark
the	DT	det
reduction	NN	nsubj
of	IN	prep
systemic	JJ	amod
side	NN	compound
effect	NNS	pobj
would	MD	aux
not	RB	neg
be	VB	ccomp
surprising	JJ	acomp
and	CC	cc
would	MD	aux
not	RB	neg
be	VB	conj
unexpected	JJ	acomp
.	.	punct

This	DT	nsubj
,	,	punct
therefore	RB	advmod
,	,	punct
raise	VBZ	ROOT
a	DT	det
substantial	JJ	amod
question	NN	dobj
as	IN	prep
to	IN	prep
the	DT	det
validity	NN	pobj
of	IN	prep
the	DT	det
claim	NNS	pobj
.	.	punct

first	RB	advmod
,	,	punct
as	IN	prep
to	IN	prep
the	DT	det
GI	NNP	compound
side	NN	compound
-	HYPH	punct
effect	NNS	pobj
,	,	punct
the	DT	det
district	NN	compound
court	NN	nsubj
find	VBD	ROOT
that	IN	mark
the	DT	det
"	``	punct
GI	NNP	compound
side	NN	compound
effect	NNS	nsubjpass
of	IN	prep
clarithromycin	NN	pobj
be	VBD	auxpass
know	VBN	ccomp
to	TO	aux
be	VB	xcomp
dependent	JJ	acomp
on	IN	prep
the	DT	det
drug	NN	compound
concentration	NN	pobj
in	IN	prep
the	DT	det
blood	NN	pobj
"	''	punct
.	.	punct

Abbott	NNP	compound
Labs.	NNP	npadvmod
,	,	punct
slip	VB	ROOT
op	RP	dobj
.	.	punct
at	IN	prep
21	CD	pobj
.	.	punct

furthermore	RB	advmod
,	,	punct
the	DT	det
district	NN	compound
court	NN	nsubj
find	VBD	ROOT
that	IN	mark
Abbott	NNP	nsubj
contend	VBD	ccomp
that	IN	mark
"	``	punct
an	DT	det
extended	JJ	amod
release	NN	compound
formulation	NN	nsubj
would	MD	aux
reduce	VB	ccomp
the	DT	det
maximum	JJ	amod
blood	NN	compound
plasma	NN	compound
concentration	NN	dobj
of	IN	prep
the	DT	det
drug	NN	pobj
"	''	punct
.	.	punct

Idaho	NNP	ROOT

thus	RB	advmod
,	,	punct
the	DT	det
result	VBG	amod
reduction	NN	nsubjpass
in	IN	prep
GI	NNP	compound
side	NN	compound
-	HYPH	punct
effect	NNS	pobj
can	MD	aux
not	RB	neg
be	VB	auxpass
say	VBN	ROOT
to	TO	aux
be	VB	xcomp
unexpected	JJ	acomp
and	CC	cc
the	DT	det
district	NN	compound
court	NN	nsubj
correctly	RB	advmod
find	VBD	conj
that	IN	mark
Teva	NNP	nsubj
raise	VBD	ccomp
a	DT	det
substantial	JJ	amod
question	NN	dobj
as	IN	prep
to	IN	prep
the	DT	det
invalidity	NN	pobj
of	IN	prep
claim	NN	pobj
2	CD	nummod
of	IN	prep
the	DT	det
'	``	punct
616	CD	nummod
patent	NN	pobj
.	.	punct

 	_SP	

second	RB	ROOT
,	,	punct
as	IN	mark
to	TO	aux
taste	VB	advcl
perversion	NN	dobj
,	,	punct
Teva	NNP	nsubj
point	VBZ	npadvmod
to	IN	prep
a	DT	det
number	NN	pobj
of	IN	prep
prior	JJ	amod
art	NN	compound
reference	NNS	pobj
include	VBG	prep
a	DT	det
study	NN	pobj
conduct	VBN	acl
by	IN	agent
Abbott	NNP	pobj
describe	VBN	acl
in	IN	prep
S.-y	NNP	pobj
.	.	punct

chu	VB	compound
et	NNP	compound
al	NNP	subtok
.	.	ROOT
,	,	punct

Single-	NNP	ROOT
and	CC	cc
Multiple	NNP	compound
-	HYPH	punct
dose	NN	compound
Pharmacokinetics	NNPS	conj
of	IN	prep
Clarithromycin	NNP	pobj
,	,	punct
a	DT	det
New	NNP	compound
Macrolide	NNP	compound
Antimicrobial	NNP	appos
,	,	punct
33	CD	nummod
J.	NNP	compound
Clin	NNP	appos
.	.	punct

Pharma	NNP	compound
col.	NN	ROOT
719	CD	nummod
-	SYM	punct
26	CD	prep
(	-LRB-	punct
1993	CD	npadvmod
)	-RRB-	punct
.	.	punct

the	DT	det
article	NN	nsubj
describe	VBZ	ROOT
a	DT	det
study	NN	dobj
of	IN	prep
single	JJ	amod
and	CC	cc
multiple	JJ	conj
dose	NN	compound
trial	NNS	pobj
of	IN	prep
clarithromycin	NN	pobj
and	CC	cc
-PRON-	PRP	nsubj
report	VBD	conj
the	DT	det
side	NN	compound
effect	NNS	dobj
encounter	VBN	acl
by	IN	agent
participant	NNS	pobj
include	VBG	prep
taste	NN	compound
perversion	NN	pobj
.	.	punct

At	IN	prep
the	DT	det
district	NN	compound
court	NN	pobj
,	,	punct
Abbott	NNP	nsubj
argue	VBD	ROOT
"	``	punct
that	IN	mark
Teva	NNP	poss
's	POS	case
reliance	NN	nsubj
on	IN	prep
[	-LRB-	punct
this	DT	pobj
]	-RRB-	punct
Abbott	NNP	compound
study	NN	pobj
disclose	VBN	ccomp
in	IN	prep
the	DT	det
Journal	NNP	pobj
of	IN	prep
Clinical	NNP	compound
Pharmacology	NNP	pobj
overstate	VBZ	ccomp
-PRON-	PRP$	poss
case	NN	dobj
.	.	punct

only	RB	advmod
one	CD	nsubj
of	IN	prep
thirty	CD	compound
eight	CD	nummod
subject	NNS	pobj
report	VBD	ROOT
taste	NN	compound
perversion	NN	dobj
as	IN	prep
a	DT	det
side	NN	compound
effect	NN	pobj
,	,	punct
and	CC	cc
only	RB	advmod
at	IN	conj
one	CD	pobj
of	IN	prep
four	CD	nummod
different	JJ	amod
dosage	NN	compound
level	NNS	pobj
"	''	punct
.	.	punct

Abbott	NNP	compound
Labs.	NNP	npadvmod
,	,	punct
slip	VB	ROOT
op	RP	dobj
.	.	punct
at	IN	prep
19	CD	pobj
.	.	punct

the	DT	det
district	NN	compound
court	NN	nsubj
seemingly	RB	advmod
agree	VBG	ROOT
with	IN	prep
Abbott	NNP	poss
's	POS	case
view	NN	pobj
of	IN	prep
that	DT	det
reference	NN	pobj
conclude	VBD	conj
that	IN	mark
"	``	punct
this	DT	det
court	NN	nsubj
agree	VBZ	ccomp
with	IN	prep
Abbott	NNP	pobj
that	IN	mark
Teva	NNP	nsubj
have	VBZ	aux
not	RB	neg
meet	VBN	ccomp
-PRON-	PRP$	poss
burden	NN	dobj
of	IN	prep
raise	VBG	pcomp
a	DT	det
substantial	JJ	amod
question	NN	dobj
as	IN	prep
to	IN	prep
the	DT	det
validity	NN	pobj
of	IN	prep
claim	NN	pobj
6	CD	nummod
.	.	punct

Teva	NNP	nsubj
rely	VBZ	ROOT
primarily	RB	advmod
on	IN	prep
only	RB	advmod
one	CD	nummod
study	NN	pobj
,	,	punct
cite	VBD	acl
apparently	RB	advmod
in	IN	prep
only	RB	advmod
one	CD	nummod
article	NN	pobj
,	,	punct
that	WDT	nsubj
mention	NNS	nsubj
taste	VBP	ccomp
perversion	NN	dobj
as	IN	prep
a	DT	det
know	VBN	amod
side	NN	compound
effect	NN	pobj
of	IN	prep
clarithromycin	NN	pobj
,	,	punct
and	CC	cc
even	RB	advmod
then	RB	advmod
,	,	punct
in	IN	prep
only	RB	advmod
one	CD	pobj
of	IN	prep
thirty	CD	compound
-	HYPH	punct
eight	CD	nummod
research	NN	compound
subject	NNS	pobj
"	''	punct
.	.	punct

Abbott	NNP	compound
Labs.	NNP	npadvmod
,	,	punct
slip	VB	ROOT
op	RP	dobj
.	.	punct
at	IN	prep
20	CD	pobj
.	.	punct

 	_SP	

Upon	IN	prep
examine	VBG	pcomp
that	DT	det
reference	NN	dobj
,	,	punct
-PRON-	PRP	nsubj
can	MD	aux
not	RB	neg
agree	VB	ROOT
with	IN	prep
Abbott	NNP	poss
's	POS	case
or	CC	cc
the	DT	det
district	NN	compound
court	NN	poss
's	POS	case
characterization	NN	pobj
.	.	punct

In	IN	prep
the	DT	det
study	NN	pobj
,	,	punct
two	CD	nummod
group	NNS	nsubj
of	IN	prep
participant	NNS	pobj
undergo	VBD	ROOT
differ	VBG	amod
treatment	NN	compound
proto	NN	compound
col	NNS	dobj
.	.	punct

see	VB	ROOT
Chu	NNP	dobj
,	,	punct
supra	NN	appos
,	,	punct
at	IN	prep
721	CD	pobj
.	.	punct

a	DT	det
group	NN	nsubj
of	IN	prep
twenty	CD	pobj
undergo	VBD	ROOT
both	CC	preconj
a	DT	det
single	JJ	amod
250	CD	nummod
mg	NN	compound
clarithromycin	NN	compound
protocol	NN	dobj
and	CC	cc
a	DT	det
multiple	JJ	amod
250	CD	nummod
mg	NN	nmod
clarithromycin	NN	compound
proto	NN	conj
col.	FW	advmod

Idaho	NNP	ROOT

From	IN	prep
among	IN	prep
these	DT	det
two	CD	nummod
250	CD	nummod
mg	NN	compound
proto	NN	compound
col	NNS	pobj
,	,	punct
no	DT	det
participant	NNS	nsubj
report	VBD	ROOT
taste	NN	compound
perversion	NN	dobj
as	IN	prep
a	DT	det
side	NN	compound
-	HYPH	punct
effect	NN	pobj
.	.	punct

Idaho	NNP	ROOT

another	DT	det
group	NN	nsubj
of	IN	prep
eighteen	CD	nummod
participant	NNS	pobj
undergo	VBD	ROOT
both	PDT	preconj
a	DT	det
single	JJ	amod
500	CD	nummod
mg	NN	compound
protocol	NN	dobj
and	CC	cc
a	DT	det
multiple	JJ	amod
500	CD	nummod
mg	NN	compound
dose	NN	compound
proto	NN	conj
col.	NN	advmod

Idaho	NNP	ROOT

From	IN	prep
among	IN	prep
these	DT	det
proto	NN	compound
col	NNS	pobj
,	,	punct
one	CD	nsubj
participant	NN	ROOT
in	IN	prep
each	DT	pobj
of	IN	prep
the	DT	det
500	CD	nummod
mg	NN	compound
proto	NN	compound
col	NNS	pobj
report	VBD	acl
taste	NN	compound
perversion	NN	dobj
.	.	punct

Idaho	NNP	ROOT

thus	RB	advmod
,	,	punct
out	IN	prep
of	IN	prep
the	DT	det
four	CD	nummod
trial	NNS	pobj
,	,	punct
neither	CC	nmod
of	IN	prep
250	CD	nummod
mg	NN	compound
proto	NN	compound
col	NNS	pobj
produce	VBD	amod
taste	NN	compound
perversion	NN	ROOT
as	IN	prep
a	DT	det
side	NN	compound
-	HYPH	punct
effect	NN	pobj
while	IN	mark
each	DT	det
500	CD	nummod
mg	NN	compound
trial	NN	nsubj
produce	VBD	advcl
one	CD	nummod
report	VBN	amod
case	NN	dobj
of	IN	prep
taste	NN	compound
perversion	NN	pobj
.	.	punct

therefore	RB	advmod
,	,	punct
Abbott	NNP	nsubj
be	VBZ	ROOT
incorrect	JJ	acomp
in	IN	prep
state	VBG	pcomp
that	IN	mark
the	DT	det
study	NN	nsubj
only	RB	advmod
report	VBD	ccomp
taste	NN	compound
perversion	NN	dobj
at	IN	prep
one	CD	pobj
of	IN	prep
four	CD	nummod
dosage	NN	compound
level	NNS	pobj
.	.	punct

admittedly	RB	advmod
,	,	punct
find	VBG	csubj
0	CD	dobj
out	IN	prep
of	IN	prep
20	CD	nummod
case	NNS	pobj
in	IN	prep
neither	CC	det
250	CD	nummod
mg	NN	compound
dosage	NN	compound
proto	NN	compound
col	NNS	pobj
and	CC	cc
1	CD	nsubj
out	IN	prep
of	IN	prep
18	CD	nummod
case	NNS	pobj
in	IN	prep
each	DT	det
500	CD	nummod
mg	NN	compound
protocol	NN	pobj
do	VBZ	aux
not	RB	neg
establish	VB	ROOT
that	IN	det
taste	NN	dobj
perversion	NN	nsubj
be	VBZ	ccomp
dose	NN	npadvmod
dependent	JJ	acomp
but	CC	cc
-PRON-	PRP	nsubj
do	VBZ	aux
support	VB	conj
such	JJ	amod
argument	NNS	dobj
.	.	punct

furthermore	RB	advmod
,	,	punct
as	IN	prep
a	DT	det
general	JJ	amod
matter	NN	pobj
,	,	punct
the	DT	det
prior	JJ	amod
art	NN	nsubj
also	RB	advmod
suggest	VBZ	ROOT
that	IN	mark
a	DT	det
know	VBN	amod
advantage	NN	nsubj
of	IN	prep
a	DT	det
sustain	VBN	amod
-	HYPH	punct
release	NN	compound
formulation	NN	pobj
be	VBZ	ccomp
"	``	punct
a	DT	det
decrease	NN	attr
or	CC	cc
elimination	NN	conj
of	IN	prep
both	CC	det
local	JJ	amod
and	CC	cc
systemic	JJ	conj
side	NN	compound
effect	NNS	pobj
"	''	punct
.	.	punct

Charles	NNP	compound
S.L.	NNP	compound
Chiao	NNP	ROOT
&	CC	cc
Joseph	NNP	compound
R.	NNP	compound
Robinson	NNP	conj
,	,	punct
Sustained	NNP	npadvmod
-	HYPH	punct
release	VBN	compound
Drug	NNP	compound
Delivery	NNP	compound
Systems	NNP	appos
,	,	punct
in	IN	prep
Remington	NNP	pobj
:	:	punct
the	DT	det
Science	NNP	appos
and	CC	cc
Practice	NNP	conj
of	IN	prep
Pharmacy	NNP	pobj
,	,	punct
1660	CD	appos
,	,	punct
1662	CD	appos
(	-LRB-	punct
A.R.Gennaro	NNP	appos
,	,	punct
ed.1995	NNP	npadvmod
)	-RRB-	punct
.	.	punct

lastly	RB	advmod
,	,	punct
Abbott	NNP	nsubj
state	VBZ	ROOT
that	IN	mark
"	``	punct
taste	NN	compound
perversion	NN	nsubj
be	VBZ	ccomp
different	JJ	acomp
from	IN	prep
simply	RB	advmod
an	DT	det
'	``	punct
unpleasant	JJ	amod
taste	NN	pobj
'	''	punct
of	IN	prep
the	DT	det
drug	NN	pobj
when	WRB	advmod
first	RB	advmod
ingested	JJ	advcl
....	.	punct

rather	RB	advmod
,	,	punct
-PRON-	PRP	nsubj
refer	VBZ	ROOT
'	''	punct
to	IN	prep
the	DT	det
continue	VBG	amod
effect	NN	pobj
of	IN	prep
the	DT	det
drug	NN	pobj
upon	IN	prep
the	DT	det
sense	NN	pobj
of	IN	prep
taste	NN	pobj
while	IN	mark
the	DT	det
drug	NN	nsubj
remain	VBZ	advcl
in	IN	prep
the	DT	det
bloodstream	NN	pobj
....	.	punct
'	''	punct
"	``	punct
In	IN	prep
other	JJ	amod
word	NNS	pobj
,	,	punct
taste	NN	compound
perversion	NN	nsubj
be	VBZ	ccomp
not	RB	neg
relate	VBN	acomp
to	IN	prep
a	DT	det
direct	JJ	amod
,	,	punct
local	JJ	amod
taste	NN	compound
sensation	NN	pobj
from	IN	prep
the	DT	det
drug	NN	pobj
on	IN	prep
the	DT	det
tongue	NN	pobj
but	CC	cc
be	VBZ	conj
rather	RB	advmod
a	DT	det
systemic	JJ	amod
side	NN	compound
effect	NN	attr
.	.	punct

In	IN	prep
regard	NN	pobj
to	IN	prep
systemic	JJ	amod
side	NN	compound
effect	NNS	pobj
generally	RB	advmod
,	,	punct
Abbott	NNP	nsubj
state	VBZ	ROOT
that	IN	mark
"	``	punct
side	NN	compound
effect	NNS	nsubj
can	MD	aux
be	VB	ccomp
either	CC	advmod
systemic	JJ	acomp
-	:	punct
in	IN	prep
which	WDT	det
case	NN	pcomp
-PRON-	PRP	nsubj
correlate	VBP	ccomp
to	IN	prep
overall	JJ	amod
drug	NN	compound
level	NNS	pobj
in	IN	prep
blood	NN	pobj
-	,	punct
or	CC	cc
local	JJ	conj
-	HYPH	punct
in	IN	prep
which	WDT	det
case	NN	pcomp
-PRON-	PRP	nsubj
correlate	VBP	relcl
with	IN	prep
the	DT	det
level	NNS	pobj
of	IN	prep
drug	NN	pobj
be	VBG	auxpass
release	VBN	acl
at	IN	prep
the	DT	det
site	NN	pobj
of	IN	prep
irritation	NN	pobj
"	''	punct
.	.	punct

From	IN	prep
these	DT	det
statement	NNS	pobj
,	,	punct
Abbot	NNP	nsubj
suggest	VBZ	ROOT
that	IN	dobj
systemic	JJ	amod
side	NN	compound
effect	NNS	pobj
like	IN	prep
taste	NN	compound
perversion	NN	compound
correlate	NN	pobj
with	IN	prep
overall	JJ	amod
drug	NN	compound
blood	NN	compound
level	NNS	pobj
.	.	punct

thus	RB	advmod
,	,	punct
Abbott	NNP	poss
's	POS	case
own	JJ	amod
statement	NNS	nsubj
from	IN	prep
-PRON-	PRP$	poss
brief	JJ	amod
support	NN	pobj
the	DT	det
argument	NN	ROOT
that	IN	mark
reduction	NN	nsubj
of	IN	prep
taste	NN	compound
perversion	NN	pobj
would	MD	aux
not	RB	neg
be	VB	acl
unexpected	JJ	acomp
when	WRB	advmod
an	DT	det
extended	JJ	amod
release	NN	compound
formulation	NN	compound
lower	VBZ	advcl
the	DT	det
concentration	NN	dobj
of	IN	prep
the	DT	det
drug	NN	pobj
in	IN	prep
the	DT	det
blood.8	NNP	compound
Based	NNP	pobj
,	,	punct
on	IN	prep
these	DT	det
reference	NNS	pobj
and	CC	cc
statement	NNS	conj
,	,	punct
a	DT	det
substantial	JJ	amod
question	NN	nsubj
exist	VBZ	conj
that	IN	mark
the	DT	det
improvement	NN	nsubj
of	IN	prep
the	DT	det
taste	NN	compound
perversion	NN	compound
side	NN	compound
-	HYPH	punct
effect	NN	pobj
would	MD	aux
not	RB	neg
be	VB	ccomp
unexpected	JJ	acomp
in	IN	prep
an	DT	det
extended	JJ	amod
release	NN	compound
formulation	NN	pobj
of	IN	prep
clarithromycin	NN	pobj
.	.	punct

 	_SP	

Teva	NNP	nsubj
have	VBZ	aux
raise	VBN	ROOT
a	DT	det
substantial	JJ	amod
question	NN	dobj
as	IN	prep
to	IN	prep
the	DT	det
validity	NN	pobj
of	IN	prep
claim	NN	pobj
6	CD	nummod
of	IN	prep
the	DT	det
'	``	punct
718	CD	nummod
patent	NN	pobj
and	CC	cc
claim	NN	conj
2	CD	dobj
of	IN	prep

the	DT	det
'	``	punct
616	CD	nummod
patent.9	NN	dep
the	DT	det
district	NN	compound
court	NN	nsubj
be	VBD	ROOT
correct	JJ	acomp
in	IN	prep
conclude	VBG	pcomp
that	IN	mark
Teva	NNP	nsubj
have	VBD	aux
also	RB	advmod
raise	VBN	ccomp
a	DT	det
substantial	JJ	amod
question	NN	dobj
as	IN	prep
to	IN	prep
invalidity	NN	pobj
of	IN	prep
claim	NN	pobj
2	CD	nummod
of	IN	prep
the	DT	det
'	``	punct
616	CD	nummod
patent	NN	pobj
and	CC	cc
,	,	punct
therefore	RB	advmod
,	,	punct
claim	NN	nsubj
2	CD	dobj
can	MD	aux
not	RB	neg
provide	VB	conj
an	DT	det
alternative	JJ	amod
ground	NNS	dobj
for	IN	prep
affirm	VBG	pcomp
the	DT	det
preliminary	JJ	amod
injunction	NN	dobj
.	.	punct

furthermore	RB	advmod
,	,	punct
as	IN	mark
discuss	VBN	advcl
above	RB	advmod
,	,	punct
Teva	NNP	nsubj
have	VBZ	aux
raise	VBN	ROOT
a	DT	det
substantial	JJ	amod
question	NN	dobj
as	IN	prep
to	IN	prep
the	DT	det
validity	NN	pobj
of	IN	prep
claim	NNS	pobj
2	CD	nummod
and	CC	cc
4	CD	conj
of	IN	prep
the	DT	det
'	``	punct
718	CD	nummod
patent	NN	pobj
.	.	punct

As	IN	prep
a	DT	det
result	NN	pobj
-PRON-	PRP	nsubj
have	VBZ	aux
raise	VBN	ROOT
a	DT	det
substantial	JJ	amod
question	NN	dobj
of	IN	prep
validity	NN	pobj
with	IN	prep
each	DT	pobj
of	IN	prep
the	DT	det
assert	VBN	amod
claim	NNS	pobj
but	CC	cc
as	IN	prep
in	IN	prep
Amazon.com	NNP	pobj
,	,	punct
-PRON-	PRP$	poss
decision	NN	nsubj
today	NN	npadvmod
in	IN	prep
no	DT	det
way	NN	pobj
resolve	VBZ	conj
the	DT	det
ultimate	JJ	amod
question	NN	dobj
of	IN	prep
invalidity	NN	pobj
.	.	punct

nonetheless	RB	advmod
,	,	punct
for	IN	prep
the	DT	det
purpose	NNS	pobj
of	IN	prep
the	DT	det
preliminary	JJ	amod
injunction	NN	pobj
Abbott	NNP	appos
as	IN	prep
the	DT	det
move	VBG	amod
party	NN	pobj
have	VBZ	aux
not	RB	neg
establish	VBN	ROOT
a	DT	det
likelihood	NN	dobj
of	IN	prep
success	NN	pobj
on	IN	prep
the	DT	det
merit	NNS	pobj
.	.	punct

 	_SP	

turn	VBG	advcl
now	RB	advmod
to	IN	prep
the	DT	det
other	JJ	amod
factor	NNS	pobj
in	IN	prep
a	DT	det
motion	NN	pobj
for	IN	prep
preliminary	JJ	amod
injunction	NN	pobj
,	,	punct
the	DT	det
district	NN	compound
court	NN	nsubj
conclude	VBD	ROOT
that	IN	mark
Abbott	NNP	nsubj
establish	VBD	ccomp
irreparable	JJ	amod
harm	NN	dobj
.	.	punct

see	VB	ccomp
eBay	NNP	dobj
,	,	punct
Inc.	NNP	appos
,	,	punct
126	CD	nummod
S.Ct	NNP	appos
.	.	punct
at	IN	prep
1839	CD	pobj
(	-LRB-	punct
"	``	punct
accord	VBG	prep
to	IN	prep
well	RB	advmod
-	HYPH	punct
establish	VBN	amod
principle	NNS	pobj
of	IN	prep
equity	NN	pobj
,	,	punct
a	DT	det
plaintiff	NN	nsubj
seek	VBG	acl
a	DT	det
permanent	JJ	amod
injunction	NN	dobj
must	MD	aux
satisfy	VB	ccomp
a	DT	det
four	CD	nummod
-	HYPH	punct
factor	NN	compound
test	NN	dobj
before	IN	mark
a	DT	det
court	NN	nsubj
may	MD	aux
grant	VB	advcl
such	JJ	amod
relief	NN	dobj
....	.	punct
These	DT	det
familiar	JJ	amod
principle	NNS	nsubj
apply	VBP	ROOT
with	IN	prep
equal	JJ	amod
force	NN	pobj
to	IN	prep
dispute	NNS	pobj
arise	VBG	acl
under	IN	prep
the	DT	det
Patent	NNP	compound
Act	NNP	pobj
"	''	punct
.	.	punct
)	-RRB-	punct
.	.	punct

the	DT	det
district	NN	compound
court	NN	nsubj
presume	VBD	ROOT
Abbott	NNP	nsubj
would	MD	aux
suffer	VB	ccomp
irreparable	JJ	amod
harm	NN	dobj
absent	JJ	advcl
the	DT	det
injunction	NN	dobj
because	IN	prep
of	IN	pcomp
-PRON-	PRP$	poss
conclusion	NN	pobj
regard	VBG	prep
likelihood	NN	pobj
of	IN	prep
success	NN	pobj
on	IN	prep
the	DT	det
merit	NNS	pobj
.	.	punct

furthermore	RB	advmod
,	,	punct
and	CC	cc
in	IN	prep
addition	NN	pobj
to	IN	prep
the	DT	det
presumption	NN	pobj
,	,	punct
the	DT	det
district	NN	compound
court	NN	nsubj
consider	VBD	ROOT
Abbott	NNP	poss
's	POS	case
economic	JJ	amod
consequence	NNS	dobj
of	IN	prep
deny	VBG	pcomp
the	DT	det
injunction	NN	dobj
and	CC	cc
-PRON-	PRP	nsubj
conclude	VBD	conj
that	IN	mark
"	``	punct
entry	NN	nsubj
of	IN	prep
the	DT	det
generic	JJ	amod
extended	JJ	amod
release	NN	compound
formulation	NN	compound
competitor	NN	pobj
will	MD	aux
likely	RB	advmod
crush	VB	ccomp
the	DT	det
market	NN	dobj
"	''	punct
.	.	punct

Abbott	NNP	compound
Labs.	NNP	npadvmod
,	,	punct
slip	VB	ROOT
op	RP	dobj
.	.	punct
at	IN	prep
27	CD	pobj
.	.	punct

On	IN	prep
appeal	NN	pobj
the	DT	det
party	NNS	nsubj
dispute	VBP	ROOT
whether	IN	mark
the	DT	det
district	NN	compound
court	NN	nsubj
properly	RB	advmod
conclude	VBD	ccomp
that	IN	mark
Abbott	NNP	nsubj
would	MD	aux
suffer	VB	ccomp
irreparable	JJ	amod
harm	NN	dobj
if	IN	mark
the	DT	det
injunction	NN	nsubjpass
be	VBD	auxpass
not	RB	neg
issue	VBN	advcl
.	.	punct

Teva	NNP	nsubj
argue	VBZ	ROOT
that	IN	mark
any	DT	det
harm	NN	nsubjpass
that	WDT	dobj
Abbott	NNP	nsubj
may	MD	aux
suffer	VB	relcl
could	MD	aux
be	VB	auxpass
remedie	VBN	ccomp
by	IN	agent
monetary	JJ	amod
compensation	NN	pobj
.	.	punct

Abbott	NNP	nsubj
respond	VBZ	ROOT
by	IN	prep
contend	VBG	pcomp
that	IN	mark
the	DT	det
sharp	JJ	amod
economic	JJ	amod
consequence	NNS	nsubj
of	IN	prep
open	JJ	amod
competition	NN	pobj
from	IN	prep
generic	JJ	amod
drug	NNS	pobj
establish	VBP	ccomp
the	DT	det
inadequacy	NN	dobj
of	IN	prep
monetary	JJ	amod
damage	NNS	pobj
and	CC	cc
irreparable	JJ	amod
harm	NN	conj
.	.	punct

  	_SP	

first	RB	advmod
,	,	punct
as	IN	mark
note	VBN	advcl
above	RB	advmod
,	,	punct
-PRON-	PRP	nsubj
conclude	VBP	ROOT
that	IN	mark
Abbott	NNP	nsubj
have	VBZ	aux
not	RB	neg
establish	VBN	ccomp
a	DT	det
likelihood	NN	dobj
of	IN	prep
success	NN	pobj
on	IN	prep
the	DT	det
merit	NNS	pobj
.	.	punct

As	IN	prep
a	DT	det
result	NN	pobj
,	,	punct
Abbott	NNP	nsubjpass
be	VBZ	auxpass
no	RB	neg
longer	RBR	advmod
entitled	JJ	ROOT
to	IN	prep
a	DT	det
presumption	NN	pobj
of	IN	prep
irreparable	JJ	amod
harm	NN	pobj
.	.	punct

see	VB	ROOT
Reebok	NNP	nmod
Int'l	NNP	compound
Ltd.	NNP	dobj
v.	IN	prep
J.	NNP	nmod
Baker	NNP	nmod
,	,	punct
Inc.	NNP	pobj
,	,	punct
32	CD	nummod
F.3d	NNP	appos
1552	CD	nummod
,	,	punct
1556	CD	npadvmod
(	-LRB-	punct
Fed	NNP	npadvmod
.	.	punct
Cir.1994	NNP	dobj
)	-RRB-	punct
.	.	punct

and	CC	cc
as	IN	prep
to	IN	prep
Abbott	NNP	poss
's	POS	case
economic	JJ	amod
argument	NNS	pobj
,	,	punct
-PRON-	PRP	nsubj
do	VBP	aux
not	RB	neg
doubt	VB	ROOT
that	IN	mark
generic	JJ	amod
competition	NN	nsubj
will	MD	aux
impact	VB	ccomp
Abbott	NNP	poss
's	POS	case
sale	NNS	dobj
of	IN	prep
Biaxin	NNP	compound
XL	NNP	pobj
,	,	punct
but	CC	cc
that	IN	nsubj
alone	RB	advmod
do	VBZ	aux
not	RB	neg
establish	VB	conj
that	IN	mark
Abbott	NNP	poss
's	POS	case
harm	NN	nsubj
will	MD	aux
be	VB	ccomp
irreparable	JJ	acomp
.	.	punct

As	IN	mark
-PRON-	PRP	nsubj
state	VBD	advcl
in	IN	prep
Illinois	NNP	compound
Tool	NNP	compound
Works	NNP	pobj
,	,	punct
Inc.	NNP	appos
v.	CC	prep
Grip	NNP	nmod
-	HYPH	punct
Pak	NNP	nmod
,	,	punct
Inc.	NNP	pobj
,	,	punct
if	IN	mark
this	DT	det
court	NN	nsubj
be	VBD	advcl
to	TO	aux
accept	VB	xcomp
a	DT	det
patentee	NN	poss
's	POS	case
"	``	punct
argu[ment	NNS	dobj
]	-RRB-	punct
that	DT	mark
,	,	punct
'	''	punct
apart	RB	advmod
from	IN	prep
the	DT	det
presumption	NN	pobj
,	,	punct
'	''	punct
-PRON-	PRP$	poss
'	``	punct
potential	JJ	amod
lose	VBN	amod
sale	NNS	nsubj
'	POS	punct
alone	RB	advmod
demonstrate	VBP	pobj
'	''	punct
manifest	NN	amod
irreparable	JJ	amod
harm	NN	dobj
'	''	punct
,	,	punct
acceptance	NN	nsubj
of	IN	prep
that	DT	det
position	NN	pobj
would	MD	aux
require	VB	ROOT
a	DT	det
finding	NN	dobj
of	IN	prep
irreparable	JJ	amod
harm	NN	pobj
to	IN	prep
every	DT	det
manufacturer	NN	nmod
/	SYM	punct
patentee	NN	pobj
,	,	punct
regardless	RB	advmod
of	IN	prep
circumstance	NNS	pobj
"	''	punct
.	.	punct

906	CD	nummod
f.2d	CD	nummod
679	CD	conj
(	-LRB-	punct
Fed	NNP	nmod
.	.	punct
Cir.1990	LS	ROOT
)	-RRB-	punct
.	.	punct

On	IN	prep
the	DT	det
other	JJ	amod
hand	NN	pobj
,	,	punct
-PRON-	PRP	nsubj
also	RB	advmod
note	VBP	ROOT
that	IN	mark
the	DT	det
district	NN	compound
court	NN	nsubj
find	VBD	ccomp
that	IN	mark
"	``	punct
the	DT	det
party	NNS	poss
'	POS	case
model	NNS	nsubj
of	IN	prep
how	WRB	advmod
the	DT	det
market	NN	nsubj
will	MD	aux
react	VB	pcomp
to	IN	prep
generic	JJ	amod
competition	NN	pobj
for	IN	prep
extended	JJ	amod
release	NN	compound
clarithromycin	NN	pobj
remain	VBP	ccomp
highly	RB	advmod
speculative	JJ	acomp
"	''	punct
and	CC	cc
Teva	NNP	nsubj
have	VBZ	aux
not	RB	neg
prove	VBN	conj
that	IN	mark
monetary	JJ	amod
damage	NNS	nsubj
will	MD	aux
suffice	VB	ccomp
.	.	punct

Abbott	NNP	compound
Labs.	NNP	ROOT
,	,	punct
slip	VB	amod
op	RP	appos
.	.	punct

at	IN	ROOT
27	CD	pobj
.	.	punct

therefore	RB	advmod
,	,	punct
where	WRB	advmod
a	DT	det
patentee	NN	nsubj
have	VBZ	aux
not	RB	neg
show	VBN	ROOT
a	DT	det
likelihood	NN	dobj
of	IN	prep
success	NN	pobj
on	IN	prep
the	DT	det
merit	NNS	pobj
,	,	punct
and	CC	cc
where	WRB	advmod
the	DT	det
patentee	NN	nsubj
have	VBZ	aux
not	RB	neg
clearly	RB	advmod
establish	VBN	conj
that	IN	mark
monetary	JJ	amod
damage	NNS	nsubj
could	MD	aux
not	RB	neg
suffice	VB	ccomp
but	CC	cc
the	DT	det
defendant	NN	nsubj
have	VBZ	aux
not	RB	neg
establish	VBN	conj
that	IN	mark
monetary	JJ	amod
damage	NNS	nsubj
do	VBP	advcl
suffice	NN	dobj
,	,	punct
-PRON-	PRP	nsubj
can	MD	aux
not	RB	neg
say	VB	ccomp
that	IN	mark
the	DT	det
irreparable	JJ	amod
harm	NN	compound
prong	NN	nsubj
of	IN	prep
the	DT	det
analysis	NN	pobj
favor	VBZ	ccomp
either	CC	det
party	NN	dobj
.	.	punct

 	_SP	

As	IN	prep
to	IN	prep
the	DT	det
third	JJ	amod
prong	NN	pobj
of	IN	prep
the	DT	det
analysis	NN	pobj
,	,	punct
the	DT	det
district	NN	compound
court	NN	nsubj
state	VBD	advcl
that	IN	mark
Teva	NNP	nsubj
be	VBD	ccomp
"	``	punct
reluctant	JJ	acomp
or	CC	cc
inable	JJ	conj
to	TO	aux
quantify	VB	xcomp
the	DT	det
hardship	NN	dobj
,	,	punct
if	IN	mark
any	DT	advcl
,	,	punct
-PRON-	PRP	nsubj
will	MD	aux
face	VB	ROOT
if	IN	mark
an	DT	det
injunction	NN	nsubjpass
be	VBZ	auxpass
incorrectly	RB	advmod
enter	VBN	advcl
"	''	punct
and	CC	cc
"	``	punct
there	EX	expl
be	VBZ	conj
little	JJ	amod
choice	NN	attr
but	CC	cc
to	TO	aux
conclude	VB	conj
that	IN	mark
the	DT	det
balance	NN	nsubj
of	IN	prep
hardship	NNS	compound
favor	NNS	pobj
[	-LRB-	punct
Abbott].	NNP	nmod
"	``	punct
Abbott	NNP	compound
Labs.	NNP	appos
,	,	punct
slip	VB	ccomp
op	RP	dobj
.	.	punct

at	IN	ROOT
30	CD	pobj
-	SYM	punct
31	CD	prep
.	.	punct

As	IN	mark
Teva	NNP	nsubj
do	VBZ	aux
not	RB	neg
appeal	VB	advcl
this	DT	det
issue	NN	dobj
,	,	punct
-PRON-	PRP	nsubj
also	RB	advmod
conclude	VBP	ROOT
that	IN	mark
the	DT	det
district	NN	compound
court	NN	nsubj
properly	RB	advmod
find	VBD	ccomp
that	IN	mark
the	DT	det
balance	NN	nsubj
of	IN	prep
hardship	NNS	pobj
favor	VBZ	ccomp
Abbott	NNP	dobj
.	.	punct

  	_SP	

lastly	RB	advmod
,	,	punct
as	IN	prep
to	IN	prep
the	DT	det
public	JJ	amod
interest	NN	compound
factor	NN	pobj
,	,	punct
the	DT	det
district	NN	compound
court	NN	nsubj
determine	VBD	ROOT
that	IN	mark
"	``	punct
to	IN	prep
the	DT	det
extent	NN	pobj
that	IN	mark
this	DT	det
court	NN	nsubj
have	VBZ	aux
find	VBN	acl
that	IN	mark
the	DT	det
patent	NNS	nsubj
in	IN	prep
suit	NN	pobj
be	VBP	ccomp
valid	JJ	acomp
,	,	punct
the	DT	det
public	JJ	amod
interest	NN	nsubjpass
be	VBZ	auxpass
best	RBS	advmod
serve	VBN	ccomp
by	IN	prep
enforce	VBG	pcomp
-PRON-	PRP	dobj
"	''	punct
.	.	punct

Idaho	NNS	nsubj
,	,	punct
slip	VB	ROOT
op	RP	dobj
.	.	punct

at	IN	ROOT
32	CD	pobj
.	.	punct

Although	IN	mark
the	DT	det
public	JJ	amod
interest	NN	compound
inquiry	NN	nsubj
be	VBZ	advcl
not	RB	neg
necessarily	RB	advmod
or	CC	cc
always	RB	conj
bind	VBN	acomp
to	IN	prep
the	DT	det
likelihood	NN	pobj
of	IN	prep
success	NN	pobj
of	IN	prep
the	DT	det
merit	NNS	pobj
,	,	punct
in	IN	prep
this	DT	det
case	NN	pobj
absent	JJ	ccomp
any	DT	det
other	JJ	amod
relevant	JJ	amod
concern	NNS	dobj
,	,	punct
-PRON-	PRP	nsubj
agree	VBP	ROOT
with	IN	prep
the	DT	det
district	NN	compound
court	NN	pobj
that	WDT	mark
the	DT	det
public	NN	nsubjpass
be	VBZ	auxpass
best	RBS	advmod
serve	VBN	ccomp
by	IN	agent
enforce	VBG	pcomp
patent	NNS	dobj
that	WDT	nsubj
be	VBP	relcl
likely	RB	advmod
valid	JJ	acomp
and	CC	cc
infringed	JJ	conj
.	.	punct

As	IN	mark
Abbott	NNP	nsubj
do	VBD	aux
not	RB	neg
establish	VB	advcl
a	DT	det
likelihood	NN	dobj
of	IN	prep
success	NN	pobj
on	IN	prep
the	DT	det
merit	NNS	pobj
,	,	punct
-PRON-	PRP	nsubj
conclude	VBP	ROOT
that	IN	mark
the	DT	det
public	JJ	amod
interest	NN	nsubjpass
be	VBZ	auxpass
best	RBS	advmod
serve	VBN	ccomp
by	IN	prep
deny	VBG	pcomp
the	DT	det
preliminary	JJ	amod
injunction	NN	dobj
.	.	punct

 	_SP	

first	RB	advmod
,	,	punct
in	IN	prep
determine	VBG	pcomp
Abbott	NNP	poss
's	POS	case
likelihood	NN	dobj
of	IN	prep
success	NN	pobj
on	IN	prep
the	DT	det
merit	NNS	pobj
,	,	punct
the	DT	det
district	NN	compound
court	NN	nsubj
clearly	RB	advmod
err	VBD	ROOT
in	IN	prep
assess	VBG	pcomp
the	DT	det
content	NN	dobj
of	IN	prep
the	DT	det
prior	JJ	amod
art	NN	pobj
.	.	punct

the	DT	det
prior	JJ	amod
art	NN	nsubj
support	VBZ	ROOT
Teva	NNP	compound
argument	NNS	dobj
and	CC	cc
Teva	NNP	nsubj
have	VBZ	aux
raise	VBN	conj
a	DT	det
substantial	JJ	amod
question	NN	dobj
regard	VBG	prep
the	DT	det
validity	NN	pobj
of	IN	prep
claim	NNS	pobj
2	CD	nummod
,	,	punct
4	CD	nummod
,	,	punct
and	CC	cc
6	CD	conj
of	IN	prep
the	DT	det
'	``	punct
718	CD	pobj
and	CC	cc
claim	NN	conj
2	CD	dobj
of	IN	prep
the	DT	det
'	``	punct
616	CD	nummod
patent	NN	pobj
.	.	punct

-PRON-	PRP	nsubj
conclude	VBP	ROOT
that	IN	mark
Abbott	NNP	nsubj
have	VBZ	aux
not	RB	neg
establish	VBN	ccomp
a	DT	det
likelihood	NN	dobj
of	IN	prep
success	NN	pobj
on	IN	prep
the	DT	det
merit	NNS	pobj
and	CC	cc
this	DT	det
support	VBZ	conj
deny	VBG	acl
the	DT	det
injunction	NN	dobj
.	.	punct

second	RB	advmod
,	,	punct
absent	JJ	advcl
the	DT	det
presumption	NN	dobj
of	IN	prep
irreparable	JJ	amod
harm	NN	pobj
and	CC	cc
in	IN	conj
light	NN	pobj
of	IN	prep
the	DT	det
arguable	JJ	amod
sufficiency	NN	pobj
of	IN	prep
monetary	JJ	amod
damage	NNS	pobj
,	,	punct
Abbott	NNP	nsubj
have	VBZ	aux
not	RB	neg
establish	VBN	ROOT
that	DT	mark
irreparable	JJ	amod
harm	NN	nsubj
support	VBZ	ccomp
the	DT	det
grant	NN	dobj
of	IN	prep
the	DT	det
injunction	NN	pobj
.	.	punct

third	RB	advmod
,	,	punct
as	IN	mark
the	DT	det
issue	NN	nsubj
be	VBD	advcl
unconteste	VBN	acomp
,	,	punct
the	DT	det
balance	NN	nsubj
of	IN	prep
hardship	NN	pobj
still	RB	advmod
support	VBZ	ROOT
the	DT	det
grant	NN	dobj
of	IN	prep
the	DT	det
injunction	NN	pobj
.	.	punct

fourth	JJ	advmod
and	CC	cc
lastly	RB	conj
,	,	punct
as	IN	mark
a	DT	det
substantial	JJ	amod
question	NN	nsubjpass
of	IN	prep
patent	NN	compound
validity	NN	pobj
have	VBZ	aux
be	VBN	auxpass
raise	VBN	ROOT
by	IN	agent
Teva	NNP	pobj
,	,	punct
the	DT	det
public	JJ	amod
interest	NN	compound
benefit	NNS	appos
from	IN	prep
a	DT	det
denial	NN	pobj
of	IN	prep
the	DT	det
injunction	NN	pobj
.	.	punct

As	IN	prep
result	NN	pobj
of	IN	prep
these	DT	det
consideration	NNS	pobj
,	,	punct
-PRON-	PRP	nsubj
vacate	VBP	ROOT
the	DT	det
preliminary	JJ	amod
injunction	NN	dobj
.	.	punct

 	_SP	

NEWMAN	NNP	ROOT
,	,	punct
Circuit	NNP	compound
Judge	NNP	npadvmod
,	,	punct
dissent	VBG	acl
.	.	punct

 	_SP	

-PRON-	PRP	nsubjpass
have	VBZ	aux
be	VBN	auxpass
confirm	VBN	ROOT
that	IN	mark
the	DT	det
remedy	NN	nsubj
of	IN	prep
injunction	NN	pobj
in	IN	prep
patent	NN	compound
case	NNS	pobj
be	VBZ	ccomp
subject	JJ	acomp
to	IN	prep
the	DT	det
sound	JJ	amod
discretion	NN	pobj
of	IN	prep
the	DT	det
district	NN	compound
court	NN	pobj
,	,	punct
upon	IN	prep
application	NN	pobj
of	IN	prep
the	DT	det
traditional	JJ	amod
criterion	NNS	pobj
by	IN	prep
which	WDT	pobj
injunctive	JJ	amod
relief	NN	nsubjpass
be	VBZ	auxpass
evaluate	VBN	relcl
and	CC	cc
apply	VBN	conj
.	.	punct

eBay	NNP	ROOT
,	,	punct
Inc.	NNP	appos
v.	CC	prep
MercExchange	NNP	pobj
,	,	punct
L.L.C.	NNP	appos
,	,	punct
547	CD	nummod
U.S.	NNP	appos
388	CD	nummod
,	,	punct
----	NFP	punct
,	,	punct
126	CD	nummod
S.Ct	NNP	subtok
.	.	punct
1837	CD	nummod
,	,	punct
1841	CD	npadvmod
,	,	punct

164	CD	nummod
l.ed.2d	NN	compound
641	CD	subtok
(	-LRB-	punct
2006	CD	meta
)	-RRB-	punct
(	-LRB-	punct
"	``	punct
-PRON-	PRP	nsubj
hold	VBP	ROOT
only	RB	advmod
that	IN	mark
the	DT	det
decision	NN	nsubj
whether	IN	mark
to	TO	aux
grant	VB	acl
or	CC	cc
deny	VB	conj
injunctive	JJ	amod
relief	NN	dobj
rest	NNS	ccomp
within	IN	prep
the	DT	det
equitable	JJ	amod
discretion	NN	pobj
of	IN	prep
the	DT	det
district	NN	compound
court	NNS	pobj
,	,	punct
and	CC	cc
that	IN	mark
such	JJ	amod
discretion	NN	nsubjpass
must	MD	aux
be	VB	auxpass
exercise	VBN	conj
consistent	JJ	oprd
with	IN	prep
traditional	JJ	amod
principle	NNS	pobj
of	IN	prep
equity	NN	pobj
,	,	punct
in	IN	prep
patent	NN	compound
dispute	VBZ	pobj
no	DT	neg
less	JJR	advmod
than	IN	prep
in	IN	prep
other	JJ	amod
case	NNS	pobj
govern	VBN	acl
by	IN	agent
such	JJ	amod
standard	NNS	pobj
"	''	punct
.	.	punct
)	-RRB-	punct

 	_SP	

These	DT	det
traditional	JJ	amod
principle	NNS	nsubj
be	VBP	ccomp
no	RB	neg
less	RBR	advmod
applicable	JJ	acomp
when	WRB	advmod
a	DT	det
preliminary	JJ	amod
injunction	NN	nsubj
be	VBZ	advcl
at	IN	prep
issue	NN	pobj
,	,	punct
particularly	RB	advmod
when	WRB	advmod
the	DT	det
purpose	NN	nsubj
be	VBZ	advcl
to	TO	aux
preserve	VB	xcomp
-	:	punct
not	RB	neg
to	TO	aux
change	VB	dep
-	:	punct
the	DT	det
relationship	NN	dobj
of	IN	prep
the	DT	det
litigant	NNS	pobj
during	IN	prep
the	DT	det
litigation	NN	pobj
.	.	punct
"	''	punct
the	DT	det
purpose	NN	nsubj
of	IN	prep
a	DT	det
preliminary	JJ	amod
injunction	NN	pobj
be	VBZ	ROOT
to	TO	aux
preserve	VB	xcomp
the	DT	det
relative	JJ	amod
position	NNS	dobj
of	IN	prep
the	DT	det
party	NNS	pobj
until	IN	mark
a	DT	det
trial	NN	nsubjpass
on	IN	prep
the	DT	det
merit	NNS	pobj
can	MD	aux
be	VB	auxpass
hold	VBN	advcl
"	''	punct
.	.	punct

Univ	NNP	ROOT
.	NNP	punct
of	IN	prep
Texas	NNP	pobj
v.	CC	prep
Camenisch	NNP	pobj
,	,	punct
451	CD	nummod
U.S.	NNP	appos
390	CD	nummod
,	,	punct
395	CD	nummod
,	,	punct

101	CD	nummod
s.ct	NN	subtok
.	.	ROOT

1830	CD	ROOT
,	,	punct
68	CD	nummod
l.ed.2d	NN	nmod
175	CD	nummod
(	-LRB-	punct
1981	CD	appos
)	-RRB-	punct
;	:	punct

Smith	NNP	npadvmod
Int'l	NNP	nummod
,	,	punct
Inc.	NNP	subtok
v.	IN	prep
Hughes	NNP	compound
Tool	NNP	compound
Co.	NNP	pobj
,	,	punct
718	CD	nummod
f.2d	CD	conj
1573	CD	nummod
,	,	punct
1578	CD	npadvmod
(	-LRB-	punct
Fed	NNP	nmod
.	.	punct
Cir.1983	LS	appos
)	-RRB-	punct
(	-LRB-	punct
"	``	punct
a	DT	det
preliminary	JJ	amod
injunction	NN	nsubj
will	MD	aux
normally	RB	advmod
issue	VB	ROOT
only	RB	advmod
for	IN	prep
the	DT	det
purpose	NN	pobj
of	IN	prep
preserve	VBG	pcomp
the	DT	det
status	NN	compound
quo	NN	dobj
and	CC	cc
protect	VBG	conj
the	DT	det
respective	JJ	amod
right	NNS	dobj
of	IN	prep
the	DT	det
party	NNS	pobj
pende	VBG	acl
final	JJ	amod
disposition	NN	pobj
of	IN	prep
the	DT	det
litigation	NN	pobj
"	''	punct
.	.	punct
)	-RRB-	punct

precedent	NN	compound
counsel	NNS	ROOT
against	IN	prep
make	VBG	pcomp
an	DT	det
important	JJ	amod
change	NN	dobj
in	IN	prep
the	DT	det
relationship	NN	pobj
of	IN	prep
the	DT	det
party	NNS	pobj
while	IN	mark
-PRON-	PRP$	poss
dispute	NN	nsubjpass
be	VBZ	aux
be	VBG	auxpass
litigate	VBN	advcl
,	,	punct
while	IN	mark
recognize	VBG	advcl
that	IN	mark
there	EX	expl
may	MD	aux
be	VB	ccomp
circumstance	NNS	attr
warrant	VBG	acl
such	JJ	amod
change	NN	dobj
,	,	punct
when	WRB	advmod
all	DT	nsubjpass
of	IN	prep
the	DT	det
legal	JJ	amod
and	CC	cc
equitable	JJ	conj
aspect	NNS	pobj
relevant	JJ	amod
to	IN	prep
a	DT	det
particular	JJ	amod
case	NN	pobj
be	VBP	auxpass
consider	VBN	relcl
.	.	punct

see	VB	advcl
,	,	punct
e.g.	RB	advmod
,	,	punct
Mikohn	NNP	compound
Gaming	NNP	compound
Corp.	NNP	dobj
v.	CC	prep
Acres	NNP	compound
Gaming	NNP	nmod
,	,	punct
Inc.	NNP	conj
,	,	punct
165	CD	nummod
F.3d	NNP	appos
891	CD	nummod
,	,	punct
895	CD	appos
(	-LRB-	punct
Fed	NNP	nmod
.	.	punct
Cir.1998	LS	appos
)	-RRB-	punct
(	-LRB-	punct
the	DT	det
preliminary	JJ	amod
injunction	NN	nsubj
serve	VBZ	ROOT
to	TO	aux
preserve	VB	xcomp
the	DT	det
status	NN	compound
quo	NN	dobj
"	''	punct
lest	IN	amod
one	CD	nummod
side	NN	npadvmod
prevent	NN	compound
resolution	NN	dobj
of	IN	prep
the	DT	det
question	NNS	pobj
or	CC	cc
execution	NN	conj
of	IN	prep
any	DT	det
judgment	NN	pobj
by	IN	prep
alter	VBG	pcomp
the	DT	det
status	NN	compound
quo	NN	dobj
"	''	punct
)	-RRB-	punct
;	:	punct
Globetrotter	NNP	compound
Software	NNP	conj
,	,	punct
Inc.	NNP	appos
v.	IN	prep

Elan	NNP	compound
Computer	NNP	nmod
Group	NNP	nmod
,	,	punct
Inc.	NNP	ROOT
,	,	punct
236	CD	nummod
f.3d	CD	appos
1363	CD	nummod
,	,	punct
1367	CD	npadvmod
(	-LRB-	punct
Fed	NNP	appos
.	.	punct
Cir.2001	LS	appos
)	-RRB-	punct
.	.	punct

 	_SP	

the	DT	det
trial	NN	compound
court	NN	poss
's	POS	case
decision	NN	nsubj
with	IN	prep
respect	NN	pobj
to	IN	prep
the	DT	det
discretionary	JJ	amod
grant	NN	pobj
of	IN	prep
a	DT	det
preliminary	JJ	amod
injunction	NN	compound
warrant	NNS	pobj
significant	JJ	amod
deference	NN	pobj
,	,	punct
for	IN	prep
equitable	JJ	amod
consideration	NNS	pobj
weigh	VBP	ROOT
heavily	RB	advmod
in	IN	prep
matter	NNS	pobj
of	IN	prep
change	NN	pobj
or	CC	cc
stability	NN	compound
pendente	NN	compound
lite	NN	conj
.	.	punct

see	VB	ROOT
Deckert	NNP	dobj
v.	IN	prep

Independence	NNP	compound
Shares	NNP	compound
Corp.	NNP	ROOT
,	,	punct
311	CD	nummod
U.S.	NNP	appos
282	CD	nummod
,	,	punct
290	CD	appos
,	,	punct

61	CD	nummod
s.ct	NN	subtok
.	.	ROOT

229	CD	ROOT
,	,	punct
85	CD	npadvmod
L.Ed	NNS	intj
.	.	punct

189	CD	dep
(	-LRB-	punct
1940	CD	appos
)	-RRB-	punct
(	-LRB-	punct
"	``	punct
'	``	punct
-PRON-	PRP	nsubj
be	VBZ	auxpass
well	RB	advmod
settle	VBN	ROOT
that	IN	mark
the	DT	det
granting	NN	nsubj
of	IN	prep
a	DT	det
temporary	JJ	amod
injunction	NN	pobj
,	,	punct
pende	VBG	prep
final	JJ	amod
hearing	NN	pobj
,	,	punct
be	VBZ	ccomp
within	IN	prep
the	DT	det
sound	JJ	amod
discretion	NN	pobj
of	IN	prep
the	DT	det
trial	NN	compound
court	NN	pobj
;	:	punct
and	CC	cc
that	IN	nsubjpass
,	,	punct
upon	IN	prep
appeal	NN	pobj
,	,	punct
an	DT	det
order	NN	nsubjpass
grant	VBG	acl
such	JJ	predet
an	DT	det
injunction	NN	dobj
will	MD	aux
not	RB	neg
be	VB	auxpass
disturb	VBN	conj
unless	IN	prep
contrary	JJ	pobj
to	IN	prep
some	DT	det
rule	NN	pobj
of	IN	prep
equity	NN	pobj
,	,	punct
or	CC	cc
the	DT	det
result	NN	conj
of	IN	prep
improvident	JJ	amod
exercise	NN	pobj
of	IN	prep
judicial	JJ	amod
discretion	NN	pobj
.	.	punct
'	''	punct
"	punct	punct
-RRB-	punct	punct
;	:	punct
Meccano	NNP	pobj
,	,	punct
Ltd.	NNP	amod
v.	IN	prep
John	NNP	compound
Wanamaker	NNP	pobj
,	,	punct
New	NNP	compound
York	NNP	npadvmod
,	,	punct
253	CD	nummod
U.S.	NNP	appos
136	CD	nummod
,	,	punct
141	CD	nummod
,	,	punct
40	CD	nummod
S.Ct	NNP	subtok
.	.	npadvmod
463	CD	nummod
,	,	punct
64	CD	nummod
L.Ed	NNS	subtok
.	.	pobj

822	CD	dep
(	-LRB-	punct
1920	CD	appos
)	-RRB-	punct
(	-LRB-	punct
"	``	punct
the	DT	det
correct	JJ	amod
general	JJ	amod
doctrine	NN	nsubj
be	VBZ	ROOT
that	IN	mark
whether	IN	mark
a	DT	det
preliminary	JJ	amod
injunction	NN	nsubjpass
shall	MD	aux
be	VB	auxpass
award	VBN	csubj
rest	NNS	ccomp
in	IN	prep
sound	JJ	amod
discretion	NN	pobj
of	IN	prep
the	DT	det
trial	NN	compound
court	NN	pobj
"	''	punct
.	.	punct
)	-RRB-	punct
.	.	punct

-PRON-	PRP	nsubj
be	VBZ	ROOT
particularly	RB	advmod
irregular	JJ	acomp
for	IN	mark
an	DT	det
appellate	JJ	amod
court	NN	nsubj
to	TO	aux
reverse	VB	advcl
this	DT	det
discretionary	JJ	amod
decision	NN	dobj
and	CC	cc
thereby	RB	advmod
to	TO	aux
make	VB	conj
a	DT	det
significant	JJ	amod
change	NN	dobj
in	IN	prep
the	DT	det
relationship	NN	pobj
of	IN	prep
the	DT	det
party	NNS	pobj
,	,	punct
while	IN	mark
present	VBG	advcl
no	DT	det
explanation	NN	dobj
of	IN	prep
how	WRB	advmod
the	DT	det
district	NN	compound
court	NN	nsubj
abuse	VBD	pcomp
-PRON-	PRP$	poss
discretion	NN	dobj
.	.	punct

 	_SP	

reversal	NN	nsubj
of	IN	prep
a	DT	det
preliminary	JJ	amod
injunction	NN	pobj
that	WDT	nsubj
preserve	VBZ	relcl
the	DT	det
status	NN	compound
quo	NN	dobj
require	VBZ	ROOT
a	DT	det
clear	JJ	amod
show	VBG	dobj
that	IN	mark
the	DT	det
district	NN	compound
court	NN	nsubj
exceed	VBD	ccomp
-PRON-	PRP$	poss
discretionary	JJ	amod
authority	NN	dobj
.	.	punct

see	VB	ROOT
-PRON-	PRP	nsubj
care	VBP	dobj
,	,	punct
Inc.	NNP	appos
v.	IN	prep

Ultra	NNP	subtok
-	NNP	punct
Mark	NNP	compound
Int'l	NNP	compound
Corp.	NNP	nsubjpass
,	,	punct
930	CD	nummod
f.2d	CD	appos
1567	CD	nummod
,	,	punct
1570	CD	npadvmod
(	-LRB-	punct
Fed	NNP	nmod
.	.	punct
Cir.1991	LS	appos
)	-RRB-	punct
(	-LRB-	punct
"	``	punct
the	DT	det
court	NN	poss
's	POS	case
determination	NN	nsubjpass
can	MD	aux
be	VB	auxpass
overturn	VBN	ROOT
only	RB	advmod
on	IN	prep
a	DT	det
showing	NN	pobj
that	IN	mark
-PRON-	PRP	nsubj
abuse	VBD	acl
-PRON-	PRP$	poss
discretion	NN	dobj
,	,	punct
commit	VBD	conj
an	DT	det
error	NN	dobj
of	IN	prep
law	NN	pobj
,	,	punct
or	CC	cc
seriously	RB	advmod
misjudge	VBD	conj
the	DT	det
evidence	NN	dobj
"	''	punct
.	.	punct
)	-RRB-	punct

-PRON-	PRP$	poss
colleague	NNS	nsubj
do	VBP	aux
not	RB	neg
discuss	VB	ROOT
the	DT	det
trial	NN	compound
judge	NN	poss
's	POS	case
careful	JJ	amod
explanation	NNS	dobj
,	,	punct
but	CC	cc
,	,	punct
upon	IN	prep
find	VBG	pcomp
that	IN	mark
Teva	NNP	nsubj
have	VBZ	aux
raise	VBN	ccomp
a	DT	det
"	``	punct
substantial	JJ	amod
question	NN	dobj
"	''	punct
about	IN	prep
patent	NN	compound
validity	NN	pobj
,	,	punct
-PRON-	PRP	nsubj
hold	VBP	conj
that	IN	mark
Teva	NNP	nsubjpass
should	MD	aux
be	VB	auxpass
permit	VBN	ccomp
to	TO	aux
practice	VB	xcomp
the	DT	det
Abbott	NNP	compound
invention	NN	dobj
before	IN	mark
patent	NN	compound
validity	NN	nsubjpass
be	VBZ	auxpass
decide	VBN	advcl
.	.	punct

With	IN	prep
all	DT	det
respect	NN	pobj
to	IN	prep
-PRON-	PRP$	poss
colleague	NNS	poss
'	POS	case
concern	NNS	pobj
,	,	punct
-PRON-	PRP	nsubj
misapply	RB	ROOT
not	RB	preconj
only	RB	advmod
the	DT	det
criterion	NNS	dobj
of	IN	prep
the	DT	det
preliminary	JJ	amod
injunction	NN	pobj
but	CC	cc
also	RB	advmod
the	DT	det
standard	NN	conj
of	IN	prep
appellate	JJ	amod
review	NN	pobj
:	:	punct

 	_SP	

first	RB	advmod
,	,	punct
as	IN	prep
to	IN	prep
patent	NN	compound
validity	NN	pobj
,	,	punct
the	DT	det
panel	NN	compound
majority	NN	nsubj
reject	VBZ	ROOT
the	DT	det
requirement	NN	dobj
that	IN	relcl
in	IN	prep
determine	VBG	pcomp
the	DT	det
likelihood	NN	dobj
that	IN	mark
the	DT	det
patent	NN	nsubjpass
will	MD	aux
be	VB	auxpass
prove	VBN	acl
invalid	JJ	oprd
-PRON-	PRP	nsubj
be	VBZ	ccomp
necessary	JJ	acomp
to	TO	aux
consider	VB	xcomp
the	DT	det
burden	NNS	dobj
of	IN	prep
proof	NN	pobj
that	WDT	nsubj
would	MD	aux
inhere	VB	relcl
at	IN	prep
trial	NN	pobj
.	.	punct

see	VB	ROOT
Canon	NNP	compound
Computer	NNP	compound
Sys	NNP	dobj
.	NNP	punct
,	,	punct
Inc.	NNP	subtok
v.	IN	prep
Nu	NNP	compound
-	HYPH	punct
Kote	NNP	pobj
Int'l	NNP	nummod

.	NNP	ROOT
,	,	punct
Inc.	NNP	appos
,	,	punct
134	CD	nummod
f.3d	CD	appos
1085	CD	nummod
,	,	punct
1088	CD	npadvmod
(	-LRB-	punct
Fed	NNP	nmod
.	.	punct
Cir.1998	LS	appos
)	-RRB-	punct
(	-LRB-	punct
"	``	punct
however	RB	advmod
,	,	punct
a	DT	det
patent	NN	nsubjpass
be	VBZ	auxpass
presume	VBN	parataxis
valid	JJ	oprd
,	,	punct
and	CC	cc
this	DT	det
presumption	NN	nsubj
exist	VBZ	conj
at	IN	prep
every	DT	det
stage	NN	pobj
of	IN	prep
the	DT	det
litigation	NN	pobj
"	''	punct
.	.	punct
)	-RRB-	punct

;	:	punct
Genentech	NNP	nsubj
,	,	punct
Inc.	NNP	appos
v.	CC	prep
Novo	NNP	compound
Nordisk	NNP	conj
,	,	punct
A	NNP	nmod
/	SYM	punct
S	NNP	appos
,	,	punct
108	CD	nummod
f.3d	CD	appos
1361	CD	nummod
,	,	punct
1364	CD	npadvmod
(	-LRB-	punct
Fed	NNP	nmod
.	.	punct
cir.1997	ADD	appos
)	-RRB-	punct
(	-LRB-	punct
criterion	NN	nmod
"	``	punct
substantial	JJ	amod
question	NNS	appos
of	IN	prep
validity	NN	pobj
"	''	punct
mean	VBZ	ccomp
that	IN	mark
"	``	punct
in	IN	prep
light	NN	pobj
of	IN	prep
the	DT	det
presumption	NNS	pobj
and	CC	cc
burden	NNS	conj
that	WDT	nsubj
will	MD	aux
inhere	VB	relcl
at	IN	prep
trial	NN	pobj
on	IN	prep
the	DT	det
merit	NNS	pobj
"	``	punct
the	DT	det
attacker	NN	nsubj
have	VBZ	ccomp
"	``	punct
a	DT	det
likelihood	NN	dobj
of	IN	prep
success	NN	pobj
"	''	punct
in	IN	prep
invalidate	VBG	pcomp
the	DT	det
patent	NN	dobj
)	-RRB-	punct
;	:	punct
PPG	NNP	compound
Indus	NNP	nsubj
.	.	punct
,	,	punct
Inc.	NNP	appos
v.	CC	prep
Guardian	NNP	compound
Indus	NNP	pobj
.	.	punct
,	,	punct
Inc.	NNP	appos
,	,	punct
75	CD	nummod
f.3d	CD	appos
1558	CD	nummod
(	-LRB-	punct
Fed	NNP	appos
.	.	punct
Cir.1996	LS	appos
)	-RRB-	punct
(	-LRB-	punct
"	``	punct
the	DT	det
ultimate	JJ	amod
question	NN	nsubj
,	,	punct
however	RB	advmod
,	,	punct
be	VBZ	ROOT
whether	IN	mark
the	DT	det
challenger	NN	poss
's	POS	case
evidence	NN	nsubj
of	IN	prep
invalidity	NN	pobj
be	VBZ	ccomp
sufficiently	RB	advmod
persuasive	JJ	acomp
that	IN	mark
-PRON-	PRP	nsubj
be	VBZ	ccomp
likely	JJ	acomp
to	TO	aux
overcome	VB	xcomp
the	DT	det
presumption	NN	dobj
of	IN	prep
patent	NN	compound
validity	NN	pobj
"	''	punct
.	.	punct
)	-RRB-	punct

In	IN	prep
the	DT	det
case	NN	pobj
now	RB	advmod
before	IN	prep
-PRON-	PRP	pobj
the	DT	det
district	NN	compound
court	NN	nsubj
analyze	VBD	ROOT
the	DT	det
evidence	NN	dobj
,	,	punct
in	IN	prep
which	WDT	pobj
technologically	RB	advmod
complex	JJ	amod
question	NNS	nsubjpass
be	VBP	auxpass
present	VBN	relcl
,	,	punct
and	CC	cc
conclude	VBD	conj
that	IN	mark
Teva	NNP	nsubj
be	VBD	ccomp
not	RB	neg
likely	JJ	acomp
to	TO	aux
prove	VB	xcomp
the	DT	det
patent	NN	nsubj
invalid	JJ	ccomp
by	IN	prep
clear	JJ	amod
and	CC	cc
convincing	JJ	conj
evidence	NN	pobj
.	.	punct

In	IN	prep
contrast	NN	pobj
,	,	punct
the	DT	det
panel	NN	compound
majority	NN	nsubj
hold	VBZ	ROOT
that	IN	dobj
if	IN	mark
the	DT	det
attacker	NN	nsubj
raise	VBZ	pobj
no	RB	neg
more	JJR	dobj
than	IN	prep
a	DT	det
"	``	punct
substantial	JJ	amod
question	NN	pobj
"	''	punct
of	IN	prep
invalidity	NN	pobj
,	,	punct
that	WDT	nsubj
suffice	VBZ	relcl
to	TO	aux
establish	VB	xcomp
the	DT	det
likelihood	NN	dobj
that	IN	mark
the	DT	det
attacker	NN	nsubj
will	MD	aux
succeed	VB	acl
on	IN	prep
the	DT	det
merit	NNS	pobj
.	.	punct

that	DT	nsubj
be	VBZ	ROOT
incorrect	JJ	acomp
in	IN	prep
law	NN	pobj
and	CC	cc
in	IN	conj
procedure	NN	pobj
.	.	punct

 	_SP	

next	RB	advmod
,	,	punct
even	RB	advmod
as	IN	mark
the	DT	det
panel	NN	compound
majority	NN	nsubj
state	VBZ	ccomp
-PRON-	PRP$	poss
agreement	NN	dobj
with	IN	prep
the	DT	det
district	NN	compound
court	NN	poss
's	POS	case
finding	NN	pobj
that	IN	mark
"	``	punct
the	DT	det
balance	NN	nsubj
of	IN	prep
hardship	NNS	pobj
favor	VBZ	acl
Abbott	NNP	dobj
,	,	punct
"	''	punct
maj	FW	ROOT
.	.	punct

op	UH	ROOT
.	.	punct

at	IN	prep
30	CD	pobj
,	,	punct
the	DT	det
majority	NN	nsubj
decline	VBZ	ROOT
to	TO	aux
weigh	VB	xcomp
this	DT	det
factor	NN	dobj
in	IN	prep
-PRON-	PRP$	poss
decision	NN	pobj
.	.	punct

see	VB	advcl
Chrysler	NNP	compound
Motors	NNPS	compound
Corp.	NNP	nmod
v.	CC	prep
Auto	NNP	compound
Body	NNP	compound
Panels	NNPS	pobj
of	IN	prep
Ohio	NNP	pobj
,	,	punct
Inc.	NNP	appos
,	,	punct
908	CD	nummod
f.2d	CD	nummod
951	CD	appos
(	-LRB-	punct
Fed	NNP	nmod
.	.	punct
Cir.1990	LS	dobj
)	-RRB-	punct
(	-LRB-	punct
"	``	punct
-PRON-	PRP$	poss
rule	NN	nsubj
regard	VBG	prep
whether	IN	mark
a	DT	det
preliminary	JJ	amod
injunction	NN	nsubjpass
should	MD	aux
be	VB	auxpass
grant	VBN	pcomp
or	CC	cc
deny	VBN	conj
be	VBZ	ROOT
that	IN	mark
the	DT	det
trial	NN	compound
court	NN	nsubj
should	MD	aux
weigh	VB	ccomp
and	CC	cc
measure	VB	conj
each	DT	dobj
of	IN	prep
the	DT	det
four	CD	nummod
factor	NNS	pobj
against	IN	prep
the	DT	det
other	JJ	amod
factor	NNS	pobj
and	CC	cc
against	IN	conj
the	DT	det
magnitude	NN	pobj
of	IN	prep
the	DT	det
relief	NN	pobj
request	VBD	acl
"	''	punct
.	.	punct
)	-RRB-	punct
.	.	punct

Abbott	NNP	nsubj
point	VBZ	ccomp
out	RP	prt
that	IN	mark
the	DT	det
status	NN	compound
quo	NN	compound
ante	NN	nsubj
will	MD	aux
not	RB	neg
easily	RB	advmod
be	VB	ccomp
recoverable	JJ	acomp
if	IN	mark
interim	JJ	amod
infringement	NN	nsubjpass
be	VBZ	auxpass
authorize	VBN	advcl
;	:	punct
Abbott	NNP	nsubj
also	RB	advmod
point	VBZ	ROOT
out	RP	prt
that	IN	mark
there	EX	expl
be	VBZ	ccomp
no	DT	det
patent	NN	compound
barrier	NN	attr
to	IN	prep
Teva	NNP	poss
's	POS	case
entry	NN	pobj
into	IN	prep
commerce	NN	pobj
with	IN	prep
-PRON-	PRP$	poss
own	JJ	amod
extended	JJ	amod
release	NN	compound
formulation	NN	pobj
instead	RB	advmod
of	IN	cc
that	DT	conj
of	IN	prep
Abbott	NNP	pobj
,	,	punct
for	IN	mark
the	DT	det
basic	JJ	amod
patent	NN	nsubj
on	IN	prep
clarithromycin	NN	pobj
have	VBZ	aux
expire	VBN	advcl
.	.	punct

thus	RB	advmod
the	DT	det
panel	NN	compound
majority	NN	nsubj
again	RB	advmod
apply	VBZ	ROOT
a	DT	det
flawed	JJ	amod
methodology	NN	dobj
,	,	punct
for	IN	mark
"	``	punct
where	WRB	advmod
-PRON-	PRP	nsubj
be	VBZ	advcl
clear	JJ	acomp
that	IN	mark
the	DT	det
move	VBG	amod
party	NN	nsubj
will	MD	aux
suffer	VB	ccomp
substantially	RB	advmod
great	JJR	amod
harm	NN	dobj
by	IN	prep
the	DT	det
denial	NN	pobj
of	IN	prep
the	DT	det
preliminary	JJ	amod
injunction	NN	pobj
than	IN	prep
the	DT	det
non	JJ	subtok
-	JJ	subtok
move	VBG	amod
party	NN	pobj
would	MD	aux
by	IN	prep
-PRON-	PRP$	poss
grant	NN	pobj
,	,	punct
-PRON-	PRP	nsubj
will	MD	aux
ordinarily	RB	advmod
be	VB	conj
sufficient	JJ	acomp
that	IN	mark
the	DT	det
movant	NN	nsubj
have	VBZ	aux
raise	VBN	ccomp
'	``	punct
serious	JJ	amod
,	,	punct
substantial	JJ	conj
,	,	punct
difficult	JJ	conj
and	CC	cc
doubtful	JJ	conj
'	''	punct
question	NNS	dobj
that	WDT	nsubj
be	VBP	relcl
the	DT	det
proper	JJ	amod
subject	NN	attr
of	IN	prep
litigation	NN	pobj
"	''	punct
.	.	punct

Ugine	NNP	compound
-	HYPH	punct
Savoie	NNP	compound
Imphy	NNP	ROOT
v.	IN	prep
United	NNP	compound
States	NNP	pobj
,	,	punct
121	CD	nummod
F.Supp.2d	NNP	appos
684	CD	nummod
,	,	punct
689	CD	appos
(	-LRB-	punct
ct	UH	appos
.	.	punct
Int'l	NNP	nummod
Trade	NNP	appos
2000	CD	nummod
)	-RRB-	punct
.	.	punct

the	DT	det
district	NN	compound
court	NN	poss
's	POS	case
consideration	NN	nsubj
of	IN	prep
this	DT	det
aspect	NN	pobj
be	VBD	ROOT
proper	JJ	acomp
,	,	punct
and	CC	cc
warrant	VBZ	conj
appellate	JJ	amod
deference	NN	dobj
.	.	punct

 	_SP	

next	RB	advmod
,	,	punct
the	DT	det
panel	NN	compound
majority	NN	nsubj
state	VBZ	ROOT
that	IN	mark
the	DT	det
question	NN	nsubj
of	IN	prep
the	DT	det
sufficiency	NN	pobj
of	IN	prep
money	NN	compound
damage	NNS	pobj
be	VBZ	aux
"	``	punct
arguable"-ignor	VBG	ccomp
the	DT	det
district	NN	compound
court	NN	poss
's	POS	case
finding	NN	dobj
that	IN	mark
this	DT	det
aspect	NN	nsubj
may	MD	aux
also	RB	advmod
favor	VB	acl
Abbott	NNP	dobj
.	.	punct

instead	RB	advmod
,	,	punct
the	DT	det
majority	NN	compound
opinion	NN	nsubj
announce	VBZ	ROOT
that	IN	mark
this	DT	det
aspect	NN	nsubjpass
will	MD	aux
not	RB	neg
be	VB	auxpass
consider	VBN	ccomp
at	RB	advmod
all	RB	advmod
.	.	punct

On	IN	prep
this	DT	det
accumulation	NN	pobj
of	IN	prep
flaw	NNS	pobj
,	,	punct
and	CC	cc
with	IN	prep
no	DT	det
reference	NN	pobj
to	IN	prep
the	DT	det
district	NN	compound
court	NN	poss
's	POS	case
well	RB	advmod
reason	VBN	amod
opinion	NN	pobj
,	,	punct
-PRON-	PRP$	poss
colleague	NNS	nsubj
reverse	VBP	ROOT
the	DT	det
preliminary	JJ	amod
injunction	NN	dobj
,	,	punct
change	VB	conj
the	DT	det
status	NN	compound
quo	NN	dobj
,	,	punct
and	CC	cc
authorize	VB	conj
infringement	NN	dobj
before	IN	mark
validity	NN	nsubjpass
be	VBZ	auxpass
decide	VBN	advcl
.	.	punct

-PRON-	PRP	nsubj
must	MD	aux
,	,	punct
respectfully	RB	advmod
,	,	punct
dissent	NN	ROOT
.	.	punct

 	_SP	

the	DT	det
Considerations	NNPS	compound
Pendente	NNP	compound
Lite	NNP	ROOT

 	_SP	

At	IN	prep
issue	NN	pobj
be	VBP	ROOT
claim	NNS	attr
2	CD	nummod
,	,	punct
4	CD	conj
,	,	punct
and	CC	cc
6	CD	conj
of	IN	prep
U.S.	NNP	compound
patent	NN	compound
No.	SYM	pobj
6,010,718	CD	nummod
(	-LRB-	punct
the	DT	det
'	``	punct
718	CD	nummod
patent	NN	appos
)	-RRB-	punct
and	CC	cc
claim	NN	conj
2	CD	dobj
of	IN	prep
U.S.	NNP	compound
patent	NN	compound
No.	SYM	pobj
6,551,616	CD	nummod
(	-LRB-	punct
the	DT	det
'	``	punct
616	CD	nummod
patent	NN	ccomp
)	-RRB-	punct
.	.	punct

the	DT	det
claim	NNS	nsubjpass
be	VBP	auxpass
direct	VBN	ccomp
to	IN	prep
an	DT	det
extend	VBN	amod
-	HYPH	punct
release	NN	compound
formulation	NN	pobj
of	IN	prep
erythromycin	NN	pobj
in	IN	prep
a	DT	det
polymer	NN	compound
matrix	NN	pobj
,	,	punct
and	CC	cc
require	VB	conj
that	IN	mark
the	DT	det
minimum	JJ	amod
plasma	NN	compound
concentration	NN	nsubj
for	IN	prep
the	DT	det
extended	JJ	amod
release	NN	compound
formulation	NN	pobj
be	VBZ	ccomp
substantially	RB	advmod
equivalent	JJ	acomp
to	IN	prep
that	DT	pobj
of	IN	prep
the	DT	det
immediate	JJ	amod
release	NN	compound
formulation	NN	pobj
;	:	punct
that	RB	advmod
is	RB	advmod
,	,	punct
the	DT	det
drug	NN	nsubjpass
be	VBZ	auxpass
release	VBN	ROOT
so	IN	mark
as	IN	mark
to	TO	aux
be	VB	advcl
present	JJ	acomp
in	IN	prep
the	DT	det
plasma	NN	pobj
at	IN	prep
the	DT	det
same	JJ	amod
minimum	JJ	amod
level	NN	pobj
for	IN	prep
both	CC	preconj
the	DT	det
immediate	JJ	amod
release	NN	pobj
and	CC	cc
extended	JJ	amod
release	NN	compound
formulation	NNS	conj
,	,	punct
and	CC	cc
with	IN	conj
less	JJR	amod
fluctuation	NN	pobj
for	IN	prep
the	DT	det
extended	JJ	amod
release	NN	compound
product	NN	pobj
.	.	punct

 	_SP	

In	IN	prep
the	DT	det
challenge	NN	pobj
to	IN	prep
validity	NN	pobj
,	,	punct
Teva	NNP	conj
and	CC	cc
Abbott	NNP	conj
both	DT	dep
present	VBD	ROOT
extensive	JJ	amod
argument	NN	dobj
and	CC	cc
briefing	NN	conj
,	,	punct
cite	VBG	advcl
various	JJ	amod
reference	NNS	dobj
.	.	punct

the	DT	det
district	NN	compound
court	NN	nsubj
,	,	punct
explain	VBG	acl
-PRON-	PRP$	poss
decision	NN	dobj
on	IN	prep
the	DT	det
question	NN	pobj
of	IN	prep
Teva	NNP	poss
's	POS	case
likelihood	NN	pobj
of	IN	prep
success	NN	pobj
in	IN	prep
prove	VBG	pcomp
the	DT	det
patent	NNS	nsubj
invalid	JJ	ccomp
,	,	punct
analyze	VBD	ROOT
the	DT	det
evidence	NN	dobj
and	CC	cc
conclude	VBD	conj
:	:	punct

 	_SP	

This	DT	det
court	NN	nsubj
find	VBZ	ROOT
that	IN	mark
Teva	NNP	nsubj
have	VBZ	aux
fail	VBN	ccomp
to	TO	aux
raise	VB	xcomp
a	DT	det
substantial	JJ	amod
question	NN	dobj
as	IN	prep
to	IN	prep
the	DT	det
validity	NN	pobj
of	IN	prep
Abbott	NNP	poss
's	POS	case
claim	NNS	pobj
2	CD	nummod
and	CC	cc
4	CD	conj
.	.	punct

the	DT	det
prior	JJ	amod
art	NN	nsubj
cite	VBN	acl
by	IN	agent
Teva	NNP	pobj
disclose	VBZ	ROOT
discrete	JJ	amod
portion	NNS	dobj
of	IN	prep
the	DT	det
assert	VBN	amod
claim	NNS	pobj
,	,	punct
but	CC	cc
Teva	NNP	nsubj
fail	VBZ	conj
to	TO	aux
demonstrate	VB	xcomp
that	IN	mark
this	DT	nsubj
would	MD	aux
be	VB	ccomp
sufficient	JJ	acomp
to	TO	aux
give	VB	xcomp
a	DT	det
person	NN	dobj
of	IN	prep
ordinary	JJ	amod
skill	NN	pobj
in	IN	prep
the	DT	det
art	NN	pobj
a	DT	det
reasonable	JJ	amod
expectation	NN	dobj
of	IN	prep
success	NN	pobj
.	.	punct

Teva	NNP	poss
's	POS	case
prior	JJ	amod
art	NN	compound
reference	NNS	nsubj
reveal	VBP	ROOT
that	IN	mark
use	VBG	csubj
HPMC	NNP	dobj
be	VBD	ccomp
a	DT	det
logical	JJ	amod
line	NN	attr
of	IN	prep
inquiry	NN	pobj
but	CC	cc
the	DT	det
dissimilarity	NNS	conj
between	IN	prep
the	DT	det
drug	NNS	pobj
with	IN	prep
which	WDT	pobj
HPMC	NNP	nsubj
have	VBD	aux
be	VBN	relcl
successfully	RB	advmod
combine	VBN	acomp
and	CC	cc
clarithromycin	JJ	compound
defeat	NN	conj

Teva	NNP	poss
's	POS	case
claim	NN	ROOT
of	IN	prep
obviousness	JJ	pobj
.	.	punct

 	_SP	

the	DT	det
district	NN	compound
court	NN	nsubj
include	VBD	ROOT
discussion	NN	dobj
of	IN	prep
the	DT	det
issue	NNS	pobj
and	CC	cc
argument	NNS	conj
present	VBN	acl
by	IN	agent
the	DT	det
party	NNS	pobj
,	,	punct
remark	VBD	conj
on	IN	prep
the	DT	det
use	NNS	pobj
of	IN	prep
various	JJ	amod
know	VBN	amod
release	NN	compound
agent	NNS	pobj
,	,	punct
and	CC	cc
the	DT	det
unpredictability	NN	conj
of	IN	prep
achieve	VBG	pcomp
successful	JJ	amod
extended	JJ	amod
release	NN	dobj
as	IN	prep
to	IN	prep
any	DT	det
particular	JJ	amod
product	NN	pobj
.	.	punct

the	DT	det
record	NN	nsubj
show	VBZ	ROOT
discussion	NN	dobj
at	IN	prep
the	DT	det
district	NN	compound
court	NN	pobj
that	WDT	mark
the	DT	det
metabolic	JJ	amod
pathway	NN	nsubjpass
of	IN	prep
the	DT	det
active	JJ	amod
ingredient	NN	pobj
must	MD	aux
be	VB	auxpass
determine	VBN	acl
,	,	punct
as	RB	advmod
well	RB	advmod
as	IN	cc
the	DT	det
physical	JJ	amod
and	CC	cc
chemical	JJ	conj
property	NNS	conj
and	CC	cc
physiologic	NN	amod
behavior	NN	conj
and	CC	cc
effectiveness	NN	conj
of	IN	prep
the	DT	det
metabolite	NNS	pobj
and	CC	cc
-PRON-	PRP$	poss
interaction	NN	conj
with	IN	prep
the	DT	det
material	NNS	pobj
in	IN	prep
the	DT	det
extended	JJ	amod
release	NN	compound
formulation	NN	pobj
.	.	punct

the	DT	det
record	NN	nsubj
show	VBZ	ROOT
discussion	NN	dobj
at	IN	prep
the	DT	det
district	NN	compound
court	NN	pobj
of	IN	prep
the	DT	det
need	NN	pobj
for	IN	prep
extended	JJ	amod
release	NN	compound
performance	NN	pobj
that	WDT	nsubj
will	MD	aux
produce	VB	ccomp
an	DT	det
effective	JJ	amod
drug	NN	compound
exposure	NN	dobj
in	IN	prep
the	DT	det
bloodstream	NN	pobj
over	IN	prep
the	DT	det
entire	JJ	amod
release	NN	compound
period	NN	pobj
,	,	punct
and	CC	cc
the	DT	det
unpredictability	NN	conj
of	IN	prep
this	DT	det
performance	NN	pobj
.	.	punct

the	DT	det
record	NN	nsubj
show	VBZ	ROOT
discussion	NN	dobj
of	IN	prep
the	DT	det
non	JJ	subtok
-	JJ	subtok
linear	JJ	amod
pharmacokinetics1	NN	pobj
exhibit	VBN	acl
by	IN	agent
clarithromycin	NN	pobj
.	.	punct

the	DT	det
district	NN	compound
court	NN	nsubj
explain	VBD	ROOT
-PRON-	PRP$	poss
decision	NN	dobj
that	IN	mark
Teva	NNP	nsubj
have	VBD	aux
not	RB	neg
show	VBN	acl
that	IN	mark
-PRON-	PRP	nsubj
be	VBD	ccomp
likely	JJ	acomp
to	TO	aux
prove	VB	xcomp
invalidity	NN	dobj
of	IN	prep
the	DT	det
claim	VBN	amod
formulation	NNS	pobj
:	:	punct

 	_SP	

This	DT	det
court	NN	nsubj
be	VBZ	ROOT
mindful	JJ	acomp
of	IN	prep
the	DT	det
Federal	NNP	compound
Circuit	NNP	poss
's	POS	case
warning	NN	pobj
about	IN	prep
the	DT	det
risk	NN	pobj
of	IN	prep
the	DT	det
"	``	punct
hindsight	NN	compound
trap	NN	pobj
,	,	punct
"	''	punct
or	CC	cc
the	DT	det
post	AFX	advmod
facto	FW	amod
belief	NN	conj
that	IN	mark
an	DT	det
invention	NN	nsubj
,	,	punct
which	WDT	nsubj
seem	VBZ	relcl
obvious	JJ	oprd
once	RB	advmod
create	VBN	advcl
,	,	punct
would	MD	aux
have	VB	aux
be	VBN	acl
obvious	JJ	acomp
to	IN	prep
people	NNS	pobj
skilled	JJ	acl
in	IN	prep
the	DT	det
art	NN	pobj
at	IN	prep
the	DT	det
time	NN	pobj
.	.	punct

Abbott	NNP	nsubj
have	VBZ	aux
provide	VBN	ROOT
ample	JJ	amod
evidence	NN	dobj
that	IN	mark
-PRON-	PRP$	poss
invention	NN	nsubj
be	VBD	acl
not	RB	neg
obvious	JJ	acomp
and	CC	cc
that	IN	mark
there	EX	expl
be	VBD	conj
many	JJ	amod
other	JJ	amod
extended	JJ	amod
release	NN	compound
formulation	NN	compound
method	NNS	attr
know	VBN	acl
in	IN	prep
the	DT	det
prior	JJ	amod
art	NN	pobj
.	.	punct

In	IN	prep
fact	NN	pobj
,	,	punct
the	DT	det
existence	NN	nsubj
of	IN	prep
alternate	JJ	amod
method	NNS	pobj
and	CC	cc
the	DT	det
attempt	VBN	amod
exploitation	NN	conj
of	IN	prep
some	DT	pobj
of	IN	prep
those	DT	det
method	NNS	pobj
provide	VBP	ROOT
secondary	JJ	amod
consideration	NNS	dobj
of	IN	prep
nonobviousness	NN	pobj
.	.	punct

These	DT	det
factor	NNS	nsubj
suggest	VBP	ROOT
that	IN	mark
there	EX	expl
be	VBD	ccomp
a	DT	det
long	RB	advmod
-	HYPH	punct
feel	VBN	amod
need	NN	attr
for	IN	prep
the	DT	det
invention	NN	pobj
,	,	punct
that	IN	mark
other	NNS	nsubj
,	,	punct
include	VBG	prep
Abbott	NNP	pobj
,	,	punct
initially	RB	advmod
fail	VBD	acl
to	TO	aux
develop	VB	xcomp
the	DT	det
invention	NN	dobj
,	,	punct
and	CC	cc
go	VB	conj
a	DT	det
long	JJ	amod
way	NN	npadvmod
to	TO	aux
account	VB	relcl
for	IN	prep
the	DT	det
commercial	JJ	amod
success	NN	pobj
that	WDT	dobj
Abbott	NNP	nsubj
have	VBZ	aux
unquestionably	RB	advmod
enjoy	VBN	relcl
with	IN	prep
-PRON-	PRP$	poss
BIAXIN	NNP	compound
XL	NNP	compound
product	NN	pobj
.	.	punct

 	_SP	

the	DT	det
panel	NN	compound
majority	NN	nsubj
do	VBZ	aux
not	RB	neg
discuss	VB	ccomp
,	,	punct
and	CC	cc
assign	VBZ	conj
no	DT	det
flaw	NN	dobj
,	,	punct
to	IN	prep
the	DT	det
district	NN	compound
court	NN	poss
's	POS	case
refusal	NN	pobj
to	TO	aux
apply	VB	acl
judicial	JJ	amod
hindsight	NN	dobj
;	:	punct
nonetheless	RB	advmod
,	,	punct
the	DT	det
majority	NN	nsubj
apply	VBZ	ROOT
such	JJ	amod
hindsight	NN	dobj
for	IN	prep
-PRON-	PRP	pobj
,	,	punct
start	VBG	advcl
with	IN	prep
the	DT	det
template	NN	pobj
of	IN	prep
the	DT	det
Abbott	NNP	compound
invention	NN	pobj
and	CC	cc
then	RB	advmod
select	VBG	conj
portion	NNS	dobj
of	IN	prep
reference	NNS	pobj
to	TO	aux
reconstruct	VB	advcl
the	DT	det
invention	NN	dobj
within	IN	prep
that	DT	det
template	NN	pobj
.	.	punct

to	TO	aux
guard	VB	advcl
against	IN	prep
such	JJ	amod
incorrect	JJ	amod
analysis	NN	pobj
,	,	punct
precedent	NN	nsubj
teach	NNS	ROOT
that	IN	mark
reference	NNS	nsubjpass
can	MD	aux
not	RB	neg
be	VB	auxpass
select	VBN	ccomp
,	,	punct
and	CC	cc
select	VBN	amod
element	NNS	nsubjpass
from	IN	prep
select	VBN	amod
reference	NNS	pobj
can	MD	aux
not	RB	neg
be	VB	auxpass
combine	VBN	conj
,	,	punct
without	IN	prep
some	DT	det
suggestion	NN	pobj
,	,	punct
motivation	NN	conj
,	,	punct
or	CC	cc
teaching	NN	conj
that	WDT	nsubj
would	MD	aux
make	VB	relcl
obvious	JJ	acomp
that	DT	det
selection	NN	dobj
and	CC	cc
that	DT	det
combination	NN	conj
.	.	punct

see	VB	ROOT
,	,	punct
e.g.	RB	advmod
,	,	punct
Karsten	NNP	compound
Mfg	NNP	subtok
.	.	punct
Corp.	NNP	dobj
v.	IN	prep
Cleveland	NNP	compound
Golf	NNP	compound
Co.	NNP	pobj
,	,	punct
242	CD	nummod
f.3d	CD	appos
1376	CD	npadvmod
,	,	punct
1385	CD	npadvmod
,	,	punct

58	CD	nummod
USPQ2d	NNS	dep
1286	CD	nummod
,	,	punct
1293	CD	npadvmod
(	-LRB-	punct
Fed	NNP	nmod
.	.	punct
Cir.2001	LS	ROOT
)	-RRB-	punct
(	-LRB-	punct
"	``	punct
In	IN	prep
hold	VBG	pcomp
an	DT	det
invention	NN	dobj
obvious	JJ	amod
in	IN	prep
view	NN	pobj
of	IN	prep
a	DT	det
combination	NN	pobj
of	IN	prep
reference	NNS	pobj
,	,	punct
there	EX	expl
must	MD	aux
be	VB	ccomp
some	DT	det
suggestion	NN	attr
,	,	punct
motivation	NN	conj
,	,	punct
or	CC	cc
teaching	NN	conj
in	IN	prep
the	DT	det
prior	JJ	amod
art	NN	pobj
that	WDT	nsubj
would	MD	aux
have	VB	aux
lead	VBN	relcl
a	DT	det
person	NN	dobj
of	IN	prep
ordinary	JJ	amod
skill	NN	pobj
in	IN	prep
the	DT	det
art	NN	pobj
to	TO	aux
select	VB	advcl
the	DT	det
reference	NNS	dobj
and	CC	cc
combine	VB	conj
-PRON-	PRP	dobj
in	IN	prep
the	DT	det
way	NN	pobj
that	WDT	nsubj
would	MD	aux
produce	VB	relcl
the	DT	det
claim	VBN	amod
invention	NN	dobj
"	''	punct
.	.	punct
)	-RRB-	punct

;	:	punct
Brown	NNP	nsubj
&	CC	cc
Williamson	NNP	compound
Tobacco	NNP	compound
Corp.	NNP	conj
v.	IN	prep
Philip	NNP	compound
Morris	NNP	compound
Inc.	NNP	pobj
,	,	punct
229	CD	nummod
f.3d	CD	appos
1120	CD	nummod
,	,	punct
1124	CD	npadvmod
-	SYM	punct
25	CD	prep
(	-LRB-	punct
Fed	NNP	nmod
.	.	punct
Cir.2000	LS	ROOT
)	-RRB-	punct
(	-LRB-	punct
"	``	punct
a	DT	det
showing	NN	nsubj
of	IN	prep
a	DT	det
suggestion	NN	pobj
,	,	punct
teaching	NN	conj
,	,	punct
or	CC	cc
motivation	NN	conj
to	TO	aux
combine	VB	acl
the	DT	det
prior	JJ	amod
art	NN	compound
reference	NNS	dobj
be	VBZ	ccomp
an	DT	det
'	``	punct
essential	JJ	amod
component	NN	attr
of	IN	prep
an	DT	det
obviousness	JJ	amod
holding	NN	pobj
'	''	punct
"	punct	punct
-RRB-	punct	punct
.	.	punct

 	_SP	

the	DT	det
panel	NN	compound
majority	NN	nsubj
acknowledge	VBZ	ROOT
the	DT	det
law	NN	dobj
,	,	punct
but	CC	cc
find	VBZ	conj
a	DT	det
motivation	NN	dobj
to	TO	aux
make	VB	acl
the	DT	det
claim	VBN	amod
formulation	NN	dobj
by	IN	prep
combine	VBG	pcomp
the	DT	det
information	NN	dobj
in	IN	prep
Abbott	NNP	poss
's	POS	case
prior	JJ	amod
art	NN	pobj
Patent	NNP	compound
No.	SYM	appos
5,705,190	CD	nummod
,	,	punct
which	WDT	nsubj
show	VBZ	relcl
extended	JJ	amod
release	NN	compound
formulation	NNS	dobj
of	IN	prep
clarithromycin	NN	pobj
and	CC	cc
azithromycin	NN	conj
in	IN	prep
"	``	punct
alginate	NN	pobj
,	,	punct
"	''	punct
a	DT	det
know	VBN	amod
release	NN	compound
agent	NN	appos
derive	VBN	acl
from	IN	prep
seaweed	NN	pobj
,	,	punct
with	IN	prep
a	DT	det
Pfizer	NNP	compound
publication	NN	pobj
designate	VBN	amod
WO	NNP	appos
95/30422	CD	nummod
,	,	punct
which	WDT	nsubj
show	VBZ	relcl
the	DT	det
HPMC	NNP	dobj
(	-LRB-	punct
hydroxypropyl	JJ	amod
methyl	NN	compound
cellulose	NN	appos
)	-RRB-	punct
of	IN	prep
the	DT	det
'	``	punct
718	CD	nummod
patent	NN	pobj
use	VBN	acl
with	IN	prep
azithromycin	NN	pobj
.	.	punct

Abbott	NNP	nsubj
state	VBD	ccomp
at	IN	prep
the	DT	det
preliminary	JJ	amod
injunction	NN	pobj
hearing	NN	acl
that	IN	mark
what	WP	nsubj
work	VBZ	csubj
for	IN	prep
a	DT	det
product	NN	pobj
in	IN	prep
an	DT	det
alginate	NN	compound
matrix	NN	pobj
be	VBZ	ccomp
not	RB	neg
predictably	RB	advmod
applicable	JJ	acomp
to	IN	prep
other	JJ	amod
product	NNS	pobj
;	:	punct
this	DT	det
statement	NN	nsubjpass
be	VBD	auxpass
not	RB	neg
contradict	VBN	ROOT
.	.	punct

the	DT	det
district	NN	compound
court	NN	nsubj
analyze	VBD	ROOT
the	DT	det
interchangeability	NN	dobj
of	IN	prep
clarithromycin	NN	pobj
and	CC	cc
azithromycin	NN	conj
,	,	punct
state	VBG	advcl
:	:	punct

 	_SP	

the	DT	det
question	NNS	nsubj
be	VBP	ROOT
:	:	punct
how	WRB	advmod
similar	JJ	acomp
and	CC	cc
dissimilar	JJ	conj
be	VBP	ccomp
the	DT	det
two	CD	nummod
molecule	NNS	attr
;	:	punct
and	CC	cc
what	WP	attr
be	VBP	conj
the	DT	det
implication	NNS	nsubj
of	IN	prep
these	DT	det
similarity	NNS	pobj
and	CC	cc
dissimilarity	NNS	conj
to	IN	prep
a	DT	det
person	NN	pobj
of	IN	prep
ordinary	JJ	amod
skill	NN	pobj
in	IN	prep
the	DT	det
art	NN	pobj
in	IN	prep
light	NN	pobj
of	IN	prep
prior	JJ	amod
art	NN	pobj
at	IN	prep
the	DT	det
time	NN	pobj
of	IN	prep
the	DT	det
invention	NN	pobj
.	.	punct

specifically	RB	advmod
,	,	punct
would	MD	aux
a	DT	det
person	NN	nsubj
of	IN	prep
ordinary	JJ	amod
skill	NN	pobj
in	IN	prep
the	DT	det
art	NN	pobj
have	VBP	aux
have	VBN	ROOT
a	DT	det
reasonable	JJ	amod
expectation	NN	dobj
of	IN	prep
success	NN	pobj
in	IN	prep
create	VBG	pcomp
an	DT	det
extended	JJ	amod
release	NN	compound
formulation	NN	dobj
of	IN	prep
clarithromycin	NN	pobj
use	VBG	advcl
a	DT	det
hydrophilic	JJ	amod
water	NN	npadvmod
-	HYPH	punct
soluble	JJ	amod
polymer	NN	dobj
base	VBN	prep
on	IN	prep
the	DT	det
prior	JJ	amod
art	NN	pobj
,	,	punct
include	VBG	prep
the	DT	det
'	``	punct
422	CD	nummod
patent	NN	pobj
for	IN	prep
an	DT	det
extended	JJ	amod
release	NN	compound
formulation	NN	pobj
of	IN	prep
azithromycin	NN	pobj
with	IN	prep
such	PDT	predet
a	DT	det
polymer	NN	pobj
?	.	punct

 	_SP	

the	DT	det
court	NN	nsubj
conclude	VBD	ROOT
that	IN	mark
-PRON-	PRP	nsubj
be	VBD	ccomp
not	RB	neg
so	RB	advmod
similar	JJ	acomp
as	IN	mark
to	TO	aux
be	VB	advcl
interchangeable	JJ	acomp
in	IN	prep
the	DT	det
context	NN	pobj
of	IN	prep
polymer	NNS	pobj
like	IN	prep
HPMC	NNP	pobj
,	,	punct
correctly	RB	advmod
reject	VBG	advcl
the	DT	det
argument	NN	dobj
that	IN	mark
"	``	punct
obvious	JJ	nsubj
to	TO	aux
try	VB	relcl
"	''	punct
can	MD	aux
establish	VB	acl
obviousness	JJ	dobj
.	.	punct

the	DT	det
court	NN	nsubj
state	VBD	ROOT
:	:	punct

 	_SP	

Teva	NNP	poss
's	POS	case
prior	JJ	amod
art	NN	compound
reference	NNS	nsubj
reveal	VBP	ROOT
that	IN	mark
use	VBG	csubj
HPMC	NNP	dobj
be	VBD	ccomp
a	DT	det
logical	JJ	amod
line	NN	attr
of	IN	prep
inquiry	NN	pobj
but	CC	cc
the	DT	det
dissimilarity	NNS	conj
between	IN	prep
the	DT	det
drug	NNS	pobj
with	IN	prep
which	WDT	pobj
HPMC	NNP	nsubj
have	VBD	aux
be	VBN	relcl
successfully	RB	advmod
combine	VBN	acomp
and	CC	cc
clarithromycin	JJ	compound
defeat	NN	conj

Teva	NNP	poss
's	POS	case
claim	NN	ROOT
of	IN	prep
obviousness	JJ	pobj
.	.	punct

 	_SP	

-PRON-	PRP$	poss
colleague	NNS	nsubj
ignore	VBP	ROOT
the	DT	det
district	NN	compound
court	NN	poss
's	POS	case
analysis	NN	dobj
,	,	punct
offer	VBG	advcl
neither	CC	preconj
deference	NN	dobj
nor	CC	cc
acknowledgment	NN	conj
.	.	punct

instead	RB	advmod
,	,	punct
the	DT	det
panel	NN	compound
majority	NN	nsubj
explain	VBZ	ROOT
that	IN	mark
-PRON-	PRP$	poss
finding	NN	nsubjpass
of	IN	prep
likelihood	NN	pobj
of	IN	prep
success	NN	pobj
in	IN	prep
prove	VBG	pcomp
obviousness	JJ	dobj
be	VBZ	auxpass
support	VBN	ccomp
"	''	punct
not	RB	neg
by	IN	agent
what	WP	pobj
the	DT	det
'	``	punct
190	CD	nummod
patent	NN	compound
disclose	NNS	nsubj
but	CC	cc
what	WP	dobj
-PRON-	PRP	nsubj
do	VBZ	aux
not	RB	neg
disclose	VB	conj
"	''	punct
(	-LRB-	punct
emphasis	NN	appos
in	IN	prep
maj	NN	pobj
.	.	punct
op	UH	intj
.	.	punct
)	-RRB-	punct
,	,	punct
propose	VBG	advcl
that	IN	mark
:	:	punct
"	``	punct
Abbott	NNP	nsubj
have	VBZ	aux
represent	VBN	ccomp
to	IN	prep
the	DT	det
U.S.	NNP	nmod
Patent	NNP	nmod
and	CC	cc
Trademark	NNP	conj
Office	NNP	pobj
that	IN	mark
the	DT	det
difference	NNS	nsubj
between	IN	prep
clarithromycin	NN	pobj
and	CC	cc
azithromycin	NN	conj
be	VBD	ccomp
such	JJ	acomp
that	IN	mark
azithromycin	NN	nsubjpass
could	MD	aux
be	VB	auxpass
substitute	VBN	ccomp
into	IN	prep
a	DT	det
control	VBN	amod
release	NN	compound
clarithromycin	NN	compound
composition	NN	pobj
by	IN	agent
a	DT	det
person	NN	pobj
of	IN	prep
ordinary	JJ	amod
skill	NN	pobj
in	IN	prep
the	DT	det
art	NN	pobj
without	IN	prep
undue	JJ	amod
experimentation	NN	pobj
"	''	punct
.	.	punct

Maj	NNP	ROOT
.	.	punct

op	UH	ROOT
.	.	punct

at	IN	ROOT
17	CD	pobj
-	SYM	punct
18	CD	prep
.	.	punct

thus	RB	advmod
-PRON-	PRP$	poss
colleague	NNS	nsubj
conclude	VBP	ROOT
that	IN	nsubj
claim	NN	ccomp
4	CD	nsubj
of	IN	prep
the	DT	det
'	``	punct
718	CD	nummod
patent	NN	pobj
be	VBZ	ccomp
"	``	punct
vulnerable	JJ	acomp
to	IN	prep
allegation	NNS	pobj
of	IN	prep
invalidity	NN	pobj
,	,	punct
"	''	punct
and	CC	cc
find	VB	conj
"	``	punct
a	DT	det
substantial	JJ	amod
argument	NN	dobj
"	''	punct
as	IN	prep
to	IN	prep
other	JJ	amod
claim	NNS	pobj
.	.	punct

These	DT	nsubj
be	VBP	ROOT
not	RB	neg
the	DT	det
criterion	NNS	attr
of	IN	prep
likelihood	NN	pobj
of	IN	prep
success	NN	pobj
.	.	punct

 	_SP	

reversible	JJ	amod
error	NN	nsubjpass
have	VBZ	aux
not	RB	neg
be	VBN	auxpass
show	VBN	ROOT
in	IN	prep
the	DT	det
district	NN	compound
court	NN	poss
's	POS	case
analysis	NN	pobj
,	,	punct
and	CC	cc
no	DT	det
basis	NN	nsubjpass
whatsoever	RB	advmod
have	VBZ	aux
be	VBN	auxpass
show	VBN	conj
for	IN	prep
overturn	VBG	pcomp
the	DT	det
court	NN	poss
's	POS	case
discretionary	JJ	amod
decision	NN	dobj
to	TO	aux
preserve	VB	acl
the	DT	det
status	NN	compound
quo	NN	dobj
while	IN	mark
the	DT	det
matter	NN	nsubjpass
be	VBZ	auxpass
litigate	VBN	advcl
.	.	punct

even	RB	advmod
if	IN	mark
Teva	NNP	nsubj
have	VBD	aux
raise	VBN	advcl
a	DT	det
substantial	JJ	amod
argument	NN	dobj
,	,	punct
as	IN	mark
-PRON-	PRP$	poss
colleague	NNS	nsubj
find	VBP	advcl
,	,	punct
the	DT	det
criterion	NNS	nsubjpass
of	IN	prep
abuse	NN	pobj
of	IN	prep
discretion	NN	pobj
have	VBP	aux
not	RB	neg
be	VBN	auxpass
meet	VBN	ROOT
.	.	punct

to	TO	aux
support	VB	advcl
a	DT	det
change	NN	dobj
in	IN	prep
the	DT	det
status	NN	compound
quo	NN	pobj
before	IN	mark
the	DT	det
merit	NNS	nsubjpass
be	VBP	auxpass
decide	VBN	advcl
,	,	punct
-PRON-	PRP	nsubjpass
must	MD	aux
be	VB	auxpass
show	VBN	ROOT
to	TO	aux
be	VB	xcomp
likely	JJ	acomp
that	IN	mark
the	DT	det
patent	NN	nsubjpass
will	MD	aux
be	VB	auxpass
hold	VBN	ccomp
invalid	JJ	oprd
under	IN	prep
the	DT	det
presumption	NNS	pobj
and	CC	cc
burden	NNS	conj
in	IN	prep
effect	NN	pobj
at	IN	prep
trial	NN	pobj
.	.	punct

the	DT	det
panel	NN	compound
majority	NN	nsubj
be	VBZ	ccomp
incorrect	JJ	acomp
in	IN	prep
hold	VBG	pcomp
that	IN	mark
-PRON-	PRP	nsubj
"	``	punct
require	VBZ	ccomp
less	JJR	amod
proof	NN	dobj
"	''	punct
to	TO	aux
authorize	VB	acl
infringement	NN	dobj
before	IN	mark
the	DT	det
merit	NNS	nsubjpass
be	VBP	auxpass
decide	VBN	advcl
;	:	punct
such	PDT	predet
a	DT	det
rule	NN	nsubjpass
,	,	punct
whereby	WRB	advmod
a	DT	det
patent	NN	nsubjpass
be	VBZ	auxpass
deprive	VBN	relcl
of	IN	prep
exclusivity	NN	pobj
during	IN	prep
litigation	NN	pobj
,	,	punct
be	VBZ	auxpass
not	RB	neg
readily	RB	advmod
invoke	VBN	ROOT
,	,	punct
for	IN	mark
-PRON-	PRP	nsubj
be	VBZ	advcl
excessively	RB	advmod
disruptive	JJ	acomp
of	IN	prep
the	DT	det
process	NNS	pobj
of	IN	prep
law	NN	pobj
.	.	punct

As	IN	mark
the	DT	det
Court	NNP	nsubj
say	VBD	advcl
in	IN	prep
eBay	NNP	pobj
v.	CC	prep
MercExchange	NNP	pobj
:	:	punct
"	``	punct
As	IN	mark
this	DT	det
Court	NNP	nsubj
have	VBZ	aux
long	RB	advmod
recognize	VBN	advcl
,	,	punct
'	''	punct
a	DT	det
major	JJ	amod
departure	NN	nsubjpass
from	IN	prep
the	DT	det
long	JJ	amod
tradition	NN	pobj
of	IN	prep
equity	NN	compound
practice	NN	pobj
should	MD	aux
not	RB	neg
be	VB	auxpass
lightly	RB	advmod
imply	VBN	ROOT
.	.	punct
'	''	punct
"	``	punct

126	CD	nummod
S.Ct	NNP	ROOT
.	.	punct
at	IN	prep
1839	CD	pobj
(	-LRB-	punct
quote	VBG	acl
Weinberger	NNP	dobj
v.	CC	prep
Romero	NNP	compound
-	HYPH	punct
Barcelo	NNP	pobj
,	,	punct
456	CD	nummod
U.S.	NNP	appos
305	CD	nummod
,	,	punct
320	CD	appos
,	,	punct
102	CD	nummod
s.ct	NN	subtok
.	.	punct
1798	CD	appos
,	,	punct
72	CD	appos
l.ed.2d	NN	npadvmod
91	CD	nummod
(	-LRB-	punct
1982	CD	npadvmod
)	-RRB-	punct
)	-RRB-	punct
.	.	punct

 	_SP	

conclusion	NN	ROOT

 	_SP	

the	DT	det
district	NN	compound
court	NN	poss
's	POS	case
conclusion	NN	nsubj
as	IN	prep
to	IN	prep
the	DT	det
challenger	NN	poss
's	POS	case
likelihood	NN	pobj
of	IN	prep
success	NN	pobj
in	IN	prep
invalidate	VBG	pcomp
all	DT	dobj
of	IN	prep
the	DT	det
claim	NNS	pobj
in	IN	prep
suit	NN	pobj
,	,	punct
and	CC	cc
the	DT	det
district	NN	compound
court	NN	poss
's	POS	case
view	NN	conj
of	IN	prep
the	DT	det
balance	NN	pobj
of	IN	prep
harm	NNS	pobj
,	,	punct
be	VBP	ROOT
well	RB	advmod
reason	VBN	acomp
and	CC	cc
fully	RB	advmod
support	VBN	conj
by	IN	agent
precedent	NN	pobj
.	.	punct

the	DT	det
district	NN	compound
court	NN	poss
's	POS	case
ruling	NN	ROOT
,	,	punct
preserve	VBG	acl
the	DT	det
status	NN	compound
quo	NN	dobj
during	IN	prep
litigation	NN	pobj
,	,	punct
warrant	NNS	conj
,	,	punct
and	CC	cc
require	VBZ	conj
,	,	punct
-PRON-	PRP$	poss
deference	NN	appos
.	.	punct

From	IN	prep
-PRON-	PRP$	poss
colleague	NNS	nmod
de	FW	nmod
novo	NN	pobj
and	CC	cc
incorrect	JJ	amod
contrary	JJ	amod
ruling	NN	conj
,	,	punct
-PRON-	PRP	nsubj
must	MD	aux
,	,	punct
respectfully	RB	advmod
,	,	punct
dissent	NN	ROOT
.	.	punct

 	_SP	

all	DT	det
Citations	NNPS	ROOT

 	_SP	
452	CD	nummod
f.3d	CD	appos
1331	CD	nummod
,	,	punct
79	CD	nummod
U.S.P.Q.2d	NNP	appos
1321	CD	nummod

 	_SP	

Footnotes	NNP	ROOT

 	_SP	

Abbott	NNP	nsubj
also	RB	advmod
allege	VBD	ROOT
infringement	NN	dobj
of	IN	prep
U.S.	NNP	compound
patent	NN	nmod
No.	SYM	pobj
6,872,407	CD	nummod
and	CC	cc
U.S.	NNP	compound
patent	NN	compound
4,680,386	CD	conj
but	CC	cc
as	IN	mark
this	DT	det
case	NN	nsubj
be	VBZ	advcl
a	DT	det
limited	JJ	amod
appeal	NN	attr
of	IN	prep
the	DT	det
district	NN	compound
court	NN	poss
's	POS	case
grant	NN	pobj
of	IN	prep
a	DT	det
preliminary	JJ	amod
injunction	NN	pobj
under	IN	prep
28	CD	nummod
u.s.c.	NN	nmod
¡±	CD	nummod
1292(c)(1	CD	pobj
)	-RRB-	punct
and	CC	cc
that	IN	mark
preliminary	JJ	amod
injunction	NN	nsubj
do	VBD	aux
not	RB	neg
extend	VB	conj
to	IN	prep
the	DT	det
claim	NNS	pobj
of	IN	prep
the	DT	det
6,872,407	CD	nummod
or	CC	cc
4,680,386	CD	conj
patent	NN	pobj
,	,	punct
those	DT	det
two	CD	nummod
patent	NNS	nsubj
be	VBP	conj
not	RB	neg
before	IN	prep
-PRON-	PRP	pobj
today	NN	npadvmod
and	CC	cc
will	MD	aux
not	RB	neg
be	VB	auxpass
discuss	VBN	conj
.	.	punct

 	_SP	

the	DT	det
dissent	NN	nsubj
appear	VBZ	ROOT
to	TO	aux
take	VB	xcomp
issue	NN	dobj
with	IN	prep
the	DT	det
conclusion	NN	pobj
that	IN	mark
a	DT	det
likelihood	NN	nsubjpass
of	IN	prep
success	NN	pobj
on	IN	prep
the	DT	det
merit	NNS	pobj
be	VBZ	auxpass
not	RB	neg
find	VBN	acl
where	WRB	advmod
there	EX	expl
exist	VBZ	ccomp
a	DT	det
substantial	JJ	amod
question	NN	dobj
of	IN	prep
validity	NN	pobj
.	.	punct

the	DT	det
majority	NN	compound
opinion	NN	nsubj
,	,	punct
however	RB	advmod
,	,	punct
be	VBZ	ROOT
duty	NN	attr
bind	VBN	acl
by	IN	agent
-PRON-	PRP$	poss
precedent	NN	pobj
which	WDT	nsubj
state	VBZ	relcl
exactly	RB	advmod
this	DT	det
proposition	NN	dobj
.	.	punct

In	IN	prep
Genentech	NNP	pobj
,	,	punct
Inc.	NNP	appos
v.	CC	prep
Novo	NNP	compound
Nordisk	NNP	conj
,	,	punct
A	NNP	nmod
/	SYM	punct
s	NN	appos
,	,	punct
this	DT	det
court	NN	nsubj
state	VBD	ROOT
that	IN	mark

 	_SP	
In	IN	prep
order	NN	pobj
to	TO	aux
demonstrate	VB	acl
that	IN	mark
-PRON-	PRP	nsubj
have	VBZ	ccomp
a	DT	det
likelihood	NN	dobj
of	IN	prep
success	NN	pobj
,	,	punct
Genentech	NNP	nsubj
must	MD	aux
show	VB	ccomp
that	IN	mark
,	,	punct
in	IN	prep
light	NN	pobj
of	IN	prep
the	DT	det
presumption	NNS	pobj
and	CC	cc
burden	NNS	conj
that	WDT	nsubj
will	MD	aux
inhere	VB	relcl
at	IN	prep
trial	NN	pobj
on	IN	prep
the	DT	det
merit	NNS	pobj
,	,	punct
(	-LRB-	punct
1	LS	meta
)	-RRB-	punct
-PRON-	PRP	nsubj
will	MD	aux
likely	RB	advmod
prove	VB	ccomp
that	IN	mark
Novo	NNP	nsubj
infringe	VBZ	ccomp
the	DT	det
'	``	punct
199	CD	nummod
patent	NN	dobj
and	CC	cc
(	-LRB-	punct
2	LS	conj
)	-RRB-	punct
-PRON-	PRP$	poss
infringement	NN	compound
claim	NN	nsubj
will	MD	aux
likely	RB	advmod
withstand	VB	ccomp
Novo	NNP	poss
's	POS	case
challenge	NNS	dobj
to	IN	prep
the	DT	det
validity	NN	pobj
and	CC	cc
enforceability	NN	conj
of	IN	prep
the	DT	det
'	``	punct
199	CD	nummod
patent	NN	pobj
.	.	punct

In	IN	prep
other	JJ	amod
word	NNS	pobj
,	,	punct
if	IN	mark
Novo	NNP	nsubj
raise	VBZ	advcl
a	DT	det
'	``	punct
substantial	JJ	amod
question	NN	dobj
'	''	punct
concern	VBG	prep
validity	NN	pobj
,	,	punct
enforceability	NN	conj
,	,	punct
or	CC	cc
infringement	NN	conj
(	-LRB-	punct
i.e.	FW	advmod
,	,	punct
assert	VBZ	ROOT
a	DT	det
defense	NN	dobj
that	IN	dobj
Genentech	NNP	nsubj
can	MD	aux
not	RB	neg
show	VB	relcl
'	``	punct
lack	VBZ	ccomp
substantial	JJ	amod
merit	NN	dobj
'	''	punct
)	-RRB-	punct

the	DT	det
preliminary	JJ	amod
injunction	NN	nsubj
should	MD	aux
not	RB	neg
issue	VB	ROOT
.	.	punct

more	RBR	advmod
specifically	RB	advmod
,	,	punct
with	IN	prep
regard	NN	pobj
to	IN	prep
Novo	NNP	poss
's	POS	case
validity	NN	compound
defense	NNS	pobj
,	,	punct
the	DT	det
question	NN	nsubj
on	IN	prep
appeal	NN	pobj
be	VBZ	ROOT
whether	IN	mark
the	DT	det
[	-LRB-	punct
defense	NNS	nsubj
have	VBP	ccomp
]	-RRB-	punct
substantial	JJ	amod
merit	NN	dobj
....	.	punct

 	_SP	

108	CD	nummod
f.3d	CD	ROOT
1361	CD	npadvmod
,	,	punct
1364	CD	npadvmod
(	-LRB-	punct
Fed	NNP	nmod
.	.	punct
cir.1997	ADD	appos
)	-RRB-	punct
;	:	punct
see	VB	appos
also	RB	advmod
Tate	NNP	compound
Access	NNP	compound
Floors	NNP	pobj
,	,	punct
Inc.	NNP	appos
v.	CC	prep
Interface	NNP	compound
Architectural	NNP	compound
Res	NNP	subtok
.	NNP	pobj
,	,	punct
Inc.	NNP	npadvmod
,	,	punct
279	CD	nummod
f.3d	CD	appos
1357	CD	appos
,	,	punct
1365	CD	npadvmod
(	-LRB-	punct
Fed	NNP	nmod
.	.	punct
Cir.2002	LS	appos
)	-RRB-	punct
,	,	punct
Purdue	NNP	compound
Pharma	NNP	compound
L.P.	NNP	appos
v.	CC	prep
Boehringer	NNP	compound
Ingelheim	NNP	compound
GMBH	NNP	pobj
,	,	punct
237	CD	nummod
f.3d	CD	appos
1359	CD	nummod
,	,	punct
1363	CD	npadvmod
(	-LRB-	punct
Fed	NNP	appos
.	.	punct
Cir.2001	LS	appos
)	-RRB-	punct
,	,	punct
Helifix	NNP	compound
Ltd.	NNP	appos
v.	CC	prep
Blok	NNP	compound
-	HYPH	punct
Lok	NNP	nmod
,	,	punct
Ltd.	NNP	pobj
,	,	punct
208	CD	nummod
f.3d	CD	appos
1339	CD	nummod
,	,	punct
1351	CD	npadvmod
(	-LRB-	punct
Fed	NNP	nmod
.	.	punct
Cir.2000	LS	parataxis
)	-RRB-	punct
.	.	punct

 	_SP	

Claim	NNP	nsubj
2	CD	nummod
of	IN	prep
the	DT	det
'	``	punct
718	CD	nummod
patent	NN	pobj
depend	VBZ	ROOT
from	IN	prep
independent	JJ	amod
claim	NN	pobj
1	CD	nummod
.	.	punct

the	DT	det
language	NN	nsubj
recite	VBN	acl
for	IN	prep
claim	NN	pobj
2	CD	nummod
include	VBZ	ROOT
the	DT	det
combined	JJ	amod
limitation	NNS	dobj
of	IN	prep
claim	NN	pobj
1	CD	dobj
and	CC	cc
claim	VB	conj
2	CD	dobj
.	.	punct

 	_SP	

there	EX	expl
be	VBZ	ROOT
little	JJ	attr
in	IN	prep
the	DT	det
patent	NN	pobj
-PRON-	PRP	appos
that	WDT	nsubj
establish	VBZ	relcl
the	DT	det
difference	NNS	dobj
(	-LRB-	punct
if	IN	mark
any	DT	appos
)	-RRB-	punct
between	IN	prep
parameter	NNS	pobj
that	WDT	nsubj
be	VBP	relcl
simply	RB	advmod
"	``	punct
low	JJR	acomp
"	''	punct
rather	RB	advmod
than	IN	prep
"	``	punct
statistically	RB	advmod
significantly	RB	advmod
low	JJR	conj
"	''	punct
and	CC	cc
the	DT	det
specification	NN	nsubj
do	VBZ	aux
not	RB	neg
explicitly	RB	advmod
define	VB	conj
when	WRB	advmod
two	CD	nummod
parameter	NNS	nsubj
be	VBP	advcl
"	``	punct
substantially	RB	advmod
equivalent	JJ	acomp
"	''	punct
.	.	punct

For	IN	prep
purpose	NNS	pobj
of	IN	prep
this	DT	det
preliminary	JJ	amod
injunction	NN	pobj
,	,	punct
-PRON-	PRP	nsubj
do	VBP	aux
not	RB	neg
reach	VB	ROOT
these	DT	det
more	RBR	advmod
nuanced	JJ	amod
issue	NNS	dobj
in	IN	prep
claim	NN	compound
construction	NN	pobj
.	.	punct

 	_SP	

As	IN	mark
mention	VBN	advcl
above	RB	advmod
,	,	punct
though	IN	mark
the	DT	det
inequality	NN	nsubj
follow	VBZ	advcl
strictly	RB	advmod
from	IN	prep
satisfy	VBG	pcomp
the	DT	det
condition	NNS	dobj
of	IN	prep
claim	NN	pobj
4	CD	nummod
,	,	punct
this	DT	nsubj
do	VBZ	aux
not	RB	neg
necessarily	RB	advmod
lead	VB	ROOT
to	IN	prep
the	DT	det
conclusion	NN	pobj
that	IN	mark
the	DT	det
fluctuation	NN	compound
index	NN	nsubj
of	IN	prep
the	DT	det
extended	JJ	amod
release	NN	compound
formulation	NN	pobj
be	VBZ	acl
"	``	punct
statistically	RB	advmod
significantly	RB	advmod
low	JJR	acomp
"	''	punct
than	IN	prep
the	DT	det
immediate	JJ	amod
release	NN	pobj
.	.	punct

but	CC	cc
nonetheless	RB	advmod
,	,	punct
the	DT	det
result	NN	nsubj
derive	VBN	acl
here	RB	advmod
be	VBZ	ROOT
enough	JJ	acomp
to	TO	aux
show	VB	xcomp
that	IN	mark
Teva	NNP	nsubj
have	VBZ	aux
produce	VBN	ccomp
substantial	JJ	amod
argument	NN	dobj
as	IN	prep
to	IN	prep
the	DT	det
invalidity	NN	pobj
of	IN	prep
claim	NN	pobj
2	CD	nummod
.	.	punct

This	DT	nsubj
be	VBZ	ROOT
true	JJ	acomp
despite	IN	prep
the	DT	det
example	NN	pobj
give	VBN	acl
in	IN	prep
the	DT	det
'	``	punct
718	CD	nummod
patent	NN	pobj
analyze	VBG	acl
Formula	NNP	compound
A	NNP	dobj
from	IN	prep
the	DT	det
'	``	punct
190	CD	nummod
patent	NN	pobj
for	IN	prep
-PRON-	PRP$	poss
pharmacokinetic	JJ	amod
parameter	NNS	pobj
,	,	punct
'	''	punct
718	CD	nummod
patent	NN	conj
,	,	punct
col.	NN	conj
10	CD	nummod
,	,	punct
will	UH	intj
.	.	punct

62	CD	ROOT
-	SYM	punct
67	CD	prep
,	,	punct
most	RBS	advmod
notably	RB	advmod
,	,	punct
because	IN	mark
Formula	NNP	compound
C	NNP	nsubj
not	RB	neg
Formula	NNP	compound
a	NN	appos
from	IN	prep
the	DT	det
'	``	punct
190	CD	nummod
patent	NN	pobj
appear	VBZ	advcl
to	TO	aux
satisfy	VB	xcomp
the	DT	det
pharmacokinetic	JJ	amod
limitation	NNS	dobj
of	IN	prep
claim	NNS	pobj
2	CD	appos
and	CC	cc
4	CD	conj
of	IN	prep
the	DT	det
'	``	punct
718	CD	nummod
patent	NN	pobj
.	.	punct

 	_SP	

the	DT	det
district	NN	compound
court	NN	nsubj
conclude	VBD	ROOT
that	IN	mark
Teva	NNP	nsubj
have	VBD	aux
make	VBN	ccomp
a	DT	det
substantial	JJ	amod
argument	NN	dobj
as	IN	prep
to	IN	prep
the	DT	det
invalidity	NN	pobj
of	IN	prep
claim	NN	pobj
2	CD	nummod
of	IN	prep
the	DT	det
'	``	punct
616	CD	nummod
patent	NN	pobj
.	.	punct

In	IN	prep
this	DT	det
appeal	NN	pobj
,	,	punct
Abbott	NNP	nsubj
argue	VBZ	ROOT
that	IN	nsubj
claim	NN	ccomp
2	CD	nsubj
of	IN	prep
the	DT	det
'	``	punct
616	CD	pobj
could	MD	aux
form	VB	ccomp
an	DT	det
alternative	JJ	amod
basis	NN	dobj
for	IN	prep
uphold	VBG	pcomp
the	DT	det
preliminary	JJ	amod
injunction	NN	dobj
and	CC	cc
therefore	RB	advmod
-PRON-	PRP	nsubj
also	RB	advmod
review	VBP	conj
the	DT	det
party	NNS	poss
'	POS	case
argument	NNS	dobj
as	IN	prep
to	IN	prep
the	DT	det
validity	NN	pobj
of	IN	prep
claim	NN	pobj
2	CD	nummod
.	.	punct

 	_SP	

As	IN	mark
oppose	VBN	advcl
to	TO	aux
claim	VB	xcomp
2	CD	dobj
and	CC	cc
4	CD	conj
of	IN	prep
the	DT	det
'	``	punct
718	CD	nummod
patent	NN	pobj
,	,	punct
claim	VBP	ROOT
6	CD	dobj
of	IN	prep
the	DT	det
'	``	punct
718	CD	pobj
and	CC	cc
claim	NN	conj
2	CD	dobj
of	IN	prep
the	DT	det
'	``	punct
616	CD	pobj
do	VBP	aux
not	RB	neg
limit	VB	ccomp
-PRON-	PRP$	poss
claim	VBN	amod
extended	JJ	amod
release	NN	compound
formulation	NNS	dobj
with	IN	prep
any	DT	det
specific	JJ	amod
pharmacokinetic	JJ	amod
parameter	NNS	pobj
.	.	punct

 	_SP	

This	DT	nsubj
do	VBZ	aux
not	RB	neg
mean	VB	ccomp
to	TO	aux
suggest	VB	xcomp
that	IN	mark
lower	VBG	csubj
drug	NN	compound
concentration	NN	dobj
will	MD	aux
lead	VB	ccomp
inexorably	RB	advmod
to	IN	prep
improve	VBN	amod
side	JJ	compound
effect	NNS	pobj
;	:	punct
rather	RB	advmod
,	,	punct
-PRON-	PRP	nsubj
only	RB	advmod
suggest	VBZ	ROOT
that	IN	mark
such	PDT	predet
an	DT	det
improvement	NN	nsubj
would	MD	aux
not	RB	neg
be	VB	ccomp
unexpected	JJ	acomp
.	.	punct

 	_SP	

other	JJ	amod
argument	NNS	nsubj
as	IN	prep
to	IN	prep
obviousness	JJ	pobj
may	MD	aux
also	RB	advmod
have	VB	ROOT
merit	NN	dobj
such	JJ	amod
as	IN	prep
argument	NNS	pobj
relate	VBG	acl
to	IN	prep
inherency	NN	pobj
.	.	punct

see	VB	ROOT
,	,	punct

e.g.	RB	advmod
,	,	punct
In	IN	ROOT
re	IN	pcomp
Wiseman	NNP	pobj
,	,	punct
596	CD	nummod
f.2d	CD	appos
1019	CD	nummod
(	-LRB-	punct
CCPA	NNP	appos
1979	CD	nummod
)	-RRB-	punct
.	.	punct

but	CC	cc
as	IN	mark
the	DT	det
argument	NNS	nsubj
relate	VBG	acl
to	IN	prep
unexpected	JJ	amod
result	NNS	pobj
demonstrate	VBP	advcl
the	DT	det
vulnerability	NN	dobj
of	IN	prep
the	DT	det
claim	NNS	pobj
to	IN	prep
invalidity	NN	pobj
,	,	punct
-PRON-	PRP	nsubj
do	VBP	aux
not	RB	neg
reach	VB	ROOT
these	DT	det
other	JJ	amod
,	,	punct
related	JJ	amod
obviousness	JJ	amod
argument	NNS	dobj
.	.	punct

 	_SP	

Abbott	NNP	nsubj
explain	VBZ	ROOT
that	IN	mark
"	``	punct
non	JJ	subtok
-	JJ	subtok
linear	JJ	acomp
"	''	punct
here	RB	advmod
mean	VBZ	ccomp
that	IN	mark
the	DT	det
amount	NN	nsubj
of	IN	prep
drug	NN	pobj
in	IN	prep
the	DT	det
blood	NN	pobj
be	VBZ	ccomp
not	RB	neg
directly	RB	advmod
proportional	JJ	acomp
to	IN	prep
the	DT	det
dosage	NN	compound
amount	NN	pobj
,	,	punct
but	CC	cc
increase	VBZ	conj
disproportionately	RB	advmod
with	IN	prep
high	JJR	amod
dos	NNS	pobj
.	.	punct

This	DT	nsubj
be	VBZ	ROOT
not	RB	neg
a	DT	det
characteristic	NN	attr
of	IN	prep
azithromycin	NN	pobj
,	,	punct
the	DT	det
product	NN	appos
whose	WP$	poss
formulation	NN	nsubjpass
be	VBZ	auxpass
rely	VBN	relcl
on	RP	prt
by	IN	agent
the	DT	det
panel	NN	compound
majority	NN	pobj
,	,	punct
as	IN	prep
discuss	VBN	amod
infra	NN	pobj
.	.	punct

 	_SP	

